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COMMON MENTAL DISORDERS AND WORK 
Common mental disorders (CMDs), consisting of mild to moderate severe mental 
disorders such as depression, anxiety and adjustment disorders, are highly prevalent in 
working populations1-4. In many Western countries, CMDs are a frequent cause of work 
disability claims5,6. The WHO expects depression to be the leading cause of 
absenteeism in industrialized countries in 20207. Furthermore, CMDs are more often 
related to long term sickness absence as compared to other health problems8-11. 
 The negative consequences of sickness absence for the individual and society have 
been well established. For the individual, not being able to work because of a health 
problem is disturbing, not only because of loss of income but also because work 
constitutes an important part of social life. Work can give meaning to a person's life by 
contributing to society and developing social relationships with colleagues12,13. On a 
societal level, sickness absence and work disability are extremely costly due to lost 
productivity. For example, costs for sickness absence and work disability are estimated 
at €20 billion annually in the Netherlands14,15. The importance of preventing work 
disability and enabling workers with health problems to perform their job has been 
stressed repeatedly by international organisations, such as the World Health 
Organisation (WHO) and the Organisation for Economic Cooperation and Development 
(OECD)5,16.  
 Considering the major impact of CMDs on sickness absence and associated 
personal and societal consequences, the management of sickness absence due to 
CMDs is high on the research agenda in the field of Occupational Safety and Health. 
The past two decades, the primary focus has been on enhancing return to work (RTW) 
of workers on sickness absence due to CMDs as long term sickness absence is related 
to an increased risk of permanent work disability8-10.  
 Recently, the focus has shifted to how workers with CMDs function at work. Two 
main findings have contributed to this shift. Firstly, research has shown that workers 
with CMDs experience on-the-job productivity loss, meaning that workers with CMDs 
experience problems with functioning while at work. In the US, costs related to lost 
productivity at work are even more substantial than the costs related to sickness 
absence17,18.  Secondly, recent studies have shown that 20% to 30% of the workers 
who have returned to work after sickness absence due to CMDs experience recurrent 
sickness absence19,20. The risk of sickness absence due to a CMD is higher in workers 
with previous sickness absence due to a CMD compared to the general working 
population. Furthermore, recurrent sickness absence after an initial sickness absence 
episode due to a CMD can be more serious and long-lasting19,21. These results stress 
the importance of providing interventions for workers who have been on sickness 
absence due to CMDs to prevent problems in work functioning and recurrent sickness 
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absence, and, thus, to enable sustainable RTW. Given the lack of interventions with 
this focus, the present thesis aims at evaluating an intervention to prevent recurrent 
sickness absence in workers who returned to work after sickness absence due to 
CMDs.  
 
THE DUTCH SOCIAL SECURITY SYSTEM 
As a country's social security system influences sickness absence, it is important to 
understand the context in which interventions focusing on sickness absence are 
developed and evaluated. In the Netherlands, at least 70% of the wage is covered by 
the employer during the first two years of sickness absence. No distinction is made 
between work-related or non-work related sickness absence, and the sick-listed worker 
cannot be fired. During these two years of sickness absence, both the employer and 
the worker are responsible for enabling RTW. The employer is obligated to hire an OP 
and has to pay for therapy or work accommodations if needed. The role of the OP is to 
give advice to the employer and worker during the RTW process. Thus, the OP plays a 
central role in the Dutch social security system. OP treatment guidelines are provided 
by the Netherlands Society of Occupational Medicine such as the guideline for 
managing mental health problems of workers22. Workers are obligated to visit the OP 
and have to collaborate with the OP and employer (often represented by the worker's 
supervisor) in developing and implementing an action plan to enable RTW. If RTW has 
not been realised within two years, a Social Security Officer (trained as an insurance 
physician) will evaluate if sufficient RTW efforts have been made by the employer and 
the worker and decides on the percentage of work disability for which the worker will be 
compensated by the Social Security Agency. 
 
EXISTING LITERATURE ON INTERVENTIONS FOR WORKERS WITH COMMON 
MENTAL DISORDERS 
So far, interventions for workers with CMDs have mainly focused on facilitating RTW for 
workers who are on sickness absence due to CMDs. Most of these interventions have 
taken a bio-psycho-social perspective, acknowledging the importance of focusing on 
other factors than biological factors like symptoms of CMDs23-27. Research has shown 
that returning to work does not automatically follow symptom recovery28,29. Thus, 
waiting for full symptom recovery before starting RTW, does not seem to be beneficial 
for successful RTW. Therefore, interventions to facilitate RTW among workers on 
sickness absence due to CMDs have integrated gradual RTW while symptom recovery 
is still taking place. These interventions focus on psychological factors (such as 
emotions and cognitions) and social factors (such as relationships with family, friends 
and especially supervisors and colleagues) which play an important role in enabling a 
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person to RTW.  Several randomised controlled trials (RCTs) have been conducted to 
evaluate interventions to facilitate RTW in workers on sickness absence due to CMDs. 
Many of these RCTs were performed in the Netherlands, and, overall, it seems that the 
most successful interventions were conducted in proximity of the workplace. An 
example is the activating intervention developed by van der Klink et al. (2003) to 
facilitate RTW for workers on sickness absence due to adjustment disorders which has 
been influential in the Netherlands23. The intervention was conducted by OPs and 
focused on activating participants to regain control over their personal and working life 
and to follow a gradual RTW plan. The intervention was evaluated in a cluster-RCT and 
proved to be effective in reducing time to RTW. Presently, the intervention has been 
integrated in the guideline on “Management of mental health problems of workers by 
occupational physicians” of the Netherlands Society of Occupational Medicine22. 
Comparably, Blonk et al. (2006) found that a brief work-directed intervention consisting 
of stress management and advice on gradual RTW provided by trained labour experts 
was more effective in reducing time to RTW than a cognitive behavioural intervention 
provided by trained psychologists and a no-treatment control group24. Interventions 
that have been provided by health care providers who are less connected to the 
workplace did not find similar results. For example, Brouwers et al. (2006) used the 
same intervention protocol as developed by van der Klink et al. (2003) in a similar 
population (i.e. workers with minor mental disorders) but used social workers to 
conduct the intervention30. The study results did not show enhanced RTW for the 
intervention group compared to the control group. Also, Bakker et al. (2007) did not 
find that monitoring the problem solving process of a sick-listed worker with stress-
related mental disorders by a general practitioner was effective in enhancing RTW 
compared to usual care31.  
 Aside from research evaluating interventions to facilitate RTW of sick-listed workers 
with CMDs, there is a need to look beyond RTW. Regardless of any intervention, about 
70% of the workers who are on sickness absence due to CMDs return to work within 
one year, but 20% to 30% of these workers experience recurrent sickness absence 
after RTW9,19. Therefore, research is needed that focuses on how to achieve 
sustainable RTW. The importance of providing guidance after RTW has also been 
stressed by workers themselves. In an interview study with workers who (partially) 
returned to work after sickness absence due to CMDs, Noordik et al. (2011) showed 
that difficulties were experienced with unsupportive communication within the working 
environment and with implementing solutions for work-related barriers32. To address 
the knowledge gap on sustainable RTW, the central theme of this thesis is the 
evaluation of an intervention to enhance sustainable RTW by preventing recurrent 
sickness absence in workers who returned to work after sickness absence due to 
CMDs.  
General introduction | Chapter 1 
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CONCEPTUAL MODEL OF THE PREVENTION OF RECURRENT SICKNESS ABSENCE 
The conceptual model of the prevention of recurrent sickness absence builds upon the 
RTW process model for workers with CMDs developed by van der Klink et al. 
(2007)23,33 and incorporated in the guideline on “Management of mental health 
problems of workers by occupational physicians” of the Netherlands Society of 
Occupational Medicine22. The conceptual model of the prevention of recurrent sickness 
absence is presented in Figure 1. The upper part of the figure shows the RTW process 
model, while the lower part is the extension of van der Klink's model, based on recent 
literature32,34,35, incorporating an intervention to prevent recurrent sickness absence.  
 In the RTW process model, sickness absence due to CMDs is proposed to follow 
from not being able to cope successfully with daily (work) stressors which results in a 
feeling of loss of control and distress. When not addressed in time and when control 
cannot be regained in the work situation, the worker will often try to avoid the feeling of 
loss of control and distress by dismissal of the work role. According to the RTW process 
model, treatment by OPs should focus on helping the worker to regain control which is 
in line with patient empowerment theories that state that treatment should be aimed at 
helping patients to get a sense of control, self-determination and goal attainment36.  
The treatment to enable RTW consists of three phases and is based on stress 
inoculation training37. The first phase is focused on providing a rationale for why 
sickness absence occurred, educating about future prospects and structuring daily life. 
In the second phase, problems are addressed that caused sickness absence, and the 
worker is stimulated to generate solutions to enable RTW. In the final phase, gradual 
RTW is started and the solutions to problems are implemented.  
 As RTW is accompanied by new stressors such as setting boundaries, implementing 
solutions and communication with supervisors and colleagues32, the RTW process 
model has been extended in this thesis with a structured intervention to prevent 
recurrent sickness absence in the post-RTW phase. After gradual RTW has started, the 
intervention should prevent a new failure to cope with stressors following RTW. The 
worker is again activated to go through the process of addressing problems and finding 
solutions but now specifically focused on problems that have occurred during RTW 
(step 1-3). Next to addressing problems, the worker can also focus on positive aspects 
such as opportunities within the work context that can further improve functioning at 
work. Discussions with the supervisor are stimulated to develop practical and 
applicable solutions that can be implemented in the work situation (step 4), as 
research has shown that the role of the supervisor is of paramount importance in the 
RTW process32,35. The final step in the extended model (step 5), is the evaluation of the 
problem solving process to enable workers to adopt this process as a common 
practice. It is hypothesized that the five-step process will prevent recurrent sickness 
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In this thesis, an intervention to prevent recurrent sickness absence in workers who 
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process. The SHARP-at work intervention is provided by OPs to align with the Dutch OP 
guideline on the management of mental health problems of workers, and because OPs 
are closely connected to the work environment. OPs guide workers through the five-
step problem solving process to find and implement solutions for problems/ 
opportunities experienced when back at work. OPs monitor that all steps are taken and 
activate and support the worker when needed. Furthermore, OPs empower the worker 
to define the problems and design solutions. Two to five consultations are 
recommended to the OPs, and assignments are available for each step of the 
intervention. The first assignment is the key element of the intervention. In this 
assignment, workers have to make an inventory of problems and opportunities at work 
and, subsequently, to define if help is needed to solve the problems or realise the 
opportunities. 
 
THESIS OBJECTIVE AND RESEARCH QUESTIONS 
The objective of this thesis is to generate knowledge on the prevention of recurrent 
sickness absence in workers who returned to work after sickness absence due to 
CMDs. The main focus is on the evaluation of the effectiveness of the SHARP-at work 
intervention in preventing recurrent sickness absence in workers who returned to work 
after sickness absence due to CMD. Alongside this effect evaluation, a process 
evaluation and an economic evaluation are presented. The process evaluation is 
helpful in explaining the results of the effect evaluation and whether these results are 
attributable to the SHARP-at work intervention. As part of the process evaluation, an in-
depth exploration of challenges with recruiting research participants by OPs is 
described. The economic evaluation provides information on the cost-effectiveness and 
cost-benefit of the intervention. Next to the evaluation of the SHARP-at work 
intervention, a systematic literature review is presented on interventions to facilitate 
return to work in adults with adjustment disorders. A specific focus on adjustment 
disorders as a subgroup of CMDs is chosen as this group has often been investigated 
in relation to RTW. Also, predictors for recurrent sickness absence among workers with 
CMDs are investigated. The following research questions form the basis of this thesis: 
 
Research question 1: Which interventions are effective in facilitating return to work in 
workers with adjustment disorders?  
Research question 2: Is the SHARP-at work intervention effective in preventing 
recurrent sickness absence and improving mental health, work functioning and 
problem solving coping in workers who returned to work after sickness absence due 
to CMDs compared to care as usual?  
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Research question 3: Is the SHARP-at work intervention conducted according to the 
protocol, does it differ from care as usual, and how are the key elements of the 
intervention related to the effect outcome (i.e. recurrent sickness absence)?  
Research question 4: What are barriers and facilitators for participant recruitment by 
occupational physicians?  
Research question 5: Is the SHARP-at work intervention cost-effective and cost-
beneficial compared to care as usual?  
Research question 6: Which factors predict recurrent sickness absence in workers who 
returned to work after sickness absence due to CMDs?  
 
THESIS OUTLINE 
This first chapter provides an overall introduction to the topic of the thesis to address 
the importance of the topic, explain the context and describe relevant constructs. In 
Chapter 2, the results of a systematic literature review are presented on the 
effectiveness of interventions to enhance return to work in workers with adjustment 
disorders. Chapter 3 describes the study design of the cluster-RCT with an effect 
evaluation, process evaluation and economic evaluation of the SHARP-at work 
intervention compared to care as usual. Chapter 4 presents the effect of the SHARP-at 
work intervention on preventing recurrent sickness absence in workers who returned to 
work after sickness absence due to CMDs. Moreover, the effects on mental health 
complaints, work functioning and coping behaviour are evaluated. In Chapter 5, the 
process evaluation of the SHARP-at work intervention is described. The chapter focuses 
on: 1) evaluating whether the SHARP-at work intervention was conducted according to 
the protocol and differed from care as usual, and 2) investigating the relationship 
between the key elements of the intervention and the primary outcome of the effect 
evaluation (i.e. recurrent sickness absence). Chapter 6 focuses on problems with 
participant recruitment by OPs. Barriers and facilitators for recruitment as experienced 
by OPs are reported, and the relationship between OP's personal and work 
characteristics and the recruitment of participants is evaluated. Chapter 7 addresses 
the economic evaluation of the SHARP-at work intervention and presents the cost-
effectiveness and cost-benefit evaluations. In Chapter 8, predictors for recurrent 
sickness absence in workers who returned to work after sickness absence due to 
CMDs are investigated. In Chapter 9, a general discussion is provided. The main 
research results are summarized and discussed, methodological considerations are 
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Interventions to facilitate return to work in adults 



















Background: Adjustment disorders are a frequent cause of sick leave and various 
interventions have been developed to expedite the return to work (RTW) of individuals 
on sick leave due to adjustment disorders. 
Objectives: To assess the effects of interventions facilitating RTW for workers with 
acute or chronic adjustment disorders. 
Search methods: We searched the Cochrane Depression, Anxiety and Neurosis Review 
Group's Specialised Register (CCDANCTR) to October 2011; the Cochrane Central 
Register of Controlled Trials (CENTRAL) to Issue 4, 2011; MEDLINE, EMBASE, PsycINFO 
and ISI Web of Science, all years to February 2011; the WHO trials portal (ICTRP) and 
ClinicalTrials.gov in March 2011. We also screened reference lists of included studies 
and relevant reviews. 
Selection criteria: We selected randomised controlled trials (RCTs) evaluating the 
effectiveness of interventions to facilitate RTW of workers with adjustment disorders 
compared to no or other treatment. Eligible interventions were pharmacological 
interventions, psychological interventions (such as cognitive behavioural therapy (CBT) 
and problem solving therapy), relaxation techniques, exercise programmes, employee 
assistance programmes or combinations of these interventions. The primary outcomes 
were time to partial and time to full RTW, and secondary outcomes were severity of 
symptoms of adjustment disorder, work functioning, generic functional status (i.e. the 
overall functional capabilities of an individual, such as physical functioning, social 
function and general mental health) and quality of life. 
Data collection and analysis: Two authors independently selected studies, assessed 
risk of bias and extracted data. We pooled studies that we deemed sufficiently clinically 
homogeneous in different comparison groups and assessed the overall quality of the 
evidence using the GRADE approach. 
Results: We included nine studies reporting on 10 psychological interventions and one 
combined intervention. The studies included 1546 participants. No RCTs were found of 
pharmacological interventions, exercise programmes or employee assistance 
programmes. We assessed seven studies as having low risk of bias and the studies 
that were pooled together were comparable. For those who received no treatment, 
compared with CBT, the assumed time to partial and full RTW was 88 and 252 days 
respectively. Based on two studies with a total of 159 participants, moderate-quality 
evidence showed that CBT had similar results for time (measured in days) until partial 
RTW compared to no treatment at one-year follow-up (mean difference (MD) -8.78, 
95% confidence interval (CI) -23.26 to 5.71). We found low-quality evidence of similar 
results for CBT and no treatment on the reduction of days until full RTW at one-year 
follow-up (MD -35.73, 95% CI -113.15 to 41.69) (one study with 105 participants 
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included in the analysis). Based on moderate-quality evidence, problem solving therapy 
(PST) significantly reduced time until partial RTW at one-year follow-up compared to 
non-guideline based care (MD -17.00, 95% CI -26.48 to -7.52) (one study with 192 
participants clustered among 33 treatment providers included in the analysis), but we 
found moderate-quality evidence of no significant effect on reducing days until full RTW 
at one-year follow-up (MD -17.73, 95% CI -37.35 to 1.90) (two studies with 342 
participants included in the analysis). 
Authors' conclusions: We found moderate-quality evidence that CBT did not 
significantly reduce time until partial RTW and low-quality evidence that it did not 
significantly reduce time to full RTW compared with no treatment. Moderate-quality 
evidence showed that PST significantly enhanced partial RTW at one-year follow-up 
compared to non-guideline based care but did not significantly enhance time to full 
RTW at one-year follow-up. An important limitation was the small number of studies 
included in the meta-analyses and the small number of participants, which lowered the 
power of the analyses. 
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PLAIN LANGUAGE SUMMARY 
Improving return to work in adults suffering from symptoms of distress 
Adjustment disorders, characterised by distress symptoms and emotional disturbance 
as a reaction to a significant life change or stressful life event, are a frequent cause of 
sick leave among workers. Apart from the negative consequences for the worker, sick 
leave poses a heavy burden on society due to the loss of productivity of the worker and 
work disability claims. Different treatments have been developed to help such workers 
return to work. Our study assessed how effective these treatments are at enabling the 
sick-listed worker to return to partial or full-time work. We searched databases 
containing articles from different scientific journals and looked for studies that tested 
whether a certain type of treatment helped the worker to return to work when on sick 
leave because of an adjustment disorder. We found nine relevant studies. In total, 10 
psychological treatments were evaluated and one combined treatment consisting of a 
psychological treatment and relaxation techniques. We found no studies on 
pharmacological interventions, exercise programmes or employee assistance 
programmes. The nine studies included in this review reported in total on 1546 
participants. Of the 10 psychological treatments, five consisted of cognitive behavioural 
therapy and five of problem solving therapy, which are commonly used types of 
treatment for patients with mental health problems. Our results showed that workers 
on sick leave because of an adjustment disorder can be helped with making their first 
step back to work (i.e. partial return to work) by treating them with problem solving 
therapy. On average, workers who are offered problem solving therapy start 17 days 
earlier with partial return to work compared to workers who receive no treatment or the 
usual treatment from their occupational physician or general practitioner. However, we 
also found that cognitive behavioural therapy or problem solving therapy does not help 
the worker return to work with full-time hours any quicker than workers who receive no 
treatment or the usual treatment from their occupational physicians or general 
practitioners. These results are based on moderate-quality evidence, which implies that 
further research is likely to have an important impact on our confidence in the results 
and may change the results. 
  




Description of the condition 
In recent years, increasing attention has been paid to mental health problems and their 
consequences in terms of sick leave and work disability1-4. In many Western countries, 
mental health problems are the main cause of sick leave5-7. Sick leave has major 
consequences for the subjective well-being of an individual. Workers who are on sick 
leave can become isolated from family members and friends who are still working. 
Furthermore, they can become marginalised from their colleagues and the 
workplace8,9. Receiving compensation benefits is a possible source of stigma due to 
perceived laziness, leading to feelings of anger, shame and guilt in workers who are on 
sick leave8,9. Apart from the negative consequences for the individual worker, sick 
leave results in a heavy societal burden because of loss of productivity and work 
disability claims10-13. 
 Adjustment disorders are a common mental health problem among workers14. The 
Bristol Stress and Health at Work Study found that more than 50% of the respondents 
reported being extremely, very or moderately stressed at work15,16. Furthermore, 
adjustment disorders are one of the most frequent causes of sick leave due to mental 
health problems17,18. In the Netherlands, work disability as a result of mental health 
problems accounts for 30% of all disability benefits19,20. Moreover, a majority (69% to 
79%) of the employees suffer from common mental health problems such as 
adjustment disorders 21,22. 
 Adjustment disorders are defined in both the Diagnostic and Statistical Manual of 
Mental Disorders (DSM-IV)23 and the International Statistical Classification of Diseases 
and Related Health Problems (ICD-10)24. DSM-IV has defined adjustment disorders as 
the occurrence of emotional and behavioural symptoms in response to an identifiable 
stressor occurring within three months after the onset of the stressor. Furthermore, the 
DSM-IV states that: 
• The symptoms or behaviours are clinically significant as evidenced by either of 
the following: 
- marked distress that is in excess of what would be expected from exposure 
to the stressor; 
- significant impairment in social or occupational (academic) functioning. 
• The stress-related disturbance does not meet the criteria for another specific 
Axis I disorder and is not merely an exacerbation of a pre-existing Axis I or Axis 
II disorder. 
• The symptoms do not represent bereavement. 
• Once the stressor (or its consequences) has terminated, the symptoms do not 
persist for more than an additional six months. 
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Adjustment disorders can be classified as acute if the disturbance lasts less than six 
months and as chronic if the disorder lasts longer than six months. The specification 
'chronic' is only applicable when the disorder lasts longer than six months as a reaction 
to a chronic stressor or a stressor with lasting consequences. 
 The ICD, a detailed description of known diseases and injuries published by the 
World Health Organization, is revised periodically (last revision in 1992) and is currently 
in its 10th edition. The ICD-10 defines the following diagnostic criteria for adjustment 
disorders: 
 States of subjective distress and emotional disturbance, usually interfering with 
social functioning and performance, arising in the period of adaptation to a significant 
life change or a stressful life event. The stressor may have affected the integrity of an 
individual's social network (bereavement, separation experiences) or the wider system 
of social supports and values (migration, refugee status), or represented a major 
developmental transition or crisis (going to school, becoming a parent, failure to attain 
a cherished personal goal, retirement). Individual predisposition or vulnerability plays 
an important role in the risk of occurrence and the shaping of the manifestations of 
adjustment disorders, but it is nevertheless assumed that the condition would not have 
arisen without the stressor. The manifestations vary and include depressed mood, 
anxiety or worry (or mixture of these), a feeling of inability to cope, plan ahead, or 
continue in the present situation, as well as some degree of disability in the 
performance of daily routine.  
 Notwithstanding these clear definitions of adjustment disorder in the DSM-IV and 
the ICD-10, this diagnosis is not frequently used in the research literature. More often, 
mental health problems such as “sub-threshold symptoms of depression,” “stress-
related mental disorder,” “burnout,” “emotional distress” or “distress” are investigated, 
which are not included in the DSM-IV or ICD-1018,25,26. However, the definitions of the 
DSM-IV and the ICD-10 show that distress or sub-threshold symptoms (e.g. depressed 
mood or anxiety), accompanied by a stressful life event, coincide with the diagnosis of 
adjustment disorder as long as no other mental disorders can be diagnosed according 
to the DSM-IV or ICD-10. Although adjustment disorders are considered mild compared 
to major psychiatric disorders, at least 20% of Dutch patients with such a disorder do 
not return to work (RTW) within a year27. In line with this, Nielsen et al. (2011) showed 
that 19% of a cohort of workers on sick leave because of stress and burnout 
complaints had not returned to work after 40 weeks of sick leave28. 
 
Description of the intervention 
Interventions have been developed to facilitate RTW of workers on sick leave because 
of adjustment disorders. A broad range of interventions is available, such as 
pharmacotherapy, psychological interventions, relaxation therapy, exercise 
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programmes, employee assistance programmes or a combination of these. 
Interventions can be developed for the individual worker or for a group of workers. 
Commonly used interventions to address adjustment disorders and RTW are 
psychological interventions, such as cognitive behavioural therapy (CBT) or problem 
solving therapy (PST). Cognitive behavioural interventions focus on behavioural 
activation strategies (e.g. rehearsing activities before executing them, assertiveness or 
communication training), restructuring maladaptive thoughts, and identifying and 
challenging automatic thoughts29. For example, Stenlund et al. (2009) studied the 
effectiveness of cognitively oriented behavioural rehabilitation in combination with 
relaxation exercises on reducing sick leave30. Problem solving interventions are 
primarily focused on identifying problems, generating and selecting solutions, 
developing an action plan and evaluating the solution31. Other examples of 
psychological interventions are psychodynamic therapy, behavioural therapy, 
counselling and interpersonal therapy. Employee assistance programmes are offered 
by the employer and were originally developed from occupational alcohol programmes. 
Currently, employee assistance programmes are also designed to address other health 
problems that have a negative impact on workers' well-being or job performance32. 
Relaxation therapy can consist of any method to help relax a person and reduce levels 
of anxiety or stress (e.g. yoga), while exercise programmes are aimed at increasing 
physical activity. 
 
How the intervention might work 
Studies on prognostic factors for RTW of workers on sick leave because of mental 
health problems have shown that on-going mental health problems are a negative 
predictor for RTW33,34. We hypothesised that pharmacological interventions may 
improve RTW by the reduction of mental health complaints such as depressive and 
anxiety symptoms, related to the adjustment disorder, caused by the medication 35. 
When the symptoms of the adjustment disorder are reduced, a worker on sick leave 
will be able to resume social roles, such as work34. The effect of psychological 
interventions, especially CBT and PST, on RTW is hypothesised to be established 
through one (or both) of two routes. Firstly, by addressing cognitions, behaviours and 
problems related to the adjustment disorder, psychological interventions may improve 
mental health. The improved mental health could then facilitate RTW36,37. Secondly, 
psychological interventions may specifically focus on cognitions, behaviours and 
problems that are work-related and may induce more adaptive cognitions and find 
solutions for the work-related problems to enhance RTW38. Also, when a graded activity 
approach for RTW is part of a psychological intervention, RTW could be facilitated by 
gradually building up exposure to the work environment and work tasks39. Relaxation 
techniques and exercise programmes may have an effect on RTW by introducing 
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enjoyable activities (i.e. relaxation or exercise) which create an understanding of the 
importance of a balance between work and leisure40. 
 
Why it is important to do this review 
For those on sick leave from work due to adjustment disorders, various interventions 
for improving RTW have been developed; it is important to evaluate which types of 
interventions are effective and to quantify the effect size. To date, no systematic review 
has investigated the effectiveness of interventions aimed at improving RTW of workers 
on sick leave due to adjustment disorders. Therefore, this is the topic of the current 
review. Recently, three Cochrane reviews have been published in the same research 
area41-43. However, the review by Marine et al. (2006) was only performed for 
healthcare workers and focused on the reduction of symptoms of occupational stress, 
while the present review is focused on all workers on sick leave because of an 
adjustment disorder and has RTW as primary outcome measure41. The review by 
Nieuwenhuijsen et al. (2008) also focused on RTW (i.e. by looking at the reduction of 
sick leave), but within a working population suffering from depression, not adjustment 
disorders42. Finally, the review of van Oostrom et al. (2009) included all workers on sick 
leave and, therefore, also those on sick leave because of an adjustment disorder43. 
Nevertheless, the review included only workplace interventions whereas the present 
review describes a broader array of interventions. 
 
OBJECTIVES 
The objective of this review was to assess the effects of interventions facilitating RTW 
for workers with acute or chronic adjustment disorders. 
 
METHODS 
Criteria for considering studies for this review 
Types of studies 
All randomised controlled trials (RCTs), including cluster RCTs, that evaluated an 
intervention to facilitate RTW of workers on sick leave due to adjustment disorders 
were considered. 
 
Types of participants 
Participant characteristics 
Workers (18 to 65 years of age) with an adjustment disorder causing sick leave. 
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Sick leave status 
When the study population consisted of a mix of workers who were working and who 
were on sick leave, studies were included if the distribution of workers on sick leave 
was comparable between study groups. Furthermore, we would only use the number of 
workers that were on sick leave in the analyses and thus “at risk” for the outcome 
(which was RTW). This was a post-hoc decision (i.e. made after the development of the 
review protocol). 
 
Diagnosis - inclusion  
Adjustment disorders were defined as acute significant emotional or behavioural 
problems in response to an identified stressor, as described in the DSM-IV23 and ICD-
1024 criteria. Studies were included when participants had a main diagnosis of 
adjustment disorder based on the DSM-IV or ICD-10 criteria. Studies were also included 
when the authors stated that a diagnosis of adjustment disorder, burnout or 
neurasthenia was made by a qualified medical or psychological professional based on 
a classification system or by excluding other psychiatric disorders based on the DSM-IV 
or ICD-10. Moreover, studies were included when participants reported a distinct level 
of (di)stress-related symptoms or burnout-related symptoms assessed by a (di)stress or 
burnout scale of a validated self-report questionnaire such as the Four-Dimension 
Symptom Questionnaire (4DSQ)44, the Depression, Anxiety and Stress Scales (DASS)45 
or the Maslach Burnout Inventory (MBI)46,47. 
 
Diagnosis - exclusion 
Studies were excluded if it was clear that more than 30% of the participants (a) 
suffered from moderate to severe depression or anxiety disorder, (b) were diagnosed 
with other psychiatric disorders than adjustment disorder, or (c) were diagnosed with 
physical disorders. This criterion allowed us to include studies in which some 
participants (maximum 30%) were misclassified, in line with the misclassifications that 
sometimes occur in practice. 
 
Types of studies 
All interventions were included that aimed at facilitating RTW of workers on sick leave 
because of adjustment disorders, using individual or group approaches. We grouped 
interventions into the following categories: 
1. Pharmacological interventions 
Pharmacological interventions could consist of any psychotropic medication. 
2. Psychological interventions 
Psychological interventions could consist of any form of psychological therapy such as 
cognitive therapy, behaviour therapy, cognitive behavioural therapy (CBT), problem 
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solving therapy (PST), psychodynamic therapy or individual psychotherapy. However, we 
only found interventions that consisted of CBT or PST. Interventions were considered to 
be CBT when at least one of the components was cognitive restructuring47. 
Interventions were considered to be PST when at least one of the components was 
identifying problems and solutions by the patient/worker31. Treatment providers could 
be any type of healthcare professional trained in the therapy being investigated in the 
study. 
3. Relaxation techniques 
Relaxation techniques could consist of techniques to learn to relax muscles and 
breathing exercises to accomplish a state of calmness. 
4. Exercise programs 
Exercise programmes could consist of enhancing physical fitness by muscle training, 
endurance training, aerobics, etc. 
5. Employee assistance programs 
Employee assistance programmes could consist of programmes offered by the 
employer to help employees deal with problems that may have a negative impact on 
their work performance and health. 
6. A combination of two or more of these interventions 
 
We grouped interventions in different comparison groups when the type of control 
group differed. We grouped the following control groups together. 
1. No treatment or waiting list condition 
2. Care as usual 
3. A similar alternative treatment 
 
Types of outcome measures 
Primary outcomes 
The primary outcome was RTW and we considered the following measures of RTW for 
this review: 
1. Time to partial RTW. Time to partial RTW was operationalized as (a) number of 
days of sick leave until partial RTW, (b) total number of days of partial sick 
leave during follow-up, or (c) rate of partial RTW at follow-up measurements. 
2. Time to full RTW. Time to full RTW was operationalized as (a) number of days 
of sick leave until full RTW, (b) total number of days of full-time sick leave 
during follow-up, or (c) rate of full RTW at follow-up measurements. 
 
When studies reported more than one measure of RTW including time to RTW, we only 
used time to RTW for data analysis because we considered this to be the most precise 
estimate of RTW. 




1. Symptoms related to an adjustment disorder as measured by a validated and 
reliable psychometric scale such as the distress scale of the Four-Dimensional 
Symptom Questionnaire (4DSQ)44, the stress scale of the Depression, Anxiety 
and Stress Scales (DASS)45 or the Maslach Burnout Inventory (MBI)46; or by 
structured diagnostic interviews like the Composite International Diagnostic 
Interview (CIDI)48.  
2. Work functioning, which we defined as productivity (economic impact of health 
problems on work) or performance (impact of health problems on the 
execution of a job) of workers49. Examples of validated work functioning 
measures are the Work Limitations Questionnaire (WLQ)50 or the Stanford 
Presenteeism Scale (SPS)51. Only total scores on questionnaires were used in 
this review. 
3. Generic functional status (the overall functional capabilities of an individual, 
such as physical functioning, social function, general mental health) and 
quality of life as measured by validated and reliable questionnaires such as 
the Short Form 36 Health Survey (SF-36)52 and EuroQol53. Only total scores on 
questionnaires were used in this review. 
 
When studies used different questionnaires to measure the same concept, only the 
results of one questionnaire were reported. The choice for one of the questionnaires 
was based on the best reflection of the concept being measured according to the 
opinion of the review authors. We grouped follow-up times into three categories that we 
considered to be sufficiently homogeneous; from zero to three months, from four to 12 
months and from one to two years. 
 
Search methods for identification of studies 
Cochrane Depression, Anxiety and Neurosis Group (CCDAN) Specialised Register 
(CCDANCTR) 
The Cochrane Depression, Anxiety and Neurosis Group (CCDAN) maintain two clinical 
trials registers at their editorial base in Bristol, UK; a references register and a studies-
based register. The CCDANCTR-References Register contains over 29,000 reports of 
randomised controlled trials in depression, anxiety and neurosis. Approximately 65% of 
these references have been tagged to individual, coded trials. The coded trials are held 
in the CCDANCTR-Studies Register and records are linked between the two registers 
through the use of unique Study ID tags. Coding of trials is based on the EU-Psi coding 
manual. Please contact the CCDAN Trials Search Co-ordinator for further details. 
 Reports of trials for inclusion in the Group's registers are collated from routine 
(weekly), generic searches of MEDLINE (1950 -), EMBASE (1974 -) and PsycINFO 
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(1967-); quarterly searches of the Cochrane Central Register of Controlled Trials 
(CENTRAL) and review-specific searches of additional databases. Reports of trials are 
also sourced from international trials registers c/o the World Health Organization’s 
trials portal (ICTRP), drug companies, the handsearching of key journals, conference 
proceedings and other (non-Cochrane) systematic reviews and meta-analyses. Details 
of CCDAN’s generic search strategies can be found on the Group's website. 
 
Electronic searches 
The CCDANCTR (Studies and References) was searched by the Group's Trials Search 
Co-ordinator (TSC), all years to 1 October 2011, using the following terms for 
POPULATION only (employees on sick leave): 
Keywords = (“sick leave” or “medical leave” or absenteeism or (vocational and 
rehabilitation) or reemployment or “leave benefits”) 
OR Free-text = ((sick and (leave or list* or absen*)) or ((sick* or absen*) and 
(workplace or (work and related) or occupation* or job)) or "return to work") 
We ran complementary searches on the following databases (see Appendix 1 for the 
search strategies): 
• Cochrane Central Register of Controlled Trials (CENTRAL) (all years to Issue 4, 
2011; 
• MEDLINE (1950 to 21 February 2011) (search terms were based on those 
used by Gehanno et al. (2009)54 in a study to identify RTW records in 
MEDLINE); 
• EMBASE (1980 to 21 February 2011); 
• PsycINFO (all years to 21 February 2011); 
• ISI Web of Science (all years to 21 February 2011); and 
• WHO trials portal (ICTRP) and the ClinicalTrials.gov (29 March 2011). 
 
We applied no restriction on date or language. An update search was conducted in 
October 2011. At this stage we took the decision to rely on the CCDANCTR alone as no 
extra studies were found by our complementary searches. 
 
Searching other sources 
We checked the reference lists of all reports retrieved as full-text papers for other 
potentially relevant studies. We also screened systematic reviews and narrative 
literature reviews. We retrieved and assessed relevant articles for possible inclusion in 
the review. 
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Data collection and analysis 
Selection of studies 
We developed a standardised selection form to make a first selection of relevant 
studies, based on the following criteria: (1) study design is an RCT, (2) study population 
consists of a working population and (3) study population includes common mental 
disorders (adjustment disorders, depressive disorders, anxiety disorders). Two review 
authors (DB and DR, DB and IA, KN and IA, or UB and IA) screened all references on 
title, keywords and abstract independently by using the standardised form. 
Disagreements were resolved by consensus of opinion. If disagreements could not be 
resolved, a third review author (JV) was consulted. We documented a record of all 
rejected papers and the reasons for rejection. Subsequently, we retrieved the full 
papers of all remaining titles and abstracts. In addition, we retrieved all other 
potentially relevant articles identified by reference checking. Papers in all languages 
were included. The two authors who independently reviewed all articles, completed a 
form for each study and scored the eligibility of the study. The reasons for exclusion 
were documented. When the same study had more than one article written on the 
outcomes, we treated all articles as one study and presented the results only once. 
Disagreements were resolved as mentioned before.   
 
Data extraction and management 
Two authors (DB and IA and AN and IA) completed the extraction of data from the 
papers to a data extraction form to elicit the following information: 
• General: published/unpublished, title, authors, source, contact address, 
country, language of publication, year of publication, duplicate publications 
• Methods: design, country, setting, randomisation procedure, recruitment, 
inclusion period, follow-up, start/end dates, loss to follow-up 
• Participants: number of participants, diagnosis, co-morbidity, 
inclusion/exclusion criteria, age, sex, days of sick leave at baseline, ethnicity, 
marital status, educational level, social economic status 
• Interventions per treatment group: number of participants, treatment 
type/content, treatment provider, number of treatment providers, treatment 
frequency/duration, training/supervision of treatment providers 
• Outcomes: length of follow-up, return to work, clinical outcomes, work 
functioning, generic functioning, quality of life and type of analysis for every 
outcome measured 
• Results: absenteeism, clinical outcomes, work functioning, generic functioning 
and quality of life (effect measure, standard deviation, test statistic, 
confidence interval) 
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If there were any disagreements about the data extraction, consensus was achieved by 
discussion between the two review authors. If disagreements could not be resolved, a 
third author was consulted (JV). 
 
Assessment of risk of bias in included studies 
Two authors (IA and UB) assessed the risk of bias of the included studies. We assessed 
risk of bias with the use of an adapted version of The Cochrane Collaboration's tool for 
assessing risk of bias as described in the Cochrane Handbook for Systematic Reviews 
of Interventions, version 5.1.0.55. We assessed the following nine criteria. 
• Random sequence generation 
• Allocation concealment 
• Blinding of participants 
• Blinding of care providers 
• Blinding of outcome assessment 
• Co-interventions avoided or similar 
• Treatment fidelity 
• Incomplete outcome data 
• Selective outcome reporting 
 
We scored the criteria as “low risk of bias,“ “high risk of bias” or “unclear risk of bias.” 
When the two review authors disagreed about the risk of bias for one of the criteria, we 
tried to reach consensus. If disagreements could not be resolved by consensus of 
opinion, the judgement of a third review author (DB) was asked for. Where resolution 
was not possible, we contacted the study author to obtain more information and 
clarification. We pilot-tested the “Risk of bias” tool on two of the included studies in the 
review. When information to assess the risk of bias was lacking in a study article, we 
contacted the authors for additional information. If the authors did not reply, or if the 
information was no longer available, the criteria were judged as “unclear risk.” 
 
Measures of treatment effect 
Dichotomous measures 
For studies that reported on dichotomous data, such as RTW rates, we used risk ratios 
as a measure of treatment effect. 
 




For studies that reported on continuous data, such as the number of days until full 
RTW, we used the mean difference (MD) because the same measurement scale was 
used. All estimates included a 95% confidence interval (CI). 
 
Unit of analysis issues 
Cross-over trials 




If studies had multiple treatment arms (e.g. two intervention arms and one control arm) 
and each treatment intervention could be used in the same meta-analysis, we chose to 
compare each treatment intervention with the comparison intervention and divided the 
number of participants in the comparison intervention over the number of treatment 
interventions. This was done to prevent double-counting of the participants in the 
comparison intervention. In case the number of participants in the comparison 
intervention could not be equally divided (e.g. there were 71 participants in the 
comparison intervention and there were two treatment interventions to make a 
comparison with), we chose to use the higher number of participants (36, following the 
example) for the comparison with the treatment intervention with the highest number 
of participants. 
 
Cluster-randomised controlled trials 
For the two studies56,57 that employed a cluster-randomised design but did not account 
for the design effect, we made the following adjustments. In one study, the cluster-level 
results were reported for the primary outcome (days until partial and full RTW), which 
we used in the data-analysis57. For the other study, no intra-cluster correlation (ICC) 
was reported for the primary outcome (days until full RTW), but information was 
available on the intra-cluster correlation for the scores on the four scales of the 4DSQ 
(which was one of the secondary outcome measures in this study). Therefore, to 
calculate the design effect for the primary outcome, we used the mean of the intra-
cluster correlations of the four 4DSQ scales56. We assumed that differences between 
treatment providers would be comparable for the reduction of distress symptoms and 
the facilitation of return to work. Furthermore, ICCs for the level of treatment providers 
are generally low and do not have a big impact on the outcome data (i.e. the effect of 
individual differences between treatment providers on the outcome is often low). We 
used the intra-cluster correlation reported by Bakker et al. (2007) for the distress scale 
of the 4DSQ to calculate the design effect for this secondary outcome measure for both 
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the studies of Bakker et al. (2007) and van der Klink et al. (2003)56,57. For the 
calculation of the design effect, we used the method described in the Cochrane 
Handbook in chapter 16.3.455. 
 
Dealing with missing data 
We contacted the authors of all nine studies to obtain data missing from their study 
report which we needed for the risk of bias assessment and/or input for the meta-
analysis. We received a response from all authors, except for Stenlund et al. (2009)30. 
For the studies of van der Klink et al. (2003)57 and Willert et al. (2011) 67, we 
calculated the standard deviations (SDs) for the primary outcome measure based on 
the 95% CI using the calculation tool provided by RevMan 5.158. For calculating the SD, 
only one of the two sides of the 95% CI needs to be entered in the calculation tool (next 
to the group mean and the group N). Therefore, we chose to enter the left side of the 
95% CI since this results in a more conservative (i.e. larger) SD. 
 
Assessment of heterogeneity 
For judging clinical similarity between studies, we followed the algorithm provided by 
Verbeek et al. (2012)59. We deemed interventions similar if the mechanism by which 
they were believed to achieve RTW was similar, such as a cognitive behavioural or a 
problem solving mechanism. For RTW outcomes, we considered both number of days 
until RTW and number of days on sick leave during follow-up as sufficiently similar. 
Studies with study populations consisting of working age participants were deemed 
similar enough because studies generally include a broad range of participants. Thus, 
we expected characteristics such as age, gender and job type to be heterogeneous in 
all studies alike. 
 For judging statistical heterogeneity, we inspected graphical representations of the 
data. In addition, we quantified statistical heterogeneity with the I2 statistic. We judged 
statistical heterogeneity as not important when the I2 was less than 40%, moderate if it 
was between 30% and 60%, substantial if between 50% and 90%, and considerable if 
between 75% and 90%55. 
 
Assessment of reporting biases 
We intended to assess publication bias with funnel plots, if 10 or more studies had 
been available for each of the seven data analyses. If there had been an indication of 
publication bias we would have used Egger's test to assess this60. 
 
Data synthesis 
We pooled studies into different comparisons with RevMan 5.1 software when they 
were judged to be clinical homogeneous and had sufficient and adequate data. The 
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data allowed us to make comparisons according to the interventions mentioned under 
the heading “Types of interventions.” We expected that possible observed differences 
between study results might not be solely due to chance, because of differences in bias 
or treatment provider. Therefore, we used random-effects models. If small studies were 
included in a comparison group, we compared the random-effects model with the fixed-
effect meta-analysis to see whether the small studies increased the estimate of the 
beneficial effect of the intervention in the random-effects model. If small studies 
significantly increased the estimate of the effect of the intervention (i.e. from a non-
significant effect in a fixed-effect meta-analysis to a significant effect in a random-
effects analysis), we chose to present the results of the fixed-effect meta-analysis. 
 For studies with continuous outcomes, we used the mean number of days until 
RTW/on sick leave and the SD of each study group to calculate the mean difference 
(MD). For studies with a dichotomous outcome measure (rate of RTW), we used risk 
ratios (RR) and combined them in the meta-analysis. 
We combined continuous measures, such as number of days until RTW, using the 
mean difference as implemented in the RevMan 5.1 software. For dichotomous 
outcomes such as rate of RTW we used the Mantel-Haenzel method to combine the 
risk ratios. 
 We assessed the overall quality of the evidence for each outcome using the GRADE 
approach as recommended by the Cochrane Handbook55. The quality of the evidence 
on a specific outcome was based on the following five domains: limitations of the study 
design, inconsistency of results, indirectness of results, imprecision of results and 
publication bias across all studies that measured that particular outcome. At the start 
of the GRADE assessment process we assumed high quality for all studies and we 
downgraded the quality of the evidence for each comparison by one to three levels 
depending on the seriousness of the violations of each domain. For limitations in study 
design, we considered a majority of studies with high risk of bias as a serious limitation 
leading to downgrading of the quality. For consistency, we considered an I2 value of 
30% to 60% as moderate inconsistency, 50% to 90% as substantial inconsistency and 
of 75% to 90% as considerable inconsistency, which would lead to downgrading quality. 
For imprecision of results, we judged serious imprecision leading to downgrading at a 
number of less than 400 participants or, for a non-significant effect, a confidence 
interval that included an effect size (ES) of 0.5. We judged publication bias with funnel 
plots when enough studies were available. If not, we looked at the characteristics (e.g. 
only studies with a positive result) of the studies that were available, to get an 
indication of possible publication bias. The interpretation of the quality level of 
evidence that resulted from these judgements was as follows: 
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• High: further research is very unlikely to change our confidence in the estimate 
of effect. 
• Moderate: further research is likely to have an important impact on our 
confidence in the estimate of effect and may change the estimate. 
• Low: further research is very likely to have an important impact on our 
confidence in the estimate of effect and is likely to change the estimate. 
• Very low: any estimate of effect is very uncertain. 
 
Subgroup analysis and investigation of heterogeneity 
We intended to carry out subgroup analyses on: (1) organisational setting, (2) 
type/level of job undertaken, (3) group versus individual therapy and (4) the setting of 
treatment providers. It could be possible that the effects of interventions are altered by 
these study features. For example, bigger organisations might be better able to create 
an infrastructure for executing an intervention, workers with a higher job level might 
have better cognitive abilities to understand intervention assignments and treatment 
providers that are more closely related to the workplace (e.g. occupational physicians) 
might have more influence on the RTW process. Furthermore, differences in 
effectiveness between individual and group therapy are not frequently investigated for 
adjustment disorders but it is interesting for practice since group therapy can be more 
cost-effective61,62. However, we did not find enough studies for these analyses. One 
study did make a direct comparison between an individual and a group intervention63, 
and we decided to compare both interventions in a separate data-analysis. 
 
Sensitivity analysis 
Methodological heterogeneity can lead to differences between the results of individual 
studies. Therefore, we intended to undertake sensitivity analyses on the results by 
looking at the possible contribution of differences in methodological quality, for 
example by excluding studies with a high or unclear risk of bias for allocation 
concealment or acceptable compliance. However, the number of studies in each 
analysis was insufficient to perform these sensitivity analyses. We did perform 
sensitivity analyses on the diagnosis of adjustment disorder, by excluding studies from 




Results of the search 
Figure 1 presents a flow diagram of included and excluded studies. The initial search in 
the electronic databases identified 3546 references; 121 in the CCDANCTR, 299 in 
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CENTRAL, 488 in EMBASE, 590 in MEDLINE, 264 in PsycINFO and 1784 in ISI Web of 
Science. After removing duplicate references, 1454 references remained. Based on 
title and abstract, we identified 59 eligible references and retrieved the full text of the 
references. Checking the references of all articles that were retrieved as full papers 
and two systematic reviews43,64 did not result in any additional studies. Following this, 





































CCDANCTR n = 121 
CENTRAL n = 299 
EMBASE n = 488 
MEDLINE n = 590 
PsychINFO n = 264 
WOS n = 1784 





WHO trials n = 2 
Records after 
duplicates removed 
n = 1454 
Records screened 
n = 1454 
Full-text articles 
assessed for eligibility 
n = 59 
Records excluded 
n = 1395 
Full-text articles excluded 
 
No RCT n = 5 
Not on sick leave n = 11 
No adjustment disorder n = 22 
>30% other disorder n = 7 
No sick leave outcome n = 5 Studies included in 
qualitative synthesis 
n = 9 
Studies included in 
quantitative synthesis 
(meta-analysis 
n = 9 
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Eight studies met the inclusion criteria and were included in the review30,39,56,57,63,65-67. 
A study by Rebergen et al. (2009) met all the inclusion criteria, except one: 32% of the 
study population had symptoms related to an anxiety or depressive disorder. The other 
68% of the study population had symptoms related to adjustment disorders. Therefore, 
we contacted the author for outcome data on the subgroup of participants with 
adjustment disorders. The author was willing to provide these data, and because the 
distribution of participants with symptoms of adjustment disorders was equal for both 
study groups (86 participants in the trial and comparison intervention), the study was 
also included in the review68. In the study of Willert et al. (2011), some of the 
participants were not on sick leave at baseline67. Therefore, we contacted the author 
and asked him to provide separate data including only the participants that were on 
sick leave at baseline. The author was willing to provide the data and the distribution of 
the participants on sick leave at baseline was comparable between the trial and 
comparison intervention (29 and 31 respectively). Thus, this study was also included. 
Two study protocols were found for studies that are still ongoing69,70. With the 




Characteristics of studies and participants 
The main characteristics of the nine included studies are summarised in Table 1. 
Seven of the nine studies were performed in the Netherlands, one in Denmark and one 
in Sweden. Overall, 1546 participants were included. The average age of the 
participants ranged between 39 and 49 years; the percentage of female participants 
ranged between 19% and 71%. All studies recruited participants with disorders that 
were compatible with our definition of adjustment disorders. Two studies used the 
DSM-IV or ICD-10 diagnostic criteria for adjustment disorder to select participants39,57. 
Two studies56,66 used a validated distress screener to select participants, based on 
three questions of the Four-Dimension Symptom Questionnaire developed by Terluin et 
al. (2006)44,73,74. Two studies used the Composite International Diagnostic Interview 
(CIDI)48 to exclude participants with other mental disorders than adjustment disorders 
and used a diagnosis of minor mental disorders according to the general practitioner 
(GP)65 or symptoms of neurasthenia diagnosed in a semi-structured interview by a 
clinical psychologist63 as inclusion criterion. In one study, a Stress Clinic was 
responsible for psychological examinations to confirm the diagnosis of burnout. 
Furthermore, participants had to score above a cut-off score on the Shirom–Melamed 
Burnout Questionnaire (SMBQ)75. In the study of Rebergen et al. (2009)68, the 
Depression, Anxiety and Stress Scales (DASS)45 were used, after diagnosis of a mental 
health problem by the OP, to define subgroups of participants with anxiety or 
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depression and a subgroup of participants with stress symptoms related to adjustment 
disorders. Finally, one study used a semi-structured assessment interview by a clinical 
psychologist to diagnose persistent symptoms of work-related stress and to exclude 
severe psychiatric conditions or a history of repeated psychiatric conditions in 
participants67. 
 In all but one of the nine studies67, participants were on sick leave at the start of 
the study. In the study of Willert et al. (2011)67, 57% of the participants were on sick 
leave. The maximum duration of sick leave at baseline differed between studies. In two 
studies, participants were only included if they were on sick leave for no longer than 
half a year63,67; two other studies chose a maximum period of sick leave of three 
months56,65. The study by Stenlund et al. (2009)30 allowed for a longer sick leave 
period, namely between three and 12 months. Compared to this, the study by van 
Oostrom et al. (2010)66 only included participants with two to eight weeks of sick leave. 
In the study by Rebergen et al. (2009)68, workers were immediately contacted in their 
first week of sick leave. Two studies had no criterion defined on the minimum or 
maximum length of sick leave39,57. 
 








































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Eight studies reported on the effect of 10 psychological interventions and one study on 
the effect of a combined intervention consisting of a psychological intervention and 
relaxation techniques. For the other intervention types (e.g. pharmacological 
intervention, exercise programme) no studies were found. Of the 10 psychological 
interventions, five were based on CBT39,63,67 and the other five were based on 
PST56,57,65,66,68. Two of the interventions were performed in groups of (seven to nine) 
participants63,67; the other eight interventions were all performed with the individual 
participant. Eight interventions39,56,57,65-68 had a strong focus on the work environment 
by incorporating consultations/assignments aimed at identifying work-related problems 
to facilitate early work resumption. The other two psychological interventions were 
performed according to strict CBT protocols (one in a group format and one in an 
individual format) which focused on giving psycho-education, cognitive restructuring, 
relaxation, conflict management and time management63. These protocols were 
tailored to general life problems and had a less specific focus on work-related 
problems. The study by Willert et al. (2011)67 also used a CBT protocol with the aim of 
enabling participants to cope with stressful situations at their workplace and 
strengthen their ability to be active at work. The main components of this intervention 
were psycho-education, cognitive restructuring, communication skills training and 
implementing strategies at work. The study of Blonk et al. (2006)39 had two 
intervention arms; in one arm, participants received CBT according to a highly 
structured and commonly used protocol (in the Netherlands) which consisted mainly of 
cognitive restructuring but also focused on work resumption, time management, 
workplace interventions, conflict handling and fatigue. The other intervention arm 
consisted of a shorter CBT programme combined with advice on work processes (e.g. 
setting priorities, planning and conflict management) by labour experts.  
 The interventions tested by Brouwers et al. (2006)65 and Rebergen et al. (2009)68 
used the same intervention as developed and evaluated by van der Klink et al. 
(2003)57. These studies used an intervention protocol based on PST. The main 
components were to (1) give information about the origin and cause of loss of control, 
(2) develop and implement problem solving strategies and (3) apply gradual RTW. 
However, in the study by Brouwers et al the treatment providers were different (social 
workers instead of OPs) and the intervention protocol was adjusted to fit this group of 
treatment providers. Likewise, Bakker et al. (2007)56 used a problem solving 
intervention which was conducted by primary care physicians (i.e. GPs). The 
intervention focused on giving information about the active role of the worker in his 
RTW process, advising about functional rehabilitation and monitoring the problem 
solving strategies of the worker. Finally, the study by van Oostrom et al. (2010)66 also 
used a problem solving intervention. However, the intervention in this study 




differentiates from the other PST-based interventions because of a participatory 
approach in which the worker and supervisor work together in the development of 
problem solving strategies. Specifically, the intervention consisted of a stepwise 
communication process between the worker and his supervisor, guided by a RTW co-
ordinator, to identify and solve obstacles for RTW. Three meetings were planned; one 
with the worker and the RTW co-ordinator, one with the supervisor and the RTW co-
ordinator and one with all three parties. Obstacles for RTW were identified from the 
perspective of the worker and the supervisor. Following this, solutions were discussed 
during the third meeting and a plan (based on consensus) was made for implementing 
the solutions. If needed, the RTW co-ordinator visited the workplace of the worker to 
give advice or instructions. One month after the meetings, the RTW co-ordinator 
planned an evaluation meeting with the worker and supervisor. 
 The combined intervention evaluated by Stenlund et al. (2009)30 consisted of 
Cognitive Behavioural Rehabilitation (CBR) in groups of six to nine participants and 
Qigong in groups of 12 to 16 participants. The CBR programme had five key 
components: education; awareness of reactions and self-talk (a form of cognitive 
restructuring); development of behavioural, cognitive and emotional skills; spiritual 
issues and life values; and preparation for RTW. Qigong is a form of relaxation 
techniques consisting of warm-up movements; basic movements to affect body 
awareness, balance and co-ordination, breathing and muscular tension; and relaxation 
and mindfulness meditation. Although participants had to perform some bodily 
exercises, we did not regard this as an exercise programme because the focus was on 
relaxation. CBR included 30 three-hour sessions over one year and Qigong included 
weekly one-hour sessions for one year. 
 Treatment providers were comparable for some studies. In three studies, (clinical) 
psychologists trained in CBT provided the intervention39,63,67. OPs were the treatment 
providers in the studies of Rebergen et al. (2009)68 and van der Klink et al. (2003)57 
and received a three-day training in the intervention. Labour experts and social workers 
conducted the intervention in the study of van Oostrom et al. (2010)66. Labour experts 
were also the treatment providers in one trial arm of the study by Blonk et al. (2006)39, 
and social workers delivered the intervention in the study by Brouwers et al. (2006)65. 
In all cases, the labour experts and social workers received training in the intervention. 
In Bakker et al. (2007)56, primary care physicians were the treatment providers, and 
they had received seven hours of training in the intervention. Finally, Stenlund et al. 
(2009)30 did not specify the professional background of the treatment providers 
providing CBR but did mention that the group leaders had received training in CBR. The 
Qigong intervention in this study was delivered by a physiotherapist trained in Qigong. 
 Three psychological interventions were compared to a waiting list control group39,67. 
Five psychological interventions were compared to non-guideline based care (defined 




as "care as usual" in the studies) by a GP56,65 or OP57,63. One psychological intervention 
was compared to minimal intervention by the OP and treatment by psychologists 
working according to cognitive behavioural principles68. The combined intervention was 
compared to Qigong30, and the participatory problem solving intervention was 
compared to treatment by the OP according to a problem solving guideline66. 
 
Study design and setting 
Seven studies were randomised controlled trials with randomisation at the level of the 
participant30,39,63,65-68 and two studies were cluster-randomised controlled trials with 
randomisation at the level of the GP 56 or OP57. Two studies had three treatment 
arms39,63. In the study by Blonk et al. (2006)39, the first trial intervention (named “Blonk 
labour expert 2006” in the analyses) consisted of CBT-based stress management 
intervention with a focus on graded RTW. The second trial intervention (named “Blonk 
psychologist 2006” in the analyses) consisted of highly structured CBT according to a 
commonly used protocol. Both trial interventions were compared to a waiting list 
control group. In the study by de Vente et al. (2008)63, the first trial intervention 
(named “de Vente individual 2008” in the analyses) was individual stress-management 
training (SMT) according to a strict protocol based on cognitive behavioural techniques. 
The second trial intervention (named “de Vente group 2008” in the analyses) was 
group SMT according to the same protocol as the individual SMT. Both trial 
interventions were compared to care as usual by the OP and GP. 
 Four studies were performed in an occupational health care setting; in three studies 
participants were treated by an Occupational Health Care Service of a company57,66,68, 
and in one study participants were treated by labour experts39. Two studies were 
performed in a primary care setting where participants were treated by their general 
physicians56 or by social workers65. Finally, three studies were performed in a clinical 
setting with treatment by a clinical psychologist 63,67 or treatment in a Stress Clinic30. 
 
Outcomes 
Time to partial or full RTW, measured as number of days or weeks between the start of 
sick leave until partial or full work resumption or the number of days on sick leave 
during follow-up, was measured in eight of the nine included studies39,56,57,63,65-68. The 
follow-up time ranged from four to 18 months. One study reported on the rate of sick 
leave at different time measurements30. Clinical status of adjustment disorder was 
measured with a validated psychometric instrument in seven studies: four studies used 
the Four-Dimension Symptom Questionnaire56,57,65,66; two studies used the Depression, 
Anxiety and Stress Scales39,63; and one study used the Shirom–Melamed Burnout 
Questionnaire30. All studies had multiple follow-up measurements between two months 
and two years after baseline. One study measured generic functional status with the 




SF-36, but only reported scores on subscales and no total scores65. None of the studies 
measured quality of life or work functioning. 
 
Excluded studies 
Of the 59 full-text retrieved studies, 50 studies were excluded from the review because 
the study was not a randomised controlled trial (N = 5), the study population was not 
on sick leave (N = 11), participants did not have an adjustment disorder according to 
the definition of this review (N = 22), more than 30% of the participants were 
diagnosed with physical disorders or other mental disorders than adjustment disorders 
(N = 7) or because sick leave was not measured (N = 5). 
 
Risk of bias in included studies 
The results are summarised in the Risk of bias graph which presents the authors' 
judgement about each “Risk of bias” item presented as percentages across all 
included studies (Figure 2). The results for each risk of bias item for each individual 
study are presented in the Risk of bias summary (Figure 3). Of the nine included 
studies, we assessed seven as having a low risk of bias39,56,57,63,66-68. We assessed the 
other two studies as having high risk of bias30,65.  
 
Allocation (selection bias) 
In all studies, an adequate system for random sequence generation was reported, as 
well as adequate allocation concealment. Overall, computer-generated random 
numbers or dice were used for randomisation. To conceal allocation, the results of the 
randomisation were hidden in opaque envelopes or an independent research assistant 
performed the randomisation. 
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Figure 2. Risk of bias graph: review authors' judgements about each risk of bias item 
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Figure 3. Risk of bias summary: review authors' judgements about each risk of bias 
item for each included study. 
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Blinding (performance bias and detection bias) 
Blinding of participants was realised in three studies39,56,57. We judged blinding of the 
care provider as having low risk of bias for two studies56,67. In the study of Bakker et al. 
(2007)56, the care providers were randomised to the intervention or control group and 
treated all their patients according to their protocol, but they were unaware of which 
patients participated in the study. In the study of Willert et al. (2011)67, two care 
providers treated participants from both the intervention and waiting list control group 
according to the intervention protocol and did not know whether their participants 
belonged to the intervention or waiting list control group. In the study of van der Klink 
et al. (2003)57, participants received a global overview of both treatment strategies 
which were presented as equally effective and of which the participants were not able 
to notice the difference. Blonk et al. (2006)39 blinded the participants in their study by 
only giving general information about the goal of the study (based on personal 
communication with the author). Bakker et al. (2007)56 used a cluster-randomised 
controlled trial by which the allocation of participants was already pre-defined by the 
allocation of their care provider (in this study, their treating GP). Therefore, the 
participants were not informed about the two different study groups and were only told 
that the study was about stress and sick leave. The care providers were blinded 
because they had to treat all their patients according to the intervention treatment or 
comparison treatment (depending on their randomisation) and were unaware of which 
patients were included. In the study of Willert et al. (2011)67, the group leaders of the 
stress management intervention (i.e. the care providers) led the different groups of 
participants without knowledge of the participants' randomisation. The first two groups 
consisted of those randomised to the intervention arm of the trial. Groups three to 10 
consisted of participants mixed from the intervention and waiting list control arms. 
Group 11 and 12 consisted of participants randomised to the waiting list control arm 
(based on unpublished information from the author). Blinding of outcome assessors 
was reported in three studies56,66,68. In these studies, the researchers responsible for 
collecting outcome data as well as the researchers responsible for analysing the data 
were kept blind to treatment allocation. 
 
Incomplete outcome data (attrition bias) 
All studies reported on drop-outs, but in four studies the reasons for drop-out were not 
comparable for all study groups30,57,63,67. Furthermore, for one study, no information 
was available about the reasons for drop-out, and this study was therefore judged as 
“unclear risk of bias”65. In all studies, except one39, an intention-to-treat analysis was 
conducted. 
 




Selective reporting (reporting bias) 
All but three studies56,66,67 were free from selective reporting. In the study of Bakker et 
al. (2007)56 and van Oostrom et al. (2010)66, analyses of secondary outcome 
measures that were planned in the study protocol were omitted from the papers in 
which the study results were reported. Willert et al. (2011)67 presented supplementary 
analyses that were not described in the methods section. 
 
Other potential sources of bias 
Two authors were not able to provide information on the use of co-interventions by the 
different groups in their study39,56. In the other six studies, co-interventions were not 
avoided and not similar for the different study groups. In four studies, treatment fidelity 
was rated as acceptable39,57,63,67. In these studies, fidelity was ensured by checking 
with questionnaires or feedback moments if care providers followed the study 
protocols. Acceptable attendance rates were reported by de Vente et al. (2008)63, and 
from Willert et al. (2011)67 unpublished information was received on acceptable 
attendance rates. We included studies with smaller (N = 8263) and larger (N = 43156) 
sample sizes, and studies with positive (e.g. Blonk et al. 200639 and van der Klink et al. 
200357) as well as non-significant results (e.g. Bakker et al. 200756 and van Oostrom et 
al. 201066) were included. However, we were not able to further analyse publication 
bias because of an insufficient number of studies. 
  
Effects of interventions 
No studies were found that evaluated pharmacological interventions, relaxation 
techniques, exercise programmes or employee assistance programmes. The nine 
included studies reported on 10 psychological interventions and one combined 
intervention, consisting of a psychological intervention and relaxation techniques. A 
complete overview of the effects of the interventions is presented in the “Data and 
analyses” section of this review. 
 
Psychological interventions 
1. Cognitive behavioural therapy (CBT) versus no treatment 
1.1 Partial return to work (RTW), follow-up one year 
Two studies39,67, one of which had two treatment arms39, compared three CBT 
interventions to a no treatment control group. The results of these two studies showed 
that there is moderate-quality evidence (Appendix 2) that days until partial RTW are 
similar for the CBT intervention groups and the no treatment control groups (mean 
difference (MD) -8.78, 95% confidence interval (CI) -23.26 to 5.71) (Figure 4). 
 
 




1.2 Full RTW, follow-up one year 
Blonk et al. (2006)39 also evaluated the effect of the two CBT interventions on time 
until full RTW compared to no treatment. The results indicated that there is low-quality 
evidence (Appendix 2) of no significant difference between the CBT interventions and 
no treatment for this outcome measure (MD -35.73, 95% CI -113.15 to 41.69) (Figure 
5). 
 
1.3 Depression, Anxiety and Stress Scales (DASS) distress score, follow-up one year 
Concerning the secondary outcome of clinical status of adjustment disorder, Blonk et 
al. (2006)39 evaluated the effect of CBT interventions on the stress scale of the DASS. 
The results showed that there is moderate-quality evidence (Appendix 2) of a similar 
outcome for the CBT interventions and no treatment for mean score on the DASS 
stress scale at one-year follow-up (MD 0.06, 95% CI -3.91 to 4.02). 
 
2. CBT versus non-guideline based care 
2.1 Full RTW, follow-up one year 
One study63, consisting of two treatment arms, assessed the effects of a group-based 
CBT intervention and an individual-based CBT intervention on time to full RTW after one 
year of follow-up. The interventions were compared to non-guideline based care by the 
occupational physician (OP) and general practitioner (GP), which was defined as "care 
as usual" in the study paper. The pooled analysis showed that the CBT interventions 
were slightly less effective in reducing time to full RTW compared to non-guideline 
based care, but this effect was not significant (MD 35.50, 95% CI -30.84 to 101.84), 
with low-quality evidence (Appendix 2). 
 
2.2 DASS distress score, follow-up three months 
De Vente et al. (2008)63 also investigated the effect of the two CBT interventions on 
mean score on the DASS stress scale at three months follow-up. The results indicated 
that there is low-quality evidence (Appendix 2) of a similar outcome for the CBT 
interventions and non-guideline based care for the mean score on the DASS stress 
scale at three months follow-up (MD 0.66, 95% CI -2.78 to 4.11). 
 
2.3 DASS distress score, follow-up one year 
Also, based on one study63, no significant difference was found between CBT 
interventions and non-guideline based care for the DASS stress scale at one-year 
follow-up (MD -0.67, 95% CI -6.06 to 4.73), with low-quality evidence (Appendix 2). 
 




3. Problem solving therapy (PST) versus non-guideline based care 
3.1 Partial RTW, follow-up one year 
One study investigated the effect of a PST-based intervention on time to partial RTW 
after one year of follow-up, compared to non-guideline based care by the OP57. The 
results showed that there is moderate-quality evidence (Appendix 2) that the PST-
based intervention significantly reduced time to partial RTW with 17 days compared to 
non-guideline based care (MD -17.00, 95% CI -26.48 to -7.52) (Figure 6). 
 
3.2 Full RTW, follow-up one year 
Based on two studies56,57, meta-analysis showed that there is moderate-quality 
evidence (Appendix 2) that PST-based interventions did not result in a significant 
reduction of time until full RTW compared to non-guideline based care by the OP or GP 
(MD -17.73, 95% CI -37.35 to 1.90). The confidence interval still included a potential 
relevant effect (Figure 7). 
 
3.3 Full RTW, follow-up one to two years 
In line with the findings for full RTW with a follow-up of one year, a PST-based 
intervention had a similar reduction of days until full RTW compared to non-guideline 
based care by the GP at one to two years follow-up (MD -4.00, 95% CI -41.61 to 33.61), 
based on low-quality evidence (Appendix 2). 
 
3.4 Four-Dimension Symptom Questionnaire (4DSQ) distress score, follow-up three 
months 
Three studies56,57,65 investigated the effect of PST-based interventions on the score on 
the distress scale of the 4DSQ, compared to non-guideline based care by the OP or GP. 
The results indicated moderate-quality evidence (Appendix 2) of a significant reduction 
in the distress score in favour of the PST-based interventions (MD -1.69, 95% CI -3.11 
to -0.27). 
 
3.5 4DSQ distress score, follow-up four to 12 months 
The significant reduction in the distress score by the PST-based interventions was not 
found for the follow-up period of three to 12 months (MD -0.36, 95% CI -1.76 to 1.04), 
based on moderate-quality evidence (Appendix 2). 
 
3.6 4DSQ distress score, follow-up one to two years 
Also, at one to two years follow-up, the results showed that there is low-quality evidence 
(Appendix 2) of no significant difference between a PST-based intervention and non-
guideline based care (MD -2.03, 95% CI -4.25 to 0.19). 
 




4. PST versus CBT 
4.1 Partial RTW, follow-up one year 
Rebergen et al. (2009)68 investigated the effect of a PST-based intervention compared 
to a CBT intervention on partial RTW after one year of follow-up. Based on moderate-
quality evidence (Appendix 2), no difference was found between these treatments in 
the effect on time to partial RTW (MD -6.28, 95% CI -29.36 to 16.80). 
 
4.2 Full RTW, follow-up one year 
For days until full RTW after one year of follow-up, a non-significant reduction of sick 
leave was found between the PST-based intervention compared to the CBT intervention 
(MD -6.74, 95% CI -37.43 to 23.95), with moderate-quality evidence (Appendix 2). 
 
5. Participatory PST versus PST 
5.1 Full RTW, follow-up one year 
One study66 investigated the effect of a participatory PST-based intervention compared 
to a PST-based intervention on full RTW after one year of follow-up. The results showed 
that there is moderate-quality evidence (Appendix 2) that there is no difference in 
effectiveness between the two treatments (MD -1.00, 95% CI -36.32 to 34.32). 
 
5.2 4DSQ distress score, follow-up three months 
Van Oostrom et al. (2010)66 also investigated the effect of the participatory PST-based 
intervention on distress score, based on the distress scale of the 4DSQ, measured at 
three months follow-up. The data analysis showed moderate-quality evidence (Appendix 
2) of no difference in distress score compared to a PST-based intervention (MD -0.40, 
95% CI -3.27 to 2.47). 
 
5.3 4DSQ distress score, follow-up four to 12 months 
There was also no effect of the participatory PST-based intervention compared to the 
PST-based intervention on distress score at three to 12 months follow-up (MD 0.63, 
95% CI -2.05 to 3.31), based on moderate-quality evidence (Appendix 2). 
 
Combination of interventions 
1. CBT and physical relaxation versus physical relaxation 
1.1 Rate of partial RTW, follow-up one year 
One study30 reported on the effectiveness of a CBT intervention and physical relaxation 
compared to physical relaxation alone on rate of partial RTW at one-year follow-up. The 
results indicate that there is low-quality evidence (Appendix 2) of a similar outcome for 
the two study groups on this outcome measure (risk ratio [RR] 1.04, 95% CI 0.58 to 
1.89). 




1.2 Rate of partial RTW, follow-up one to two years 
For rate of partial RTW with a follow-up of one to two years, no significant difference 
was found between the CBT intervention and physical relaxation versus physical 
relaxation alone (RR 0.82, 95% CI 0.50 to 1.34). This result was based on low-quality 
evidence (Appendix 2). 
 
1.3 Rate of full RTW, follow-up one year 
In the same study by Stenlund et al. (2009)30, the combined intervention was also 
compared to physical relaxation for the effect on rate of full RTW after one year of 
follow-up. The analysis showed low-quality evidence (Appendix 2) of a similar outcome 
for the two study groups (RR 0.72, 95% CI 0.23 to 2.20). 
 
1.4. Rate of full RTW, follow-up one to two years 
For rate of full RTW after one to two years follow-up, the results showed no significant 
difference between the combined intervention and physical relaxation (RR 1.25, 95% 
CI 0.64 to 2.43), based on low-quality evidence (Appendix 2). 
 
1.5 Shirom–Melamed Burnout Questionnaire (SMBQ) score, follow-up one year 
Stenlund et al. (2009)30 also investigated if the CBT intervention and physical 
relaxation had an effect on the SMBQ score at one-year follow-up compared to physical 
relaxation alone. The results indicated that there is low-quality evidence (Appendix 2) of 
a significant reduction in the SMBQ score in favour of the combined intervention (RR -
0.50, 95% CI -0.97 to -0.03). 
 
1.6 SMBQ score, follow-up one to two years 
There was no significant difference in mean SMBQ score at one to two years follow-up 
between the combined intervention and physical relaxation alone (RR -0.40, 95% CI -
0.92 to 0.12), based on low-quality evidence (Appendix 2). 
 
Subgroup analyses 
1. Individual CBT versus group CBT 
1.1 Full RTW, follow-up one year 
A direct comparison between individual-based CBT and group-based CBT on time until 
full RTW, based on the data from the study by de Vente et al. (2008)63, indicated that 
there is low-quality evidence (Appendix 2) that there is no significant difference 
between individual-based and group-based CBT on time to full RTW (MD 2.94, 95% CI -
12.07 to 17.95). 
 




1.2 DASS distress score, follow-up three months 
The study by de Vente et al. (2008)63 also evaluated the effect of individual-based CBT 
versus group-based CBT on distress score at three months follow-up based on the 
DASS. The results showed that there is low-quality evidence (Appendix 2) of no 
significant difference between the two study groups (MD -1.80, 95% CI -6.21 to 2.61). 
 
1.3 DASS distress score, follow-up four to 12 months 
For the distress score at three to 12 months follow-up, the results also showed no 
significant difference between individual-based CBT and group-based CBT (MD -0.86, 
95% CI -5.84 to 4.12), based on moderate-quality evidence (Appendix 2). 
 
Sensitivity analyses 
1. CBT versus no treatment, full adjustment disorder diagnosis 
1.1 Partial RTW, follow-up one year 
A sensitivity analysis was conducted for the comparison of CBT versus no treatment 
excluding the study of Willert et al. (2011)67 because adjustment disorder was not 
diagnosed according to the DSM-IV or ICD-10 in this study. The analysis showed that 
there is moderate-quality evidence (Appendix 2) that there is no significant difference 
between CBT and no treatment on time to partial RTW (MD -24.92, 95% CI -80.58 to 
30.74). 
 
2. PST versus non-guideline based care, full adjustment disorder diagnosis 
2.1 Full RTW, follow-up one year 
When excluding the study by Bakker et al. (2007)56, based on no diagnosis of 
adjustment disorder according to the DSM-IV or ICD-10, the results showed that there 
is moderate-quality evidence (Appendix 2) of a significant difference between PST and 
non-guideline based care for full RTW after one year of follow-up (MD -24.00, 95% CI -
47.58 to -0.42) (Figure 8). 
 
2.2 4DSQ distress score, follow-up three months 
Results for the distress score at three months follow-up based on studies including a 
diagnosis of adjustment disorder according to the DSM-IV or ICD-10 criteria showed 
that there is moderate-quality evidence (Appendix 2) of no significant difference 
between PST and non-guideline based care (MD -1.90, 95% CI -4.69 to 0.89). 
 
2.3 4DSQ distress score, follow-up four to 12 months 
Similarly, there was no significant difference between PST and non-guideline based 
care for the distress score at four to 12 months follow-up (MD -1.06, 95% CI -3.86 to 















































































































































































































































Summary of main results 
We found nine RCTs reporting on ten psychological interventions and one intervention 
that combined a psychological intervention with physical relaxation. We did not find 
RCTs of pharmacological interventions, exercise programmes or employee assistance 
programmes. Of the ten psychological interventions, five consisted of CBT and five of 
PST. Our results showed moderate-quality evidence that time until partial return to 
work (RTW) was similar for workers receiving CBT or no treatment (mean difference 
(MD) -8.78, 95% confidence interval (CI) -23.6 to 5.71) at one-year follow-up. A 
sensitivity analysis, including studies in which adjustment disorder was diagnosed 
according to the DSM-IV and ICD-10, confirmed this result (MD -24.92, 95% CI -80.58 
to 30.74). For full RTW, we found low-quality evidence that CBT did not significantly 
reduce days until full RTW at one-year follow-up compared to no treatment. There was 
also moderate-quality evidence that CBT did not significantly reduce distress 
complaints at one-year follow-up compared to no treatment. 
 PST significantly reduced time until partial RTW by 17 days (MD -17.00, 95% CI         
-26.48 to -7.52) after one year of follow-up compared to non-guideline based care, but 
no significant differences were found for full RTW and distress complaints at one-year 
follow-up. However, a sensitivity analysis, only including studies with a diagnosis of 
adjustment disorder according to the DSM-IV or ICD-10, showed a significant difference 
between PST and non-guideline based care for full RTW after one year follow-up (MD  
-24.00, 95% CI -47.58 to -0.42). 
 Moderate-quality evidence showed that PST led to similar effects on partial and full 
RTW as CBT. Participatory PST led to similar results as PST. The rate of partial and full 
RTW was similar after a combined intervention consisting of CBT and physical 
relaxation compared to physical relaxation alone at one and two years follow-up. 
Finally, we found moderate-quality evidence that individual CBT and group CBT led to a 
similar time to full RTW. 
 
Overall completeness and applicability of evidence 
We have performed an extensive literature search for this study to find all relevant 
RCTs. By searching the WHO trials portal and ClinicalTrials.gov, we also found studies 
that are still being conducted and which can be followed until they are finished and 
ready to be assessed for inclusion in this review. Furthermore, the review authors are 
all experts in the field of occupational health care and work disability prevention and 
are knowledgeable about the studies that have been performed in this field. This 
ensures that most available studies have been found for this review. Considering the 
variability in the interventions that are included in this review and because we have not 




searched the grey literature, there remains a possibility that some studies have not 
been found. 
 Regarding the overall completeness of the review, it should be noted that we only 
found studies on psychological interventions and a combined intervention which 
consisted of a psychological intervention and physical relaxation. Thus, studies on the 
effect of other types of interventions, such as pharmacological interventions or exercise 
programmes, on RTW are lacking. Furthermore, not enough studies were included to 
perform subgroup analyses for organisational setting, treatment setting and type of job, 
which impedes generalisation of the results. Also, we could not assess publication bias 
because of the small number of studies included in the review. We have to 
acknowledge that the review might have been affected by publication bias. On the 
other hand, there were a wide range of participants included in the studies. The mean 
age of participants ranged between 39 and 49 years, and the percentage of females 
ranged from 19% to 71%. The percentage of participants with a high educational level 
ranged from 4% to 52%. This indicates that the current review consists of a rather 
heterogeneous group of participants. Some studies did not provide information on job 
type, but the studies that did so, indicated that participants worked, for example, for a 
postal company, the police department, a university, a hospital and a steel company. 
Although this shows a relative mixture of job types, it may be interesting to conduct 
more research on workers in job types that are known to be related to high sick leave 
rates because of adjustment disorders, such as in health care and education76,77. 
Furthermore, the results that we found in this review for partial RTW were based on 
studies which mainly consisted of men39,57. It could be that this is a gender-specific 
effect and it should be studied more among women. 
 Applicability of the findings of this review may be restricted to the Dutch context, 
since seven of the nine included studies were performed in the Netherlands. In 
particular, the term adjustment disorder, which is commonly used in the Netherlands to 
refer to the group of patients suffering from distress-related complaints, is not 
frequently used in other countries. Terminology such as burnout, distress, minor mental 
disorders or (occupational or work) stress is more common78-80. Furthermore, the term 
“common mental disorders” is becoming more popular in research articles, where 
distress-related complaints are defined as being a subgroup of common mental 
disorders26,68,81,82. This made it challenging to operationalize the diagnosis of 
adjustment disorder for this review. Our aim was to only include participants with 
burnout-related or distress-related complaints and, therefore, we excluded participants 
suffering from more debilitating disorders, such as anxiety and depressive disorders. 
For future research, it would be helpful to come to a shared definition for the group of 
patients that suffer from adjustment disorders and to validated assessment tools to 
enhance comparability between studies. 




Although the majority of the included studies was performed in the Netherlands, the 
problem of sick leave related to adjustment disorders is encountered in many other 
countries6,83. It could be that the interventions evaluated in this review are more 
effective in other countries than the Netherlands because the comparison 
interventions may have included effective interventions. Occupational physicians (OPs) 
in the Netherlands have a guideline for managing sick leave because of mental health 
problems since 200084,85. Furthermore, with the Gatekeeper Improvement Act, that 
has been effective in the Netherlands since 2002, more investments have been made 
in RTW by employers, employees and occupational health care services. Six of the 
Dutch studies included in this review were performed after these dates. Thus, 
participants in the comparison interventions of these studies were obliged to see the 
OP to be supported in RTW and will have received support from their employers to 
enhance RTW. This may have led to small contrasts between study groups in some of 
the Dutch studies, such as the studies of van Oostrom et al. (2010)66 and Rebergen et 
al. (2009)68. However, when comparing the mean days until partial or full RTW for the 
comparison interventions of the Dutch studies performed before 2002 and after 2002, 
no clear difference in time to RTW can be seen. When looking at the two studies 
included in this review that were performed in other countries (Denmark and Sweden), 
one study showed a significant difference in sick leave days between the experimental 
(CBT) and comparison (no treatment) group67. The other study, comparing CBT and 
physical relaxation versus physical relaxation alone, did not detect a significant 
difference in rate of sick leave30. Thus, our hypothesis that the interventions included 
in this review might be more effective in other countries than the Netherlands needs to 
be evaluated in future research to be confirmed. 
 Finally, the follow-up time in most studies was one year. Only two studies had a 
follow-up time of 18 months65 and two years30. However, we believe that a follow-up 
time of one year is sufficient when evaluating the effect of an intervention on RTW, 
because most workers on sick leave because of adjustment disorders return to work 
within one year. 
 
Quality of the evidence 
We were able to include nine RCTs. We considered this a fair number, since it is not 
easy to perform randomised studies in a healthcare setting. Furthermore, we used a 
clear definition of adjustment disorders, also including studies that did not use a strict 
DSM-IV or ICD-10 diagnosis but did focus on a study population with comparable 
complaints. Since only two studies used a strict DSM-IV and ICD-10 diagnosis, our 
broadened definition of adjustment disorders allowed us to give a good overview of the 
research done on study populations with more mild mental health complaints. The 
drawback of the broadened definition is that the different studies did not consist of 




homogeneous populations. We dealt with this by performing sensitivity analyses on the 
studies that did use the diagnostic criteria of the DSM-IV or ICD-10 to assess whether 
participants had an adjustment disorder. In future research, a strict diagnosis of 
adjustment disorder, based on the DSM-IV or ICD-10, should be used to enhance 
comparability between studies. 
 The studies mainly included small numbers of participants with a mean number of 
156 participants. The outcome measure of mean days until partial or full RTW had a 
large standard deviation (SD) with approximately the same magnitude as the mean. 
Given these large SDs, the power to detect relevant differences in these studies may 
have been insufficient. Moreover, most comparisons were based on one study and only 
a few comparisons consisted of two or three studies. In light of this, results have to be 
interpreted carefully. The extent to which the findings are applicable to other study 
settings and future trials may be limited. Future researchers investigating interventions 
to facilitate RTW of workers with adjustment disorders should try to recruit double the 
amount of participants and will need to find ways to overcome recruitment problems. 
 A potential threat to the quality of the evidence could be the way we incorporated 
multiple trial arms in the meta-analyses. We chose to include each trial arm in the 
comparison and divide the control group in two. This method can influence the 
estimation of between-study variance, especially because of the small number of 
studies in the meta-analyses. Thus, these estimates are imprecise and should be 
interpreted cautiously. 
 Some studies used the median when reporting days until partial or full RTW 
because sick leave data are known to be skewed. Although the mean number of days 
until partial and full RTW was used in this review, our results are comparable to the 
results of the individual studies. For example, van Oostrom et al. (2010)66 reported on 
the median days until full RTW and found a non-significant hazard ratio (HR) of 0.99, 
which is comparable to the mean difference of one day found in this review. In general, 
it is known that the t-test is fairly robust for data being skewed to one side86. 
 All studies had acceptable randomisation and treatment allocation procedures. 
However, only one study succeeded in keeping co-interventions comparable between 
the treatment and control group63. The fact that the other studies did not succeed in 
preventing co-interventions or keeping them similar for all study groups, makes it 
difficult to draw strong conclusions on the effectiveness or ineffectiveness of the 
interventions in this review. If control groups had easy access to psychiatrists, 
psychologists and psychotropic medication, the contrast with the intervention groups, 
and thus the chance of finding an effect of the intervention, will have been diminished. 
Furthermore, compliance to the treatment was not acceptable in four of the nine 
studies56,65,66,68. This could explain our finding that most of the interventions had no 
significant effect. Thus, researchers need to become more aware of avoiding or 




keeping co-interventions similar for all study groups and ensuring compliance to the 
study protocol by care providers. 
 Another problem encountered in the studies in this review was the lack of blinding 
of participants and care providers. Only three studies succeeded in blinding 
participants39,56,57 and two in blinding care providers56,67. This problem often arises in 
studies that are designed as pragmatic trials, such as the studies in this review. 
Pragmatic trials investigate the effectiveness of an intervention in everyday practice. 
Often, it is difficult to blind participants and care givers for the treatment intervention, 
because it is clearly different from normal practice87. A possible solution to this 
problem is to design a cluster-randomised controlled trial or to pre-randomise 
participants88. In a pre-randomised design, randomisation takes place before detailed 
information is given about the study, and participants allocated to one study group are 
kept blind to the randomisation procedure and to the existence of the other study 
group. 
 We also planned to analyse, as a secondary outcome measure, outcomes related to 
work functioning or work productivity, but the studies in this review only used time until 
RTW as a work-related outcome measure. It would be interesting to know more about 
workers after they have returned to work. It could be that workers are less productive 
or not functioning well after their RTW. Therefore, it would be helpful to include other 
work-related outcomes in addition to sick leave measures to gain insight into the 
process after RTW in future studies. 
 
Potential biases in the review process 
In this review, we did not restrict the languages in which studies were published. This 
prevented bias in the selection of studies only published in the English language. 
However, it should be mentioned that two of the review authors were the study authors 
of one of the included studies68. To prevent biased assessment, these authors were 
not involved in the selection, risk of bias assessment and data extraction for this study. 
Moreover, all these steps of the review process were always independently performed 
by two review authors. To prevent reporting bias, we reported on individual studies, not 
on individual articles. For every RCT, we traced all articles that were related to the 
same study and used these articles for data extraction for that single study. 
 Potential bias might have occurred in defining the different interventions included in 
the review. Instead of using the names that the authors gave to their intervention, we 
first predefined which components should be part of an intervention to frame it as CBT 
or PST. Following this, we checked the components of every intervention and, based on 
this, we classified it as being CBT or PST. We feel that this approach is more systematic 
than using the names that were given to the interventions by the authors, and we 
believe that it has not biased our results. 




We combined studies that evaluated the same intervention, but in which the 
intervention was provided by different health care professionals. In some studies, these 
professionals were specialised psychologists and in other studies they were OPs or GPs 
with little experience in providing CBT or PST. This could increase heterogeneity in two 
ways. First of all, because of a higher-intensity treatment and better effect with more 
professional treatment. Secondly, the relationship of the health care professional with 
the employer and the focus on work differs between professionals and could have an 
effect on how a treatment is delivered. However, we were not able to evaluate these 
hypotheses because of an insufficient number of studies. 
 Finally, bias might have been introduced by using the intra-cluster correlation (ICC) 
of the distress score, which was given in the study of Bakker et al. (2007)56, to 
calculate the ICC for RTW in Bakker et al. (2007)56 and the ICC for distress in the study 
of van der Klink et al. (2003)57. This could have inflated the variance for both outcomes 
and misrepresented the true degree of variation of the study population for the 
outcomes concerned. 
 
Agreements and disagreements with other studies or reviews 
There are other reviews that have also focused on interventions to facilitate RTW but 
for different study populations. For example, Schaafsma et al. (2010)89 investigated 
the effect of physical conditioning programmes for improving work outcomes in workers 
with back pain. In this systematic review, the authors could not find an effect of light or 
intensive physical conditioning programmes on the reduction of sick leave, compared 
to usual care or other exercise programmes. These results are in line with the results of 
this review, which mainly showed no significant effects of the interventions on time to 
full RTW at one-year follow-up, although CBT and PST did show a significant effect for 
time to partial RTW. Nieuwenhuijsen et al. (2008)42 investigated the effect of 
interventions aimed at improving occupational health in depressed people and did not 
find clear evidence of an effect of medication, enhanced primary care, psychological 
interventions or a combination of these interventions with medication on sick leave in 
depressed workers. A systematic review evaluating the effect of workplace 
interventions on sick leave for all types of disorders only found a significant effect of a 
workplace intervention on the reduction of sick leave among workers with 
musculoskeletal disorders, compared to usual care. No effect was found of workplace 
interventions for back pain, upper-extremity disorders or mental health problems66. 
Finally, de Boer et al. (2011)90 recently published a systematic review on interventions 
to enhance RTW for cancer patients. This review showed that physical training was not 
effective in reducing time to RTW compared to usual care. Furthermore, medical 
interventions with a functioning conservative approach were not more effective in 
increasing RTW rates than more radical treatments. There was only a positive effect of 




multidisciplinary interventions (consisting of physical, psychological and vocational 
components) on RTW rates compared to care as usual. 
 When combining the results of this review and the reviews mentioned above, we 
can conclude that there are already quite a number of studies performed on the effects 
of different types of intervention on reducing sick leave or time to RTW for different 
study populations. Overall, none of the reviews showed high-quality evidence that any 
type of intervention was effective in reducing sick leave or time to RTW. 
 
AUTHORS' CONCLUSIONS 
Implications for practice 
We found moderate-quality evidence that time until partial return to work (RTW) at one-
year follow-up was similar for workers receiving cognitive behavioural therapy (CBT) or 
no treatment. Results from low-quality evidence indicate that CBT was not significantly 
effective in reducing time to full RTW at one-year follow-up compared to no treatment. 
Moderate-quality evidence showed that problem solving therapy (PST) significantly 
enhanced partial RTW at one-year follow-up compared to non-guideline based care but 
did not significantly enhance time to full RTW at one-year follow-up. A PST intervention 
could readily be implemented in a work context by occupational health care 
professionals to enable participants to take the first steps towards RTW. This might 
also reduce the costs related to sick leave. However, there was insufficient evidence 
that PST or CBT are effective in restoring individuals back to their full duties. 
 
Implications for research 
International consensus should be reached on the terminology used to address the 
group of workers with adjustment disorders and assessment tools need to be 
developed and validated for diagnosing adjustment disorders. Almost every study in 
this review used different terms for describing complaints related to adjustment 
disorders, such as distress, stress, burnout and minor mental disorders, which impedes 
making comparisons. 
 Future studies should include more women and should focus research on 
participants with certain job types that are prone to adjustment disorders (e.g. distress 
complaints and burnout), such as nurses and teachers. Because of the large standard 
deviations related to mean days until RTW, which led to a loss of power, studies need 
to recruit at least 300 or more participants. 
 Researchers may consider exploring other possible interventions, in addition to CBT 
and PST interventions, to try to affect full RTW. Moreover, in future studies more 
attention should be paid to proper blinding of participants, care providers and data 
analysts, and to controlling of co-interventions and compliance with the treatment 




protocol by care providers. Comparison conditions such as “usual care” should be 
better defined and described. Otherwise, it is hard to compare the effects of different 
studies. Finally, different types of work-related outcome measures, such as work 
functioning and work productivity, should be used besides sick leave days and time 
until RTW to better understand how workers are performing following RTW. 
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APPENDIX 1: SEARCH STRATEGIES 
CENTRAL search terms 
#1 MeSH descriptor ADJUSTMENT DISORDERS, this term only; #2 MeSH descriptor BURNOUT, 
PROFESSIONAL, this term only; #3 MeSH descriptor NEURASTHENIA, this term only; #4 (mental NEXT 
disorder*):ti,ab; #5 (adjustment NEXT disorder*):ti,ab,kw; #6 (burnout):ti,ab,kw; #7 (reactive NEXT 
disorder*):ti,ab,kw; #8 (reactive NEXT depression):ti,ab,kw; #9 (psychologic* or mental health or depress* or 
anxi* or somat* or distress or stress[TSC2] ):ti,ab,kw; #10 ((sick* NEAR/3 leave) or (sick NEAR/3 list*) or 
(sick NEAR/3 absen*)):ti,ab,kw; #11 (workplace or (work NEAR/3 related) or occupation* or job):ti,ab,kw; 
#12 (#9 and (#10 or #11)); #13 (#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #12); #14 MeSH 
descriptor SICK LEAVE, this term only; #15 MeSH descriptor ABSENTEEISM, this term only; #16 MeSH 
descriptor REHABILITATION, VOCATIONAL, this term only; #17 ((sick* NEAR/3 leave) or (sick NEAR/3 list*) or 
(sick NEAR/3 absen*)):ti,ab,kw; #18 (return* NEAR/3 work*):ti,ab,kw; #19 ((sick* or absen*) AND 
(workplace or (work NEAR/2 related) or occupation* or job)):ti,ab,kw; #20 (#14 or #15 or #16 or #17 or #18 
or #19); #21 (#13 and #20) 
 
OVID MEDLINE search terms 
1. randomized controlled trial.pt.; 2. controlled clinical trial.pt.; 3. randomi#ed.ti,ab.; 4. randomly.ab.; 5. 
placebo.ab.’6. drug therapy.fs.; 7. trial.ab.; 8. groups.ab.; 9. (control$ adj3 (trial or study)).ab,ti.; 10. ((singl$ 
or doubl$ or tripl$ or trebl$) adj3 (blind$ or mask$ or dummy)).mp.; 11. or/1-10; 12. ADJUSTMENT 
DISORDERS/; 13. BURNOUT, PROFESSIONAL/; 14. *MENTAL DISORDERS/ 
15. NEURASTHENIA/; 16. adjustment disorder*.tw.; 17. burnout.tw.; 18. reactive disorder*.tw.; 19. reactive 
depression.tw.; 20. (psychologic* or mental health or mental disorder* or depress* or anxi* or somat* or 
distress or stress).tw.; 21. ((sick* adj3 (leave or list* or absen*)) or (workplace or (work adj2 related)) or 
occupation* or job).tw.; 22. 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or (20 and 21); 23. SICK LEAVE/; 
24. ABSENTEEISM/; 25. REHABILITATION, VOCATIONAL/; 26. (sick adj3 (leave or list* or absen*)).tw.; 27. 
(return* adj3 work*).tw.; 28. ((sick* or absen*) adj5 (workplace or (work adj2 related) or occupation* or 
job)).tw.; 29. or/23-28; 30. 11 and 22 and 29 
 
OVID EMBASE search terms 
1. randomized controlled trial.de.; 2. randomization.de.; 3. placebo.de.; 4. placebo$.ti,ab.; 5. 
randomi#ed.ti,ab.; 6. randomly.ab.; 7. ((singl$ or doubl$ or trebl$ or tripl$) adj3 (blind$ or mask$ or 
dummy)).mp.; 8. factorial$.ti,ab.; 9. allocat$.ti,ab.; 10. assign$.ti,ab.; 11. volunteer$.ti,ab.; 12. crossover 
procedure.de.; 13. (crossover$ or cross over$).ti,ab.; 14. (quasi adj (experimental or random$)).mp.; 15. 
(control$ adj3 (trial$ or study or studies or group$)).ti,ab.; 16. ((animal or nonhuman) not (human and 
(animal or nonhuman))).de.; 17. or/1-15; 18. 17 not 16; 19. adjustment disorder/; 20. neurasthenia/; 21. 
burnout/; 22. job stress/; 23. *mental disease/; 24. reactive depression/; 25. adjustment disorder*.tw.; 26. 
burnout.tw.; 27. reactive disorder*.tw.; 28. reactive depression.tw.; 29. (psychologic* or mental health or 
mental disorder* or depress* or anxi* or somat* or distress or stress).tw.; 30. ((sick* adj3 (leave or list* or 
absen*)) or (workplace or (work adj2 related)) or occupation* or job).tw.; 31. 19 or 20 or 21 or 22 or 23 or 
24 or 25 or 26 or 27 or 28 or (29 and 30); 32. medical leave/; 33. absenteeism/; 34. vocational 
rehabilitation/; 35. (sick adj3 (leave or list* or absen*)).tw.; 36. (return* adj3 work*).tw.; 37. ((sick* or 
absen*) adj5 (workplace or (work adj2 related) or occupation* or job)).tw.; 38. or/32-37; 39. 18 and 31 and 
38 
 
OVID PsycInfo search terms 
1. treatment effectiveness evaluation.sh.; 2. clinical trials.sh.; 3. mental health program evaluation.sh.; 4. 
placebo.sh.; 5. placebo$.ti,ab.; 6. randomly.ab.; 7. randomi#ed.ti,ab.; 8. trial.ti,ab.; 9. ((singl$ or doubl$ or 
trebl$ or tripl$) adj3 (blind$ or mask$ or dummy)).mp.; 10. (control$ adj3 (trial$ or study or studies or 
group$)).ti,ab.; 11. factorial$.ti,ab.; 12. allocat$.ti,ab.; 13. assign$.ti,ab.; 14. volunteer$.ti,ab.; 15. 
(crossover$ or cross over$).ti,ab.; 16. (quasi adj (experimental or random$)).mp.; 17. "2000".md.; 18. or/1-
17; 19. Adjustment Disorders/; 20. asthenia/ or myasthenia/ or neurasthenia/; 21. occupational stress/ or 
work related illnesses/; 22. *mental disorders/; 23. Reactive Depression/; 24. adjustment disorder*.tw.; 25. 
burnout.tw.; 26. reactive disorder*.tw.; 27. reactive depression.tw.; 28. (psychologic* or mental health or 
mental disorder* or depress* or anxi* or somat* or distress or stress).tw.; 29. ((sick* adj3 (leave or list* or 
absen*)) or (workplace or (work adj2 related)) or occupation* or job).tw.; 30. 19 or 20 or 21 or 22 or 23 or 
24 or 25 or 26 or 27 or (28 and 29); 31. employee leave benefits/; 32. employee absenteeism/; 33. 




reemployment/; 34. exp vocational rehabilitation/; 35. (sick adj3 (leave or list* or absen*)).tw.; 36. (return* 
adj3 work*).tw.; 37. ((sick* or absen*) adj5 (workplace or (work adj2 related) or occupation* or job)).tw.; 38. 
or/31-37; 39. 18 and 30 and 38 
 
Web of Science search terms 
1. Topic=(randomized controlled trial); 2. Topic=(randomi*ed); 3. Topic=(placebo); 4. Title=(trial); 5. 
Topic=(groups); 6. Topic=((singl* OR doubl* OR tripl* or trebl*) SAME (blind* OR mask* OR dummy)); 7. 
Topic=(control* SAME (trial* or study or studies or group*)); 8. Topic=(factorial* OR allocat* OR assign* OR 
volunteer* OR crossover* OR cross-over*); 9. Topic=(quasi SAME (experimental or random*)); 10. 1 OR 2 OR 
3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9; 11. Topic=("adjustment disorder*"); 12. Topic=(burnout); 13. 
Topic=(reactive SAME disorder*); 14. Topic=(reactive SAME depression); 15. Topic=(psychologic* OR mental 
health OR depress* OR anxi* OR somat* OR distress OR stress*); 16. Topic=((sick SAME (leave OR list* OR 
absen*)) OR (workplace OR (work SAME related) OR occupation* OR job)); 17. 15 AND 16; 18. 11 OR 12 OR 
13 OR 14 OR 17; 19. Topic=(absentee*); 20. Topic=(rehabilitat* SAME (vocation* or workplace)); 21. 
Topic=((sick* SAME leave) OR (sick* SAME list*) OR (sick* SAME absen*)); 22. Topic=(return* SAME 
work*); 23. Topic=((sick* OR absen*) AND (workplace OR (work SAME related) OR occupation* OR job)); 24. 
19 OR 20 OR 21 OR 22 OR 23; 25. 10 AND 18 AND 24 
  
International trial registers (ICTRP, clinicaltrials.gov) search terms 
The WHO Trials Portal (ICTRP) and ClinicalTrials.gov was searched by entering individual keywords and 
phrases related to return to work: "return to work"; "sick leave"; "absenteeism"; "vocational rehabilitation"; 
"sickness absence"; "workplace" 
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Prevention of recurrent sickness absence among 
employees with common mental disorders: Design 
of a cluster-randomised controlled trial with cost-
benefit and effectiveness evaluation  
 
I. Arends 
J.J.L. van der Klink 
U. Bültmann 
 
BMC Public Health 2010, 10: 132. 
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Background: Common mental disorders, such as depression, anxiety disorder, and 
adjustment disorder, have emerged as a major public and occupational health problem 
in many countries. These disorders can have severe consequences such as 
absenteeism and work disability. Different interventions have been developed to 
improve the return to work of employees with common mental disorders, but still a 
large proportion of employees experiences health and work problems after their return 
to work. For this reason, the SHARP-at work intervention is developed to prevent a 
relapse of sickness absence among employees who have returned to work after a 
period of sickness absence because of common mental disorders. We aim to evaluate 
the effectiveness, cost-benefit and process of the intervention compared to care as 
usual. 
Methods/Design: The study is designed as a cluster-randomised controlled trial with 
randomisation at the level of the occupational physician. Employees who have returned 
to work after a period of sickness absence because of a common mental disorder are 
included in the study. Employees in the intervention group will receive the SHARP-at 
work intervention. The intervention focuses on active guidance of employees by 
occupational physicians during the first weeks of work after sickness absence. 
Employees in the control group will receive care as usual. Outcomes will be assessed at 
baseline and at 3, 6, and 12 months follow-up. The primary outcome is cumulative 
recurrent sickness absence days. Secondary outcome measures are mental health, 
work functioning and coping. Adherence to the protocol, communication between 
stakeholders and satisfaction with the treatment are the process measures assessed 
in both study groups. Cost-benefit is calculated from a societal perspective. Finally, 
prognostic factors for a relapse of sickness absence are investigated. 
Discussion: This study goes beyond return to work by focussing on the prevention of 
recurrent sickness absence. The study incorporates not only outcomes on sickness 
absence and mental health but also on health-related work functioning. The results of 
this study can contribute to a further development of practice guidelines and the 
promotion of sustainable work participation. 













Common mental disorders (CMDs), such as depression, anxiety disorder and 
adjustment disorder, have emerged as a major public and occupational health problem 
in many countries1. Several studies have found a relationship between CMDs and long 
term sickness absence and work disability2-7. In the Netherlands, about one in every 
three new work disability benefit recipients is disabled for work because of mental 
health problems8,9. The increase in sickness absence and work disability because of 
CMDs has serious negative economic consequences calling for preventive 
action3,5,7,10,11. 
 Recently, attention is also given to the at-work decrements in performance because 
of CMDs which seem to be even more costly than absenteeism1,6,12-15. In their review, 
Lerner and Henke show that depression is significantly associated with a reduction in 
job performance and productivity; it was demonstrated that employees with a 
significant improvement in depression still have more trouble with performing well 
compared to their healthy colleagues6. These findings emphasize the importance of 
interventions aiming at employees with CMDs who are at work. Yet, most interventions 
for employees with mental health problems are curative and focus on reintegration16-20. 
No interventions exist which aim at providing support after return to work although it is 
known that employees who return to work often are not fully recovered from their initial 
complaints16-20. Moreover, research in the Netherlands showed that one out of five 
employees who have returned to work after a sickness absence period because of a 
CMD experiences a relapse of sickness absence due to CMDs (Koopmans et al., 
submitted for publication). For these reasons, we have developed an intervention 
aiming at the prevention of a relapse of sickness absence among employees who have 
(partially/fully) returned to work after a period of sickness absence because of a CMD. 
 The intervention is called “SHARP-at work.” SHARP is an acronym for Stimulating 
Healthy participation And Relapse Prevention. The intervention is based on the 
guideline “Management of mental health problems of workers by occupational 
physicians” of the Netherlands Society of Occupational Medicine. This evidence-based 
guideline, developed in 2000 and revised in 2007, is introduced to facilitate the return 
to work of employees on sickness absence because of mental health problems21,22. 
The goal of the guideline is to activate the employee when stagnation occurs in the 
process of problem identification, problem solving and implementation of solutions 
regarding issues that caused sickness absence and factors that hinder return to work. 
By this, employees learn to control their own recovery. The guideline has shown to be 
effective in reducing the number of employees who are on long-term sickness absence 
because of CMDs18,23,24. 
Chapter 3 | Study design for the evaluation of the SHARP-at work intervention 
80 
 
The SHARP-at work intervention is developed to improve problem solving strategies 
regarding problems or opportunities at work for employees who have returned to work. 
Successful implementation of solutions is stimulated by guiding employees in involving 
their line manager (i.e. the supervisor). This intervention will be implemented by the 
occupational physicians (OPs) of the employees. The goal of the intervention is the 
prevention of a relapse of sickness absence and improving mental health and work 
functioning.  
 Given the serious consequences of CMDs for the individual employee and the high 
social and economic costs for the workplace, the employer, the health system and 
society, the promotion of sustainable work participation among employees with CMDs 
is very important. Therefore, the primary aim of this study is to evaluate the 
effectiveness of the SHARP-at work intervention compared to care as usual (CAU) in 
preventing a relapse of sickness absence among employees who have returned to work 
after a period of sickness absence because of a CMD. We hypothesise that employees 
who return to work, after sickness absence because of a CMD, and undergo the 
SHARP-at work intervention will have less recurrent sickness absence days compared 
to employees who receive CAU. Secondary aims are to improve mental health and work 
functioning and to stimulate better coping mechanisms. In addition, the cost-benefit of 
the intervention will be examined. Along with these evaluations, we will conduct a 
process evaluation among employees, OPs and line managers. Finally, prognostic 
factors for a relapse of sickness absence will be investigated. To our knowledge, this is 
the first study focussing on guiding employees at work after they have returned to work 
because of a period of sickness absence due to CMDs.  
 
METHODS/DESIGN 
The CONSORT statement and the extension for cluster-randomised trials is used to 
describe the design of the study25,26.  
 
Study context 
In the Netherlands, both the employer and the employee are responsible for return to 
work. According to the Dutch Gate Keeper Act, the employer has a two-year obligation 
to pay an employee on sickness absence. After this period, the employee can apply for 
work disability benefit. During the first two years of sickness absence, the employer 
and the employee have to make all efforts possible to realise a return to work for the 
employee. For this reason, the employer is obliged to contract an occupational 
physician (OP). The employee has to visit the OP when being on sickness absence. OPs 
treat employees according to guidelines. For CMDs, the evidence-based guideline of 
the Netherlands Society of Occupational Medicine is used to support employees on 




sickness absence because of mental health problems21,22. The OP and the employee 
should be meeting each other regularly as long as the employee has not fully returned 
to work. After full return to work, at least one meeting should take place to focus on 
relapse prevention. In practice, OPs do not seem to act upon this last step of the 
guideline (Rebergen et al., submitted for publication). 
 
Study design 
The study is designed as a two-armed cluster-randomised controlled trial for the 
prevention of a relapse of sickness absence by the SHARP-at work intervention 
compared to CAU (Figure 1). The study is conducted among employees who have 
returned to work after a period of sickness absence because of a CMD. Randomisation 
occurs at the level of the OP because employees cannot be randomly assigned to OPs 
and OPs cannot be expected to provide both guidance according to the SHARP-at work 
intervention and CAU. OPs, who have given their consent for participation, are 
randomised in the intervention or control group. OPs in the intervention group receive 
training in the SHARP-at work intervention. OPs in the control condition do not receive 
this training until the end of the study period and provide CAU. 
 Employees will be included from December 2009 to December 2010. OPs will invite 
an employee to participate in the study if the employee is diagnosed with a CMD at the 
start of the sickness absence period and ready to return to work. Employees treated by 
an OP trained in the intervention will receive the intervention. Employees who are 
treated by an OP in the control group will receive CAU. Regardless of the treatment 
group, employees still have the possibility to be treated simultaneously by other health 
care workers. 
 The Medical Ethical Board of the University Medical Center Groningen has given 
approval for the study design, the research protocol, questionnaires, information letters 
and the informed consent. Employees can participate voluntarily in this study. They are 
informed that they can leave the study at any time without consequences. All 
employees sign an informed consent. If an employee drops out, care will be continued.  
 
Recruitment of occupational physicians 
Recruitment of OPs takes place in collaboration with ArboNed, one of the largest 
Occupational Health Services (OHS) in the Netherlands. OPs participating in this study 
are employed at this OHS and are affiliated with companies of different sizes, in 
different sectors and in different parts of the Netherlands. Company size ranges from 
less than five employees up to more than a 1000 employees in different sectors, for 
instance industry, education, health care and customer services. All regions in the 
Netherlands, except the south, are participating in the study. OPs are excluded when 
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they: 1. have an upcoming retirement, resignation, sabbatical, or pregnancy leave, or 2. 
are unable to use the internet and/or email.  
 
Figure 1. Study design. 
 
 
Recruitment of participants 
Inclusion criteria 
Employees participating in the study are between 18 and 63 years old and employed in 
a paid job. Furthermore, they have: 1. a diagnosis of a CMD given by their OP at the 
start of the sickness absence period, 2. a period of sickness absence due to a CMD of 
at least two weeks, and 3. a planned return to work within two weeks. 
 
Recruitment of OPs by researchers 
OPs randomly allocated to 
intervention or control group 
Training in intervention 
Recruitment of employees by OPs 
Informed consent & baseline 
questionnaire 
Intervention 
Follow-up questionnaires at 3, 6, and 
12 months 
No training 
Recruitment of employees by OPs 
Informed consent & baseline 
questionnaire 
 
Care as usual 
Follow-up questionnaires at 3, 6, and 
12 months 





Employees are excluded when: 1. the present sickness absence spell has been longer 
than 12 months, 2. they have had a period of sickness absence due to a CMD three 
months prior to the present sickness absence spell, 3. they have severe mental 
disorders, like psychotic disorders, bipolar disorder or post-traumatic stress disorder, 4. 
they have somatic complaints or disorders that have a predominant influence on work 
disability, 5. they are pregnant or have an upcoming retirement, resignation or layoff, 
and 6. they are unable to speak, read, write or understand the Dutch language.  
 
Procedure 
Employees are recruited by the OPs participating in the study. The OP checks all 
inclusion and exclusion criteria. The diagnosis of a CMD has been made by the OP at 
the start of the sickness absence period. OPs are trained in diagnosing mental 
disorders and use a nationwide coding system, Classification of Diseases (in Dutch: 
CAS)27, based on the International Classification of Diseases28. 
 If the employee is interested in participating in the study, the OP asks whether 
contact information of the employee can be given to the researcher (IA) and hands over 
an information folder about the study. After the employee has received the information 
and has given approval for the researcher to make contact, the OP gives the contact 
information to the researcher. The researcher contacts the employee and asks if the 
employee would like to participate in the study. If the employee is willing to participate, 
informed consent and the baseline questionnaire (electronic or paper version) are send 
to the employee with a postage paid envelope.  
 When the informed consent and the baseline questionnaire are filled in and 
returned to the researcher, OPs in the intervention group are informed that the 
intervention can be started. OPs in the control group keep on treating their employees 
according to CAU. Follow-up questionnaires are send to the employee at 3, 6 and 12 
months. At these points in time, administrative data on cumulative sickness absence 
days are also collected by means of the registry system of the OHS.  
 
Intervention 
Training of occupational physicians in the intervention group 
OPs receive a two-day training in the SHARP-at work intervention. Training is provided 
by experienced trainers in occupational health interventions.  
 
Treatment of participants in the intervention group 
The intervention consists of five steps the employee has to undertake when return to 
work is started. The OP monitors that the employee follows these steps and uses 
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interventions to activate the employee when needed. The five steps are delineated 
below.  
1. Make an inventory of problems and/or opportunities encountered at work  
2. Brainstorm on solutions  
3. Write down the solutions and the support needed and assess the applicability 
4. Discuss the solutions with the line manager and make an action plan 
5. Evaluate the action plan and the implementation of solutions 
 
The OP can use assignments for the employee to write down and structure the process. 
In general, the OP will counsel on the process level. (S)he does not discuss the content 
of problems and solutions but challenges the employee to reflect on the relative 
seriousness of problems and the feasibility of solutions. This can be done by asking 
questions that stimulate the employee to think about possible perspectives. This form 
of guidance is related to Socratic questioning. The intervention differs from the 
guideline of the Netherlands Society of Occupational Medicine by the emphasis on 
problems and possibilities encountered at work when an employee has already 
returned to work.  
  
Care as usual 
Training of occupational physicians in the control group  
All OPs participating in the study are trained in the guideline of the Netherlands Society 
of Occupational Medicine. There is no additional training of OPs in the control group as 
part of this study. At the end of the study period these OPs will be trained in the SHARP-
at work intervention if it proves to be effective. 
 
Treatment of participants in the control group 
CAU is delivered according to the evidence-based guideline of the Netherlands Society 
of Occupational Medicine21,22. CAU comprises guidance in regaining control and 
activating problem solving when the employee is still on sickness absence and at least 
one consultation session after return to work, addressing relapse prevention.  
 
Sample size 
For the power calculation, recurrent sickness absence days are considered the primary 
outcome measure. To calculate the sample size, administrative data from the sickness 
absence registry of the OHS was used. From 2001 to 2007, recurrent sickness 
absence days among employees, who returned to work after a period of sickness 
absence because of CMDs, were registered. For the power calculation, only recurrent 
sickness absence days of the first recurrence episode until 1 year later were used to 




approximate the 1 year follow-up of the present study (N=4443). The variance in 
recurrent sickness absence days at the level of the OP was taken into account. 
 During the above-mentioned period, the mean days of recurrent sickness absence 
was 68.5 (standard deviation is 119.6). The target of the present study is to reduce the 
recurrent sickness absence days with 20%, i.e. an average of 12.7 recurrent sickness 
absence days per employee per year. The OPs in this OHS’s dataset were randomly 
divided into two groups. One group was called “the intervention group” from which 20% 
of the recurrent sickness absence days was subtracted to create the difference 
between the intervention and control group and to calculate an effect size. 
 For a decrease of 12.7 recurrent sickness absence days per employee during 1 year 
at alpha = 0.05 and ICC = 0.05, 50 OPs, each providing five employees, need to be 
included in each group (the intervention and control group)29. The five employees must 
be viewed as the average number per OP. For this multilevel power calculation, an 
effect size of 0.18 was taken into account. This effect size was calculated by using a 
log-transformation on the data to create a normal distribution and subsequently by 
dividing the difference in mean days of recurrent sickness absence between the 
intervention and control group (difference is 0.25) by the standard deviation (standard 
deviation of difference is 1.4). To include the effect size in the multilevel power 
calculation, it had to be transformed to a correlation coefficient, which resulted in a 
correlation of 0.0930. 
 The collaborating OHS serves approximately one million insured employees. A total 
of 350 OPs is working for this OHS and each OP serves around 2500 to 3000 
employees. Of these employees it is estimated that 1.3% (30% of the national sickness 
absence rate among Dutch employees of 4.3%) will be on sickness absence because of 
a CMD during a 1 year period31. Therefore, an OP will see around 32 to 39 employees 
per year who are absent because of CMDs. Following this, the source population of the 
OHS is large enough to recruit the required number of OPs and employees according to 
the sample size calculation. 
 
Randomisation and treatment allocation 
Employees cannot be randomly assigned to OPs trained in the intervention or OPs not 
trained in the intervention because the OPs and employees are bound to each other by 
the company. It is also impossible to train all OPs and to let them randomly apply the 
intervention or CAU to employees because of the risk of contamination. Therefore, 
randomisation occurs at the level of the OP. OPs who have given their consent to 
participate in the study are randomly assigned to the intervention group or the control 
group. To ensure a good contrast between these two groups, OPs in the intervention 
group are specifically asked not to talk about the intervention with OPs in the control 
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group. Additionally, the OPs in the intervention group have two feedback meetings to 
discuss the application of the intervention with each other.  
 A computerised random allocation sequence for randomising the OPs is developed 
by an independent researcher. When all OPs are recruited, the independent 
researcher, who is blind to the identity of the OPs, uses the allocation sequence to 
randomise the OPs. After this, the allocation of the OPs cannot be changed and the 
independent researcher informs the researchers about the allocation of the OPs. The 
allocation of employees follows the allocation of their OP. Employees with an OP in the 
intervention group are automatically allocated to the intervention group and employees 
with an OP in the control group are automatically allocated to the control group.  
 
Blinding 
Validity can be threatened if employees in the intervention and control group would 
know about the other group. Because this study is a pre-randomised trial, in which the 
employees are already randomised before informed consent is given, different 
information about the study can be provided to the intervention and control group32. To 
ensure that employees are not aware and stay unaware of the two study conditions, 
the OPs are requested not to talk about this with the employees. Whereas employees 
are blinded for treatment allocation, blinding of allocation for OPs is not possible 
because they will know if they are trained in the intervention or not.  
 
Primary outcome 
The primary outcome measure is a relapse of sickness absence, measured as 
cumulative recurrent sickness absence days. A relapse is defined as a 30% decrease in 
working days per week or a decrease of at least one day per week because of sickness 
absence. Recurrent sickness absence days are operationalized as days of sickness 
absence among employees who have worked a steady amount of days during the first 
two weeks after they have returned to work. This information will be obtained by record 




Mental health problems 
The Four-Dimensional Symptom Questionnaire (4DSQ) is used to measure symptoms of 
distress, depression, anxiety and somatisation. The 4DSQ is a self-report questionnaire 
of 50 items and measures distress, depression, anxiety and somatisation. The 4DSQ 
has been validated in a primary care and working population33,34. 
 The HADS is a 14-item self-report questionnaire used to measure depression (7 
items) and anxiety (7 items)35. The questionnaire can be used in somatic, psychiatric 




and primary care patients, as well as in the general population36 and in working 
populations37. The HADS has been validated in different groups of Dutch subjects38. 
 
Work functioning 
Work functioning is measured by the Work Role Functioning Questionnaire (WRFQ)39,40. 
The questionnaire has been cross-culturally adapted and translated into Dutch and pre-
tested in a working population (Abma et al., submitted for publication). Results of the 
pre-test showed that the cross-cultural adaptation was successful. The WRFQ 
measures the perceived difficulties in meeting work demands among employees given 
their physical health or emotional problems. The WRFQ consists of 27 items divided 
into five subdomains: 1. work scheduling demands, 2. output demands, 3. physical 
demands, 4. mental demands, and 5. social demands.  
 
Coping behaviour 
Coping behaviour is measured by the 19-item version of the Utrecht Coping List (UCL) 
which assesses coping styles41. The questionnaire consists of the following five (coping 
style) scales: 1. active problem-focussing, 2. seeking social support, 3. palliative 
reaction pattern, 4. avoidance behaviour, and 5. expression of emotions.  
 
Economic evaluation measures 
Along with the sickness absence data from the OHS’s registry system, administrative 
data of the OHS on consultations of the employee with the OP and company welfare 
workers is collected. Furthermore, the Trimbos/iMTA questionnaire for Costs 
associated with Psychiatric Illness (Tic-P), a validated Dutch questionnaire, is used to 
measure medical consumption and at-work decrements in performance42. Finally, an 
extra item on out-of-pocket costs is added to the Tic-P to calculate medical expenses 
that are not covered by health insurance. 
  
Process evaluation measures 
A process evaluation is conducted to examine a) the appraisals, attitudes and activities 
of OPs, employees and line managers in the intervention and control group during the 
treatment period and b) whether OPs adhere to their protocol. OPs who are trained in 
the intervention receive a questionnaire before and after the training to examine the 
quality of the training and the skills and attitudes of the OPs. For the intervention 
group, a questionnaire is developed for the OP and the employee at baseline. These 
questionnaires contain items on readiness for change concerning the intervention. At 
3-months follow-up, the employees and the OPs in both the intervention and control 
group receive a questionnaire about the process of treatment during the first three 
months of return to work. The questions elaborate on what was discussed during the 
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consultations, whether assignments were given, which assignments were made, 
satisfaction with the treatment and communication between the employee, OP and line 
manager. For the intervention group, a questionnaire is also developed for the line 
manager. The line manager receives a questionnaire on readiness for change before a 
meeting takes place with the employee as part of the intervention. At 3-months follow-
up, the line manager receives a second questionnaire with the same questions as the 
questionnaires at 3 months for the employee and the OP. 
 
Prognostic measures 
Research on prognostic variables for a relapse of sickness absence has only been 
conducted in a few studies. For this reason, a range of variables is included in this 
study to investigate prognostic factors for a relapse of sickness absence. At baseline, 
the following variables are measured: personal characteristics (e.g. age, gender, 
marital status, educational level and physical health), job characteristics (e.g. tenure, 
size of the company, sector, profession, contract type, number of contract hours before 
and after sickness absence and work accommodations after return to work) and 
psychosocial work characteristics (job demands, decision latitude, social support43,44, 




Due to the multilevel design of the study (i.e. employees are nested in OPs), multilevel 
regression analyses will be performed according to the intention-to-treat principle. Per 
protocol analyses will be conducted to explore if deviations from the protocol have 
caused bias. Descriptive statistics will be used to measure differences in baseline 
characteristics between the intervention and control group. In case of significant 
differences, these will be controlled for in the effect evaluations. 
 
Effect evaluation 
The primary outcome variable “cumulative recurrent sickness absence days during 
follow-up” will be compared between the intervention and control group in the 
multilevel regression analyses. Time until a relapse of sickness absence will be 
examined by using Cox proportional hazard analysis to estimate hazard ratio’s for a 
relapse and the 95% confidence interval. In case no software is available to conduct 
these analyses in a multilevel structure, cluster level survival analyses will be 
conducted with means for each cluster. In these analyses, cluster size will be 
introduced as a weighting factor. To investigate differences between the intervention 
and control group in changes (improvement) on all secondary outcomes, multilevel 
longitudinal analysis will be used. Pre-planned subgroup analyses on type of CMD, line 




manager participation in the study, size of the company, perceived decision latitude, 
type of work and expectancy to stay-at-work will be conducted. 
 
Economic evaluation 
The economic evaluation will be performed as a cost-benefit analysis from a societal 
perspective. For this evaluation, the primary outcome measure, i.e. the number of 
recurrent sickness absence days after return to work, will be expressed in monetary 
terms. The time window will be from return to work until 1 year follow-up. Discounting 
will not be applied. Both direct and indirect costs will be measured and valued. Costs of 
the intervention will be calculated by using the hourly wages of OPs. All contacts 
between the OP and the employee will be registered. The costs of health care 
consumption outside the intervention will be calculated by using tariffs of Dutch 
Guideline prices47 based on information collected by the Tic-P questionnaire42. Out-of-
pocket costs made by the employees in relation to their condition will also be included. 
The indirect costs of production losses due to sickness absence and presenteeism will 
be calculated by using the Friction costs method48,49 according to the Dutch guidelines 
for economic evaluation47.  
 
DISCUSSION 
This study is designed to investigate if employees, who have returned to work after a 
period of sickness absence because of a CMD, benefit from extra support during their 
first weeks of return to work. Effectiveness analyses will be performed to examine if the 
SHARP-at work intervention is successful in reducing recurrent sickness absence days 
compared to CAU. A cost-benefit analysis will be conducted to evaluate if the 
intervention is efficient, e.g. if better results are not at the expense of higher costs. 
Furthermore, the process of the intervention will be evaluated by inquiring employees, 
OPs and line managers on adherence to the protocol and satisfaction with the 




This study design has important strengths. First of all, the cluster-randomisation 
diminishes the risk of contamination of employees participating in the study. OPs are 
randomised in the intervention or control group, i.e. they will only treat employees, 
participating in the study, according to the SHARP-at work intervention or CAU. 
Furthermore, OPs in the intervention and control group work for different companies or 
for different departments of big companies. Hence, it is unlikely that employees in the 
intervention group will get in contact with employees in the control group. Additionally, 
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the pre-randomisation in the cluster design makes it possible to blind employees for 
the study condition. Another strength of this study is the combination of objective and 
subjective data. Recurrent sickness absence days are not only measured by asking the 
employees on days of sickness absence after their return to work, but also by the 
OHS’s sickness absence registry system. Finally, the study covers a large geographical 
area in the Netherlands and companies of different sizes and sectors are included. This 
will make it possible to generalise the results to a relatively large working population. 
 A limitation of the study is the inclusion of participants by the OPs. The possibility 
exists that OPs in both study groups select those employees who have, in their view, 
good potential for fast recovery and small chances for a relapse of sickness absence. 
Although it has been stressed to all OPs to invite all employees eligible for the study, we 
cannot exclude the possibility of bias. Questions to investigate if participating 
employees were thought to be more suitable for the study are included in the process 
evaluation for OPs. Another possibility for bias to occur is the selection of employees 
who have a good relationship with their OP. Unfortunately, we cannot exclude this bias, 
but we ask questions in the process evaluation on the relationship between the OP and 
the employee. Finally, recruiting 500 employees for the study is a challenge. Most 
studies in this field have problems with recruiting participants. We have tried to 
minimise these problems by embedding this study in one large OHS. All participating 
OPs work for the same OHS and are stimulated to contribute to the study by this OHS. 
Moreover, we expect fewer refusals to participate because OPs invite employees to 
participate in the study. The OP has already built a relationship with the employee 
which will contribute to a safe environment to make the choice to participate in the 
study.  
 
Relevance/impact of results 
This study goes beyond return to work by focussing on sustainable work participation 
after return to work. It incorporates not only outcomes on sickness absence and mental 
health but also on health-related work functioning. The study has a high societal 
relevance because costs for sickness absence could be lowered and a sustainable 
working life could be facilitated. Furthermore, OPs and other occupational health 
professionals may benefit from the intervention as it could serve as an extension of the 
already existing guideline of the Netherlands Society of Occupational Medicine. Results 
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Objectives: Workers with common mental disorders (CMDs) frequently experience 
recurrent sickness absence but interventions to prevent this are lacking. The goal of 
this study was to evaluate the effectiveness of the SHARP-at work intervention in 
preventing recurrent sickness absence in workers who returned to work after sickness 
absence due to CMDs. 
Methods: We performed a cluster-randomised controlled trial with 3, 6 and 12 months 
follow-up. Treatment providers were randomised to either a 2-day training in the 
SHARP-at work intervention, a problem solving intervention, or usual care. Primary 
outcome measures were the incidence of recurrent sickness absence and time to 
recurrent sickness absence. Secondary outcome measures were mental health 
complaints, work functioning and coping behaviour. 
Results: 80 participants were randomised in the intervention group and 78 in the 
control group. The adjusted odds ratio for the incidence of recurrent sickness absence 
was 0.40 (95% confidence interval (CI) 0.20 to 0.81) and the adjusted hazard ratio for 
time to recurrent sickness absence was 0.53 (95% CI 0.33 to 0.86) for the intervention 
group compared to CAU.  
Conclusions: This study demonstrates the 12-month effectiveness of a problem solving 
intervention for reducing recurrent sickness absence in workers with CMDs and 
emphasizes the importance of continuous attention for workers who have been on 
sickness absence due to CMDs.  
Trial registration number: NTR1963. 




Common mental disorders (CMDs), such as depressive, anxiety and adjustment 
disorders, are an important contributor to the global burden of disease1-4. Besides the 
detrimental effects on the individual, CMDs have an enormous impact on society in 
terms of medical care consumption, work disability and associated costs3,5-14. 
Moreover, reduced job performance persists after clinical improvements in mental 
health complaints15,16, and workers with CMDs frequently experience recurrent 
sickness absence. Recent findings from the Netherlands and Finland have shown that 
20% to 30% of the workers who returned to work after sickness absence due to CMDs 
experience recurrent sickness absence. Moreover, the risk of sickness absence due to 
a CMD is higher in workers with previous sickness absence due to a CMD compared to 
a general worker population17-19. In several studies, cognitive behavioural and problem 
solving interventions have been evaluated for effectiveness in facilitating return to work 
(RTW) of workers on sickness absence due to CMDs20-25. These studies have used RTW 
as main outcome measure, but little attention has been given to preventing recurrent 
sickness absence.  Recurrent sickness absence, however, has a major health impact 
because frequent sickness absence episodes are related to an increased risk of work 
disability in later years19,26. Furthermore, recurrent sickness absence after an initial 
sickness absence episode due to a CMD is often more serious and long-lasting17. 
Hence, interventions that focus on the treatment of workers with CMDs after RTW to 
prevent recurrent sickness absence are of paramount importance.  
 To our knowledge, no interventions have been developed and evaluated that focus 
on the prevention of recurrent sickness absence after RTW. This study aims to evaluate 
the effect of the Stimulating Healthy participation And Relapse Prevention at work 
(SHARP-at work) intervention, developed to prevent recurrent sickness absence in 
workers who returned to work after sickness absence due to CMDs. The intervention 
was based on the guideline “Management of mental health problems of workers by 
occupational physicians” of the Netherlands Society of Occupational Medicine. This 
evidence-based guideline, developed in 2000 and revised in 2007, aims to facilitate 
RTW of workers on sickness absence due to mental health problems by OPs28. The 
guideline is effective in improving RTW in workers on sickness absence due to 
CMDs20,29. According to the guideline, one relapse prevention consultation has to take 
place after RTW, but this is rarely done by OPs30. The SHARP-at work intervention was 
developed to prevent recurrent sickness absence by structuring OP treatment after 
RTW. We hypothesize that compared to care as usual the SHARP-at work intervention 
(1) prevents recurrent sickness absence, (2) reduces mental health complaints and (3) 
enhances work functioning and problem solving coping. 
 




Study setting and participants 
The study was designed as a cluster-randomised controlled parallel-group trial (cluster-
RCT). Occupational physicians (OPs), responsible for conducting the intervention, were 
recruited through 365/ArboNed, one of the largest Occupational Health Services (OHS) 
in the Netherlands. Research participants were recruited by participating OPs. Inclusion 
criteria were: age 18 to 63 years; employed in a paid job; a diagnosis of a CMD given by 
the OP (based on ICD-10 codes) at the start of the sickness absence period; an episode 
of sickness absence of at least two weeks; a planned RTW within two weeks (so the 
intervention could start directly when a worker started RTW). Exclusion criteria were: a 
sickness absence episode >12 months; a prior sickness absence episode due to a 
CMD in the past three months; severe mental disorders, such as psychotic disorder or 
bipolar disorder; somatic complaints/disorders that would affect RTW; pregnancy, an 
upcoming retirement/resignation/lay-off; not able to read, write and understand Dutch. 
More detailed information on the study design can be found elsewhere27. The Medical 
Ethical Board of the University Medical Center Groningen provided approval for the 
study design, the research protocol, questionnaires, information letters, and the 
informed consent. Participants participated voluntarily in this study and signed an 
informed consent.  
 
Interventions 
SHARP-at work intervention 
The intervention guides the workers through a five-step problem solving process to find 
and implement solutions for problems experienced when back at work. Consultations 
between the worker and supervisor are included in this process as research showed 
that the importance of the supervisor in the RTW process is stressed by workers and 
health care professionals31,32. The following five-step problem solving process had to 
be followed by the worker when RTW was started: 
• Make an inventory of problems and/or opportunities encountered at work 
after RTW 
• Brainstorm about solutions 
• Write down solutions and the support needed and assess the applicability of 
these solutions 
• Discuss solutions and make an action plan with the supervisor 
• Evaluate the action plan/implementation of solutions 
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The OP started the intervention when the workers were in their first two weeks of RTW, 
monitored that all steps were taken and activated and supported the worker when 
needed. The role of the OP was to counsel the worker on the process level; not to 
comment on the content of the problems or solutions of the worker. The OP 
empowered the worker to define his own problems and design his own solutions. Two 
to five consultations were recommended to the OPs within three months after RTW 
started depending on what was necessary for the individual worker, but two 
consultations were set as a minimum to be able to conduct the intervention. In the 
Netherlands, OPs have about 30 minutes for a consultation, thus this was the length of 
the consultations in the intervention group. The first of five assignments (i.e. making an 
inventory of problems and opportunities and assessing the help needed to solve them) 
instigated the problem solving process and was therefore a key element. More detailed 
information on the intervention's content and process evaluation is described 
elsewhere (Arends et al., submitted). 
 OPs received a two-day training in the intervention, provided by experienced trainers 
in occupational health interventions. Three feedback moments of two hours were 
organised to jointly discuss problems and successes with conducting the intervention.  
 
Care as usual 
OPs of the OHS delivered care as usual (CAU) according to the guideline on 
“Management of mental health problems of workers by occupational physicians”28. No 
additional training of OPs in the control group was provided as part of the study.  
 
Primary outcome measure 
Recurrent sickness absence 
Based on administrative data of the OHS, we measured recurrent sickness absence 
days and recurrent sickness absence incidence due to all causes at three, six and 12 
months follow-up and time to first episode of recurrent sickness absence (measured in 
calendar days). Recurrent sickness absence was defined as ≥ 30% decrease in working 
days per week due to sickness absence, regardless of partial or full RTW. No limits 
were set on a minimum or maximum time period for which the ≥ 30% decrease should 
hold. When a worker returned to <30% decrease in working days per week, this was 
recorded as the end of the recurrent sickness absence episode. In the Netherlands, 
RTW is gradually built up, and, therefore, recurrent sickness absence could also occur 
during RTW and not only after full-time RTW. Recurrent sickness absence days were 
corrected for part-time sickness absence by dividing the sickness absence days by 
1/RTW percentage.  
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Secondary outcome measures 
Mental health complaints 
The Hospital Anxiety and Depression Scale (HADS) was used to assess depression and 
anxiety (each 7 items). The questionnaire has been validated for working populations33 
and for the Dutch population34. Each item is scored on a 4-point Likert scale indicating 
the extent to which an item was experienced in the past week. The Four-Dimensional 
Symptom Questionnaire (4DSQ) was used to assess symptoms of distress, depression, 
anxiety and somatisation. The 4DSQ has been validated in a primary care and working 
population35,36. It consists of 50 items in four subscales (somatisation, distress, anxiety 
and depression) and is scored on a 5-point Likert scale ranging from 1 = no to 5 = very 
often or continuous. Lower scores indicate lower symptom levels. 
 
Work functioning 
Work functioning was assessed with the Work Role Functioning Questionnaire, which 
has been cross-culturally adapted to the Dutch language and is validated in the 
working population 37,38.  The WRFQ assesses the perceived difficulties in meeting work 
demands given physical or emotional problems. It contains 27 items, scored on a 5-
point Likert scale from 100% (all of the time) to 0% (none of the time), with an option to 
score “not applicable.” Scores are converted to 0 and 100, with higher scores 
indicating better work functioning. 
 
Coping behaviour 
Coping behaviour was assessed with the 14-item version of the Utrecht Coping List 
(UCL)39. The questionnaire consists of three (coping style) scales: (1) active problem 
focused coping, (2) emotional coping and (3) looking for distraction and decreasing 
tension. Each item is scored on a 4-point Likert scale ranging from 1 = seldom or never 
to 4 = very often. Lower scores indicate low usage of a certain coping style. 
 
Sample size 
The sample size calculation was based on the outcome of recurrent sickness absence 
days. Recurrent sickness absence days of a first recurrent episode (after full RTW) 
within one year were extracted from the OHS sickness absence registry, including 4443 
workers. The variance in recurrent sickness absence days at OP level was taken into 
account. The mean number of days of recurrent sickness absence was 68.5 
(SD=119.6). The target of the present study was to reduce recurrent sickness absence 
days with 20% (i.e. 12.7 days). We calculated that 25 OPs per group were needed, 
each providing five participants, in order to have 80% power to find a mean difference 
in decreased recurrent sickness absence days during 1 year follow-up of 12.7 days, 
assuming an alpha of 0.05 and an intraclass correlation coefficient of 0.0540.  




Randomisation took place at OP level because participants could not be randomly 
assigned to OPs. A computerised random allocation sequence was developed by an 
independent statistician to randomise the OPs over the SHARP and the CAU group. 
When all OPs were recruited, the independent researcher, who was blinded to the 
identity of the OPs, used the allocation sequence to randomise the OPs. After 
randomisation, the allocation of the OPs could not be changed and the statistician 
informed the researchers about OP allocation.  
 
Blinding 
In this pre-randomised trial, the allocation of the participants was already decided 
based on the allocation of their OPs. Therefore, we were able to provide different 
information about the study to the intervention and control group41. Participants were 
blinded for study design and group comparison. Blinding OPs for allocation was not 
possible. An independent researcher at the OHS, blinded for study group, collected the 
administrative data on recurrent sickness absence days.  
 
Statistical analyses 
Baseline characteristics of the participants were compared to assess the success of 
randomisation. Per follow-up measurement, the number of workers with a recurrence 
and the median number of recurrent sickness absence days were calculated per study 
group. We predefined the following potential confounders based on previous 
research42-45:  age, sex, educational level, mental health complaints and days of 
sickness absence at baseline. All outcome measures were assessed at baseline and at 
three, six and 12 months follow-up. 
 
Primary outcome measures  
Differences in number of recurrent sickness absence days between the two treatment 
groups were not analysed because of the skewed distribution; at each follow-up 
measurement, more than 50% of the study population had no recurrent sickness 
absence days. We examined the difference in incidence of recurrent sickness absence 
between the two treatment groups during follow-up with multilevel longitudinal 
regression analyses to account for the three-level design. In addition, we included 
interaction terms of treatment X time to assess whether he difference between the two 
groups changed between the three follow-up measurements. Crude analyses were 
followed by analyses adjusted for the predefined confounders. Kaplan-Meier survival 
analyses were conducted to compare time to first recurrent sickness absence episode 
in the two treatment groups. Participants were censored when lost to follow-up or when 
recurrent sickness absence had not occurred at the end of the 12 months follow-up 
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period. The cox proportional hazard model was used to estimate hazard ratios (HR). 
The proportional hazard assumption was tested46. A separate model was run to adjust 
for the predefined confounders. No clustering effect was found in the multilevel logistic 
regression analyses, i.e. we did not adjust for clustering in the cox model. 
 
Secondary outcome measures 
To assess differences between the two treatment groups on mental health complaints, 
work functioning and coping behaviour, linear mixed models with unstructured 
covariance matrices were used.  
 
Effect modification 
We analysed modification of the group effects by size of company, decision latitude 
and readiness to stay at work. Company size was assessed with one single question 
and dichotomised to <100 workers versus >100 workers. Decision latitude was 
assessed with the Job Content Questionnaire47,48. Items were scored on a 4-point Likert 
scale ranging from 1 = totally disagree to 4 = totally agree. Scores were divided into the 
following tertiles: 34-64, 65-72 and 73-92). Readiness to stay at work was assessed 
with the Readiness to Stay at Work Scale49. Scores were divided at the 50% percentile 
to form two groups (scores 10-20 and scores 21-29).  Subgroups were too small to 
conduct subgroup analyses on ICD-10 diagnosis, supervisor participation in the RTW 
process and type of occupation.  
 
All analyses were performed according to the intention-to-treat principle. We used 
MLwiN, version 2.23 and SPSS, version 20.0, for the analyses.  
 
RESULTS 
Between January 2010 and June 2011, OPs recruited 212 workers. Of these workers, 
158 agreed to participate in the study. Recruitment fell short according to the sample 
size calculation and reasons for the recruitment problems have been described 
extensively elsewhere (Arends et al., submitted for publication). Workers who did not 
want to participate did not significantly differ from those who agreed to participate with 
regard to gender and age. The participant flow and reasons for non-participation are 
presented in Figure 1. Of the 158 included participants, 80 participants were 
randomised to the SHARP group and 78 participants to the CAU group. Table 1 shows 
the baseline characteristics of the participants in both groups. Follow-up 
measurements ended in June 2012. 
 
 



































SHARP = intervention group; CAU = care as usual group; OP = occupational physician. 
*Reasons for withdrawal from the study for the intervention group were: health problems (n = 1), research 
too burdensome (n = 2), a new OP (n = 1), pregnancy (n = 1), no time (n = 2), job loss (n = 2) or unknown (n = 
14). Reasons for the control group were: health problems (n = 1), research too burdensome (n = 1), job loss 
(n = 2), refused (n = 2), no time (n = 2) or unknown (n = 20). Numbers pertain to the secondary outcome 
measures. 
 
Figure 1. Flowchart of participant recruitment, allocation and outcome assessment. 
OPs randomised 
n = 253 
SHARP 
n = 126 OPs 
CAU 
n = 127 OPs 
Trained in 
intervention 
n = 73 OPs 
Received 
information 
n = 81 OPs 
Excluded: n = 53  
  Refused to  
  participate n = 53 
Excluded: n = 46  
  Refused to  
  participate n = 46 
Workers recruited 
by OPs 
n = 109 
Workers recruited 
by OPs 
n = 103 
SHARP 
n = 80 workers 
Excluded: n = 29  
 No reaction n = 9 
 Did not meet inclusion 
 criteria n = 13 
 Too burdensome n = 4 
 Refused n = 3 
3-month follow-up 
n = 71 workers 
6-month follow-up 
n = 67 workers 
12-month follow-up 
n = 57 workers 
Excluded: n = 25  
 No reaction n = 15 
 Did not meet inclusion 
 criteria n = 8 
 Too burdensome n = 1 
 Refused n = 1 
CAU 
n = 78 workers 
3-month follow-up 
n = 67 workers 
Withdrew from 
study: n = 9* 
Withdrew from 
study: n = 11* 
6-month follow-up 
n = 55 workers 
Withdrew from 
study: n = 4* 
Withdrew from 
study: n = 12* 
Withdrew from 
study: n = 10* 
12-month follow-up 
n = 50 workers 
Withdrew from 
study: n = 5* 
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(n = 80) 
 CAU 
(n = 78) 
Characteristics M / n SD / %  M / n SD / % 
Socio-demographic characteristics    
 Age (years) 41.3 9.4  43.3 9.8 
 Gender (male) 27 33.8  38 48.7 
 Marital status (married or living together) 67 83.8  60 76.9 
 Breadwinner (yes) 40 50.0  49 62.8 







16.7  Low 
 Intermediate 36 45.0  40 51.3 
 High 38 47.5  23 29.5 
Clinical characteristics    







15.4  F32.9 Depressive episode, unspecified 
 F41.9 Anxiety disorder, unspecified 0 0.0  2 2.6 
 F43.2 Adjustment disorders 58 72.5  39 50.0 
 F43.9 Reaction to severe stress, 
unspecified 
1 1.25  0 0.0 
R45 Symptoms and signs involving 
emotional state  
7 8.75  14 17.9 
Z73.0 Burn-out 2 2.5  7 9.0 
Other 8 10.0  4 5.1 
Work-related characteristics    
 Type of occupation    
 Commercial service providers 23 28.8  11 14.1 
 Management 11 13.8  15 19.2 
 Administrative staff 19 23.8  12 15.4 
 ICT staff 4 5.0  4 5.1 
 Sales staff 2 2.5  5 6.4 
 Health care providers 12 15.0  12 15.4 
 Hotel and catering staff 3 3.8  0 0.0 
 Stock and/or transport staff 1 1.3  11 14.1 
 Designers/planners 3 3.8  2 2.6 
 Mechanics/repairmen 2 2.5  5 6.4 
 Employment (hours per week) 32.6 7.0  32.9 7.3 
 Irregular work (e.g. shift work) 6 7.5  10 12.8 
 Executive/manager responsibilities 23 28.8  21 26.9 
 WRFQ-Total score 66.9 15.5  61.0 20.0 
 RTW % 48.7 32.2  43.1 27.2 
 Duration of sickness absence 130.9 94.2  99.3 66.1 
Health-related characteristics    
 4DSQ Distress 13.8 7.5  15.5  7.5 
 Depression 1.5 2.1  2.0  2.4 
 Anxiety 3.1 3.3  3.6   3.5 
 Somatisation 7.9 5.3  7.9   5.5 
 HADS Depression 7.0 4.5  7.3   4.4 
 Anxiety 7.2 3.9  7.8   3.4 
SHARP = intervention group; CAU = care as usual group; OP = occupational physician; WRFQ = Work Role 
Functioning Questionnaire; 4DSQ = Four-Dimensional Symptom Questionnaire; HADS = Hospital Anxiety and 
Depression Scales; M = mean; SD = standard differentiation. 
 
 
Loss to follow-up 
Administrative data on recurrent sickness absence at three, six and 12 months follow-
up and time to recurrent sickness absence were available for 147 participants (N=72 
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for the SHARP group and N=75 for the CAU group). For six participants, administrative 
data could not be retrieved. Furthermore, one participant who became pregnant and 
experienced pregnancy-related complaints and four participants who left their company 
during follow-up were censored. For the self-reported outcomes, 20 participants did not 
respond at three months follow-up, 36 participants at six months follow-up and 51 
participants at 12 months follow-up. Reasons for non-response per study group are 
reported in Figure 1. No significant differences were found between respondents and 
non-respondents for age, sex, educational level, mental health complaints and duration 
of sickness absence at baseline. 
 
Non-compliance 
At three months follow-up, 67 participants of the SHARP group completed a 
questionnaire on received intervention components. Of this group, 43 (64%) 
participants reported that they had two or more consultations with the OP and had 
made the first intervention assignment.  
 
Co-interventions 
In the intervention group, two participants (2.5%) reported that they visited a 
psychiatrist, 34 (42.5%) a psychologist (mean number of visits in a 4-week period was 
1.6) and one (1.3%) a social worker. Seven participants (9%) reported that they used 
psychopharmacologic medication. In the control group, nine participants (12%) 
reported that they visited a psychiatrist, 21 (27%) a psychologist (mean number of 
visits in a 4-week period was 1.7) and three (3.8%) a social worker. 
Psychopharmacologic medication was used by 15 participants (19%).  
 
Recurrent sickness absence 
Compared to CAU, the SHARP group had a lower incidence of recurrent sickness 
absence. In both groups, the median number of recurrent sickness absence days was 
0 at all follow-up measurements, but there were some differences between the 75th 
percentiles of the two groups (Table 2). The multilevel logistic regression analyses 
showed that, when adjusted for confounders, the OR for recurrent sickness absence of 
the SHARP group compared to CAU was 0.40 (95% CI 0.20 to 0.81). Analysis of the 
interaction between group and time showed that the effect of the SHARP-at work 
intervention on recurrent sickness absence did not significantly differ at the different 
time points (Table 3). None of the subgroup analyses on company size, decision 
latitude and readiness to stay at work showed a significant interaction with treatment 
group on the incidence of recurrent sickness absence.  
 
 




Table 2. Number of workers with a recurrent sickness absence episode and the 
duration of recurrence in the SHARP and CAU group 
  SHARP   CAU  
Outcome T1 T2 T3 T1 T2 T3 
Recurrence, n (%) 8 (11) 15 (21) 24 (34) 17 (22) 29 (39) 35 (47) 
Recurrent sickness absence days, 
median (IQR) 
0 (0-0) 0 (0-0) 0 (0-5) 0 (0-0) 0 (0-4) 0 (0-8) 
SHARP = intervention group; CAU = care as usual group; IQR = interquartile range 25th – 75th percentile; T1 = 
3 months, T2 = 6 months, T3 = 12 months. 
 
 
Time to recurrent sickness absence 
Figure 2 shows the cumulative survival curves of time to first recurrent sickness 
absence episode for the SHARP and CAU group. Because the event was defined as first 
recurrent sickness absence, longer survival indicated a favourable outcome. The 
SHARP group had a median of 365 days (inter quartile range (IQR) 174 to 365) to 
recurrent sickness absence and the CAU group had a median of 253 days (IQR 117 to 
365) (Log Rank test; p = 0.003). When adjusted for confounders, time to recurrent 
sickness absence was significantly longer in the SHARP group compared to the CAU 
group (adjusted HR = 0.53, 95% CI 0.33 to 0.86). No violation was found of the 
proportional hazards assumption based on three analyses of interactions between 
treatment group and dichotomised time variables. The three time variables were 
constructed using three different cut-off points based on time points in the survival plot 
that seemed to indicate a change in survival between the two groups (at 100, 150 and 
200 days). 
 
Mental health complaints, work functioning and coping behaviour 
The effect of the intervention on mental health complaints, work functioning and 
coping behaviour are presented in Table 3. Both treatment groups improved on mental 
health complaints and work functioning. No clear differences were found between the 
two groups on mental health complaints at the follow-up measurements. The SHARP 
group had a better score on work functioning at 12-month follow-up and slightly higher 
usage of all three coping behaviours at all follow-up measurements. No significant 
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CAU = care as usual (n = 76); SHARP = intervention group (n = 74). 
 
Figure 2. Cumulative probability of recurrent sickness absence from baseline 




Our primary aim was to evaluate if the SHARP-at work intervention was effective in 
preventing recurrent sickness absence compared to CAU. At each follow-up 
measurement, the incidence of recurrent sickness absence was lower in the SHARP 
group compared to the CAU group. The adjusted OR for the incidence of recurrent 
sickness absence was 0.40 (95% CI 0.20 to 0.81) in favour of the SHARP group. At six 
months follow-up, i.e. three months after the intervention was finished, the biggest 
difference was found between the SHARP and CAU group in incidence of recurrent 
sickness absence. However, no significant interaction was found between group and 
time indicating that the effect of the SHARP-at work intervention did not significantly 
differ between three, six and 12 months follow-up. Time to first recurrent sickness 
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group (median number of 112 days longer for the SHARP group). The expected effects 
on improved work functioning and problem solving coping and reduced mental health 
complaints were not observed.  
 Currently, no other studies have been published on the effects of an intervention to 
prevent recurrent sickness absence in workers with CMDs. Van der Klink et al. (2003), 
evaluated an intervention that was primarily aimed at enhancing RTW in workers with 
adjustment disorders, but also the effect on recurrent sickness absence was analysed. 
The authors found no significant differences between the intervention and control 
group on incidence of recurrent sickness absence and time to recurrent sickness 
absence20. Although the SHARP-at work intervention is comparable to the intervention 
of van der Klink et al., the different results might be explained by the different timing of 
the interventions. Whereas the intervention of van der Klink et al. took place at the 
start of and during the sickness absence period and focused on helping the worker to 
RTW, the SHARP-at work intervention is offered when a worker has started RTW and 
focuses on the prevention of recurrent sickness absence and helping the worker to 
stay at work. The process evaluation, which was conducted alongside the effect 
evaluation, showed that the intervention was conducted as planned. Compared to the 
CAU group, participants in the SHARP group had significantly more often ≥2 
consultations with the OP and ≥1 consultation with the supervisor and made 
significantly more assignments (Arends et al., submitted for publication). Therefore, we 
conclude that the observed effect on recurrent sickness absence is due to the 
intervention. The SHARP-at work intervention could be used as an extension of the 
intervention of van der Klink et al. (which has become a guideline for OPs in the 
Netherlands), reinforcing the problem solving process at the moment workers are back 
at work and preventing recurrent sickness absence. Our finding that the SHARP-at work 
intervention did not cause significant reductions in mental health complaints compared 
to CAU, is corroborated by findings of several other studies on the effectiveness of 
different types of interventions (e.g. cognitive behavioural treatment, problem solving 
treatment and occupational therapy) to enhance RTW in workers with mental health 
problems20-23. Thus, the effect on recurrent sickness absence cannot be explained 
through a mediating effect of better mental health. In the literature, explanations for 
the lack of effect on mental health complaints vary. It has been suggested that usual 
care is of such quality that a difference in symptom level is hard to achieve or that 
natural recovery may hinder the detection of treatment effects21. Another explanation 
could be that the interventions are primarily aimed at improving social functioning and 
not the reduction of mental health complaints21, as is the SHARP-at work intervention. 
Finally, participants might already have a higher level of mental health complaints 
before they develop a mental disorder (trait effect)50.  
 




Strengths and limitations 
A strength of this study is the cluster-randomised design which allowed participant 
blinding. Participants knew the study was aimed at investigating the treatment process 
after the start of RTW but were unaware that groups were compared. Because 
participants were recruited by OPs that worked for companies of different sizes, in 
different sectors and in different parts of the Netherlands, our study population was 
quite diverse regarding type of occupation, company size and geographical location. 
This enhances the generalizability of our results. A problem of the study is that we 
could not recruit the number of participants according to the sample size calculation. 
Furthermore, the sample size calculation was based on the outcome of recurrent 
sickness absence days which we were not able to analyse due to a very skewed 
distribution. However, we were able to detect relevant differences between the SHARP 
and CAU group for the incidence of recurrent sickness absence and time to recurrent 
sickness absence. The distribution of baseline characteristics between the SHARP and 
CAU group showed that there were some differences between the two groups regarding 
gender, educational level and sickness absence days. For the variable “educational 
level,” this was probably due to selection bias by OPs in the SHARP group. During 
feedback moments, OPs mentioned that it was easier to conduct the intervention with 
more highly educated workers, and as the baseline data show, participants in the 
SHARP group were more highly educated. All analyses were adjusted for baseline 
differences in educational level, sickness absence, gender, age and mental health 
complaints. However, the results might not be generalisable to workers with a low 
educational level. Finally, we could not distinguish between different causes of 
recurrent sickness absence because the reasons for the recurrences were not 
consistently registered in the administrative database.  
 
Future research 
Although the incidence of recurrent sickness absence was significantly lower in the 
SHARP group compared to the CAU group, the SHARP group had a considerable 
amount of recurrent sickness absence episodes at six and 12 months follow-up (21% 
and 34% respectively). Because the SHARP-at work intervention took place during the 
first three months following return to work, future research should investigate whether 
follow-up “booster” treatment after six months might help to further reduce recurrent 
sickness absence and enhance mental health and work functioning. It would be 
interesting to investigate the long-term effects of the intervention. Furthermore, an in-
depth investigation of the specific characteristics of the group of workers that 
experience recurrent sickness absence, persistent mental health complaints and work 
functioning problems can help to focus the intervention on the needs of the most 
vulnerable group. Although both the SHARP and CAU group showed a reduction in 
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mental health complaints, both groups still had relatively high scores on some of the 
mental health scales at 12 months follow-up. In addition, both treatment groups 
showed improvements in work functioning over time, but after 12 months follow-up the 
mean score on work functioning was still lower compared to a healthy working 
population38. Possibly, not being fully recovered from mental health complaints 
impedes optimal work functioning, which would explain why both study groups still had 
sub-optimal work functioning scores. For example, in a recent study, Lerner et al. 
(2012) found that a work-focused intervention for workers with depression, who were 
not on sickness absence, decreased depression symptom severity and increased at-
work performance51. Future research needs to focus on how reductions in mental 
health complaints and improvements in work functioning can be accomplished for 
workers who have returned to work after sickness absence due to CMDs. Furthermore, 
research would benefit from including outcome measures related to social functioning, 
such as colleague/supervisor support. 
 
Implications 
For workers who returned to work after sickness absence due to CMDs, the SHARP-at 
work intervention is effective in reducing the incidence of recurrent sickness absence. 
Our study demonstrates that continuous attention is needed for workers who have 
been on sickness absence due to CMDs. Before implementation of this intervention in 
practice, the economic benefit of the intervention also needs to be demonstrated.  
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Common mental disorders (CMDs) are a major cause of sickness absence. Twenty to 
30% of the workers who returned to work after sickness absence due to CMDs 
experience recurrent sickness absence. We developed the SHARP-at work intervention, 
a problem solving intervention delivered by occupational physicians (OPs), to prevent 
recurrent sickness absence in this worker population. A process evaluation was 
conducted alongside a cluster-randomised controlled trial to (1) evaluate whether the 
SHARP-at work intervention was implemented according to the protocol and differed 
from treatment in the control group, and (2) to investigate the relationship between the 
key elements of the intervention and the effect outcome (i.e. recurrent sickness 
absence). We collected process data for the intervention and control group on 
recruitment, reach, dose delivered, dose received, fidelity, context and satisfaction. 
Data on recurrent sickness absence was collected through the registry system of the 
collaborating occupational health service. The study was performed in the Netherlands. 
Between 2010 and 2012, 154 OPs and 158 participants participated. Compared to 
the control group, participants in the intervention group more frequently had two or 
more consultations with the OP (odds ratio [OR] = 3.2, 95% confidence interval [CI] = 
1.2 to 8.8) and completed more assignments (OR = 33.8, 95% CI = 10.4 to 109.5) as 
recommended in the intervention protocol. OPs and participants were satisfied with the 
intervention and rated it as applicable. Several individual intervention components 
were linked to the effect outcome. The process evaluation showed that the SHARP-at 
work intervention was conducted according to the protocol for the majority of the 
participants and well-received by OPs and participants. Furthermore, the intervention 
differed from treatment in the control group. Overall, the results provide support for 
implementing the intervention in practice.  
  




In many Western countries, common mental disorders (CMDs), such as depression, 
anxiety and adjustment disorders, are highly prevalent in the labour force1-3. CMDs do 
not only cause sickness absence and work disability1,4-8, but are also related to on-the-
job productivity loss because of reduced work functioning9-11. To reduce the individual 
and societal burden of sickness absence due to CMDs, interventions have been 
developed to facilitate return to work (RTW)12-18. The primary goal of these 
interventions is to get the worker back to work, though research has shown that 20% to 
30% of the workers who return to work after sickness absence due to CMDs experience 
recurrent sickness absence19,20. 
 To prevent recurrent sickness absence in workers who have been on sickness 
absence due to CMDs, the “Stimulating Healthy participation And Relapse Prevention 
(SHARP)-at work” intervention was developed21. The intervention is provided by 
occupational physicians (OPs) and aims to guide workers through a problem solving 
process, to solve new arising problems and realise improvements when back at work. 
Furthermore, the supervisor is involved to enable practical solutions that can be 
implemented. The intervention was evaluated in a cluster-randomised controlled trial 
(cluster-RCT), and the effect evaluation showed that the intervention group had a 
significantly lower incidence of recurrent sickness absence compared to the control 
group (Arends et al., submitted for publication).  
 Although an effect evaluation is often the primary goal of intervention research, it 
does not provide insight into why and how an intervention was successful or failed. This 
impedes the generalisability and implementation of intervention results22-24. A process 
evaluation can be conducted to collect data about how interventions were planned and 
implemented. A properly conducted process evaluation can help explain the success or 
failure of finding a relationship between the intervention and the outcome(s) of 
interest. Kristensen (2005) emphasised the importance of distinguishing between 
theory and program failure25. When an intervention is delivered and received as 
planned but no effect of the intervention is found, theory failure is plausible. However, 
when an intervention is poorly executed (i.e. not delivered or received according to the 
protocol), this indicates program failure and no conclusions should be drawn about the 
effectiveness of the intervention. 22,25. The process evaluation framework of Steckler 
and Linnan (2002) can be related to the theoretical model of Kristensen because in 
this framework the different elements are specified that need to be evaluated to 
understand whether program failure occurred. Steckler and Linnan summarised the 
elements of a process evaluation into seven components: fidelity (quality), recruitment, 
reach (participation rate), dose delivered (completeness), dose received (exposure), 
implementation and context26.  
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Previous research on process evaluations of occupational intervention studies has 
been fragmented and unstructured23,27. Especially, the linkage of process variables 
(e.g. reach, dose received) to effect outcomes to investigate which elements of an 
intervention are related to the effects is often missing. Murta et al. (2007) performed a 
systematic review of process evaluations conducted for occupational stress 
management programs and found that only 46% of the 84 included studies made an 
explicit link between process evaluation variables and the outcome23.  
 This study reports on a theoretically founded and structured process evaluation of 
the SHARP-at work intervention. The framework of Steckler and Linnan was used to 
develop, plan and guide the process evaluation23,24,26. The aims of the study were: 1) to 
evaluate whether the SHARP-at work intervention was conducted according to the 
protocol and differed from care as usual, and 2) to investigate the relationship between 





The process evaluation was part of a cluster-RCT in which the effectiveness of the 
SHARP-at work intervention was evaluated on the prevention of recurrent sickness 
absence in workers who returned to work after sickness absence due to CMDs. The 
trial was conducted in the Netherlands. OPs were randomised into intervention and 
control groups. Workers were recruited by the OPs and their allocation followed the 
allocation of their OP. For more detailed information on the design of the cluster-RCT, 
see Arends et al. (2010)21.  
 
Participants 
OPs were recruited from one of the largest occupational health services (OHS) in the 
Netherlands. All OPs were eligible except those with an upcoming retirement, 
resignation, sabbatical or pregnancy leave. After the recruitment and training of OPs, 
workers between 18 and 63 years were invited by their OP to participate in the study. 
Participants had to be diagnosed by their OP with a CMD at the start of their sickness 
absence period (of at least two weeks) and had to have planned RTW within two weeks. 
Detailed information on exclusion criteria can be found elsewhere21.  
 
Procedure 
The Medical Ethical Board of the University Medical Center Groningen approved the 
study design, research protocol, questionnaires, information letters, and the informed 
consent. After workers were recruited by their OP and consented to participate in the 
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study, they received the baseline questionnaire. Following this, the OPs in the 
intervention group initiated the intervention. OPs in the control group continued with 
treatment according to care as usual. Three months post baseline, questionnaires were 
sent to participants and OPs including questions about the treatment process.  
 
Intervention 
OPs received a two-day training in the SHARP-at work intervention which was provided 
by experienced trainers in occupational health care interventions and guideline 
training. Three feedback moments (approximately 6, 12 and 18 months after the 
intervention training) were organised to discuss problems and successes with 
conducting the intervention. 
 The SHARP-at work intervention expands on the guideline of the Netherlands 
Society of Occupational Medicine on “Management of mental health problems of 
workers by occupational physicians”28,29. This is an evidence-based guideline directed 
at structuring OP’s treatment to help sick-listed workers with mental health problems to 
RTW. The goal of the guideline is to help workers regain control by activating them to go 
through a problem solving process to find and implement solutions for problems that 
caused sickness absence and hinder RTW. This is in line with patient empowerment 
theories which state that treatment should be aimed at helping patients to get a sense 
of control, self-determination and goal attainment30,31. Though relapse prevention is 
part of the guideline (one consultation has to take place after RTW to address relapse 
prevention), limited attention is given to a structured follow-up by OPs after RTW has 
been accomplished. The SHARP-at work intervention was developed to focus on the 
prevention of recurrent sickness absence by structuring OP’s guidance after RTW. The 
intervention was started by OPs when participants on sickness absence due to CMDs 
were ready to RTW and consisted of five steps which had to be followed by the 
participant when RTW was started. The OP monitored that all steps were taken and 
activated the participant when needed. The five steps comprised: (1) making an 
inventory of problems and/or opportunities encountered at work after RTW, (2) 
brainstorming about solutions, (3) writing down solutions and the support needed and 
assessing the applicability of these solutions, (4) discussing solutions and making an 
action plan with the supervisor, and (5) evaluating the action plan/implementation of 
solutions.  
 For each step of the intervention, the OP could give assignments to stimulate the 
participant to write down and structure the problem solving process. The first 
assignment was the key assignment and focused on making an inventory of problems 
and opportunities at the workplace. A separate component of the assignment was to 
decide whether help was needed to solve/realise problems/opportunities (options: A. 
the participant could do it him-/herself; B. help of someone else was needed; C. it was 
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unsolvable at the moment). This first assignment was meant to activate the participant 
to reflect on his/her work situation when back at work. The other four assignments 
were: writing down solutions, preparing a consultation with the supervisor, making an 
action plan and evaluating the problem-solving process. The role of the OP was to guide 
the participant on the process level. The content of problems and solutions was not 
discussed by the OP. Rather, the OP empowered the participant to define the problems 
and to design solutions. Furthermore, the OP had to stimulate the participant to reflect 
on the significance of problems and the feasibility of solutions. When the participant 
was ready to discuss problems, opportunities and solutions with the supervisor, the OP 
could join this conversation as a neutral third party if requested by the participant. Two 
to five consultations within three months were recommended to the OPs for conducting 
the intervention. 
 
Care as usual 
All participating OPs have been trained in the evidence-based guideline of the 
Netherlands Society of Occupational Medicine “Management of mental health 
problems of workers by occupational physicians”29 which has been described above. 
No additional training of OPs in the control group was part of the study and they were 
not familiar with the SHARP-at work intervention.  
 
The process evaluation 
The process evaluation was based on Steckler and Linnan’s framework and included 
the components: recruitment, reach, dose delivered, dose received, fidelity and 
context. Additionally, as recent research and debates on process evaluation have 
suggested that Steckler and Linnan’s framework needs to be extended with other 
concepts, such as stakeholders’ beliefs and attitudes23,32, we added a component on 
OPs’ and participants’ satisfaction with the intervention.  
 
Data collection 
Administrative data on the trial’s primary outcome, incidence of recurrent sickness 
absence (yes/no), were collected during the 12-month follow-up period from the OHS’ 
registry. At 3-months follow-up, the components of the process evaluation were 
assessed with questionnaires. Data on the components were collected on OP and 
participant level in the intervention and control group. Fidelity was not assessed in the 
control group as this component relates to the extent to which the intervention was 
delivered as planned which is not applicable for the control group. The different 
components of the process evaluation were operationalised as follows: 
 





The number of OPs that agreed to participate in the study. OPs were recruited through 
a large OHS. The OHS’ research coordinator randomly selected several group practices 
(i.e. clinical units in which OPs are organised) and invited all OPs in these group 
practices to participate in the study. 
 
Participant level 
The number of participants that agreed to participate in the study by filling out the 




The number of OPs randomised into the intervention group who completed the 
intervention training and the number of OPs randomised in the control group who 
participated in the information session on the study’s procedure. 
 
Participant level  
The number of consultations between (1) the participant and the OP, (2) the participant 
and the supervisor and (3) the participant, the OP and the supervisor. The number of 
consultations between the participant and the OP was categorised into <2 
consultations or ≥2 consultations as a minimum of two consultations was advised to 
the OPs in the intervention group. For the other two components of reach, the number 




Dose delivered was assessed at the OP level by questioning OPs and participants about 
the number and type of assignments given to the participant by the OP. Furthermore, 
participants were asked two questions on whether the OP stimulated them to be 
actively involved in the consultations and to make their own decisions. Both aspects 
were stressed during the training in the intervention for the OPs. The questions were 
scored on a five-point Likert scale from 1 = totally disagree to 5 = totally agree, with the 




Dose received was assessed at the participant level by questioning OPs and 
participants about the number and type of assignments completed by the participant. 
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Additionally, participants were questioned about the number and type of topics 
discussed between the OP and the participant (a selection of seven topics related to 




The number of participants to whom the two key elements of the intervention was 




The number of participants who had two consultations with the OP and completed the 




Factors related to the private and work environment of the participant that could have 
influenced the treatment or the trial outcome (i.e. recurrent sickness absence). The 
incidence of a major life event in private life was measured with one question at 
baseline: “Did you experience any stressful life events in the past year, such as a 
serious illness, an accident, death, a divorce?” (yes/no). The influence of the work 
environment was measured with six statements for both participant and OP. One 
question focused on organisational changes during RTW that influenced the participant 
(yes/no) and a second question asked how these changes were experienced (positive, 
negative, neither positive nor negative). Furthermore, four statements were formulated 
regarding contextual factors at work that might have influenced the intervention or the 
trial outcome (see Appendix 1). The statements were scored on a five-point Likert scale 
(1 = totally disagree and 5 = totally agree, with the option to choose not applicable).  
 
Satisfaction 
OP and participant level 
First, satisfaction was assessed by seven statements about the process of the 
treatment (see Appendix 1) and were rated on a five-point Likert scale (1 = totally 
disagree and 5 = totally agree, with the option to choose not applicable). Second, the 
OP and the participant were asked to indicate what was most helpful for the participant 
during the post-RTW phase. The following options could be selected: consultations with 
the OP; consultations with the supervisor; consultations with both the OP and 
supervisor; the assignments; and something else (with open space to respond).  




Descriptive statistics were generated on the components of the process evaluation for 
the intervention and control group. Multilevel logistic regression analyses (with 2nd 
order penalised quasi-likelihood as estimation method) and multilevel linear regression 
analyses were performed to investigate whether differences between the two groups 
on reach, dose delivered, dose received, context and satisfaction were significant. We 
used multilevel analysis to control for dependency of participants within OP’s. 
 To investigate the relationship of the different intervention components with 
recurrent sickness absence, multilevel logistic regression analyses were performed 
with recurrent sickness absence at three, six and 12 months follow-up as the 
dependent variable and the components of the intervention as independent variables. 
The responses of the participants were used for these analyses, as the participants 
were blinded for their allocation status, as opposed to the OPs who were not blinded. 
The intervention components that constituted the key elements of the intervention 
were added in a multivariable multilevel logistic regression analysis. The following 
components were considered to constitute the core of the intervention: (a) number of 
consultations between the OP and the participant (2≤ consultations or ≥2 
consultations); (b) number of consultations between the supervisor and the participant 
(1≤ consultations or ≥1 consultations); (c) having completed the problem inventory 
assignment (yes/no) and (d) the inventory on whether help is needed with solving 
problems or realising opportunities (yes/no) (these inventories together constitute the 
first intervention assignment); (e) having discussed with the OP problems at work 
(yes/no); (f) having discussed with the OP possible opportunities at work (yes/no); (g) 
having discussed with the OP solutions for the problems (yes/no); (h) having discussed 
with the OP how to realise opportunities (yes/no).  Additionally, the relationship 
between the sum score of the total number of components received (0-8) and the 
incidence of recurrent sickness absence was investigated to assess whether having 
received more intervention components was related to a lower risk of recurrent 
sickness absence. We used an alpha of <0.05 to indicate statistical significance. We 
did not control for potential confounders because the small sample size did not allow 
many variables in the regression model. Furthermore, potential confounders (i.e. sex, 
age, educational level, baseline symptom severity and number of sickness absence 
days) did not significantly correlate with the outcome recurrent sickness absence. 
Analyses were performed with SPSS (20.0) and MLwiN (2.23).  
 
RESULTS 
Tables 1 and 2 present the baseline characteristics of the OPs and participants for the 
intervention and control group.  Tables 3 and Table 4 present the responses of the 
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participants and OPs on the components reach, dose delivered, dose received, fidelity, 




Table 1. OP characteristics per study group.  
 
 
 SHARP  
(n = 73) 
 CAU 
(n = 81) 
Characteristics of OPs M / n SD / %  M / n SD / % 
Age (years) 49.9  7.6  50.5  6.9 
Gender (male) 42 58.0  52 64 
Years working for OHS 10.0 4.9  11.1   8.4 








































Note. SHARP = intervention group; CAU = care as usual group; OP = occupational physician; OHS = 




OP and participant level 





As shown in Figure 1, 73 (58%) of the 126 OPs randomised in the intervention group 
participated in the intervention training, and 81 (64%) of the 127 OPs randomised in 
the control group participated in the information session on the study procedure. The 
main reasons for non-participation were having been delegated new and extra duties 
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(n = 80) 
 CAU 
(n = 78) 
Characteristics M / n SD / %  M / n SD / % 
Socio-demographic characteristics    
 Age (years) 41.3 9.4  43.3 9.8 
 Gender (male) 27 33.8  38 48.7 
 Marital status (married or living together) 67 83.8  60 76.9 
 Breadwinner (yes) 40 50.0  49 62.8 







16.7  Low 
 Intermediate 36 45.0  40 51.3 
 High 38 47.5  23 29.5 
Clinical characteristics    







15.4  F32.9 Depressive episode, unspecified 
 F41.9 Anxiety disorder, unspecified 0 0.0  2 2.6 
 F43.2 Adjustment disorders 58 72.5  39 50.0 
 F43.9 Reaction to severe stress, 
unspecified 
1 1.25  0 0.0 
R45 Symptoms and signs involving 
emotional state  
7 8.75  14 17.9 
Z73.0 Burn-out 2 2.5  7 9.0 
Other 8 10.0  4 5.1 
Work-related characteristics    
 Type of occupation    
 Commercial service providers 23 28.8  11 14.1 
 Management 11 13.8  15 19.2 
 Administrative staff 19 23.8  12 15.4 
 ICT staff 4 5.0  4 5.1 
 Sales staff 2 2.5  5 6.4 
 Health care providers 12 15.0  12 15.4 
 Hotel and catering staff 3 3.8  0 0.0 
 Stock and/or transport staff 1 1.3  11 14.1 
 Designers/planners 3 3.8  2 2.6 
 Mechanics/repairmen 2 2.5  5 6.4 
 Employment (hours per week) 32.6 7.0  32.9 7.3 
 Irregular work (e.g. shift work) 6 7.5  10 12.8 
 Executive/manager responsibilities 23 28.8  21 26.9 
 Duration of sickness absence 130.9 94.2  99.3 66.1 
 WRFQ-Total score 66.9 15.5  61.0 20.0 
Health-related characteristics    
 4DSQ Distress 13.8 7.5  15.5  7.5 
 Depression 1.5 2.1  2.0  2.4 
 Anxiety 3.1 3.3  3.6   3.5 
 Somatization 7.9 5.3  7.9   5.5 
 HADS Depression 7.0 4.5  7.3   4.4 
 Anxiety 7.2 3.9  7.8   3.4 
 Incidence of recurrent sickness absence      
 3 months1 8 11  17 22 
 6 months2 15 21  29 39 
 12 months3 24 34  35 47 
Note. SHARP = intervention group; CAU = care as usual group; OP = occupational physician; 4DSQ = Four-
Dimensional Symptom Questionnaire; HADS = Hospital Anxiety and Depression Scales. 
1n = 76 in intervention group. 
2n = 72 in intervention group; n = 74 in control group. 
3n = 71 in intervention group; n = 74 in control group. 
 
 






























SHARP = intervention group; CAU = care as usual group; OP = occupational physician. 
For the intervention group, reasons for withdrawal were: health problems (n = 1), research too burdensome 
(n = 1), a new OP (n =1), or unknown (n = 10). For the control group, reasons for withdrawal were: health 
problems (n = 1), research too burdensome (n = 1), job loss (n = 2), not in the mood (n = 1), no time (n = 1), 
or unknown (n = 8). 
 




Compared to the control group, participants in the intervention group more frequently 
had ≥2 consultations with the OP (OR = 3.2, 95% CI = 1.2 to 8.8) and ≥1 consultation 
with the supervisor (OR = 3.6, 95% CI = 1.1 to 12.0), as recommended in the SHARP-at 
OPs randomised 
n = 253 
SHARP 
n = 126 OPs 
CAU 
n = 127 OPs 
Trained in 
intervention 
n = 73 OPs 
Received 
information 
n = 81 OPs 
Excluded: n = 53  
  Refused to  
  participate n = 53 
Excluded: n = 46  
  Refused to  
  participate n = 46 
Workers recruited 
by OPs 
n = 109 
Workers recruited 
by OPs 
n = 103 
SHARP 
n = 80 workers 
Excluded: n = 29  
 No reaction n = 9 
 Did not meet inclusion 
 criteria n = 13 
 Too burdensome n = 4 





n = 67 workers 
Excluded: n = 25  
 No reaction n = 15 
 Did not meet inclusion 
 criteria n = 8 
 Too burdensome n = 1 
 Refused n = 1 
CAU 





n = 64 workers 
Withdrew from 
study: n = 13* 
Withdrew from 
study: n = 14* 
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work intervention protocol. There was no significant difference between the two groups 




All OPs in the intervention group reported that they had given assignments to the 
participant. Of the participants in the intervention group, 73% confirmed they had 
received assignments from the OP. For the control group, these responses were 
significantly lower; 29% of the OPs and 8% of the participants reported that 
assignments had been given. OPs and participants from the intervention group 
indicated which of the five assignments of the SHARP-at work intervention were 
provided. Regarding the first and most important assignment of the intervention 
(making an inventory of problems and possibilities for improvement at work), 66% of 
the participants reported that they had received the first assignment, while 98% of the 
OPs reported they had given the first assignment to the participant. For the other 
assignments, 54% of the participants replied they had received the assignment on 
writing down solutions, 48% had received the assignment on making an action plan 
and preparing a consultation with the supervisor and 36% had received the assignment 
on evaluating the problem-solving process (not presented in table). Finally, 64% of the 
participants agreed that the OP had stimulated them to be actively involved in 
consultations and to make their own decisions (not presented in table).  
 
Dose received 
Participant level  
Comparable to the results for dose delivered, participants in the intervention group 
more often completed assignments that were provided by the OP compared to the 
control group (OR = 33.8, 95% CI = 10.4 to 109.5). Of the participants in the 
intervention group that completed assignments, 88% made the first assignment, 65% 
the second assignment, 57% the third assignment, 55% the fourth assignment and 
37% the fifth assignment (not presented in table). Participants indicated which of the 
seven topics, related to the RTW process, were discussed during consultations with the 
OP. In the intervention group, the most common topics that were discussed were 
problems at work (84%), possible solutions for the problems (58%), and who could help 
with solving the problems (55%). Significantly less participants in the control group 
reported that these topics were discussed with the OP.  
 





In the intervention group, 63% of the participants reported that they had ≥2 
consultations with the OP and they received the first assignment from the OP. Almost 
all OPs (96%) reported that they had acted according to the intervention (i.e. ≥2 
consultations with participant and first assignment distributed to participant). 
 
Participant level 
In the intervention group, 64% of the participants reported that they had ≥2 
consultations with the OP and that they completed the first assignment (one participant 
who reported that the OP did not provide the first assignment did report that he/she 
made the first assignment, explaining the difference with the 63% reported above). Of 
the OPs, 79% reported that they had ≥2 consultations with the participant and that the 




For the participants in the intervention group, the context in which the treatment took 
place was characterised by good communication with the OP and the supervisor. 
Participants in the control group also responded that in general communication with 
the OP and the supervisor was good. In the intervention group, 51% had to deal with an 
organisational change during the first three months of RTW compared to 39% in the 




OPs in the intervention and control group were both positive about the treatment they 
had provided. OPs in the intervention group indicated that the intervention was 
applicable. With respect to aspects that helped in the post-RTW phase, OPs (36% in 
both the intervention and control group) reported that support and treatment from 
other health care professionals (mainly psychologists and social workers) were helpful.  
 
Participant level 
Overall, participants in the intervention and control group were both positive about the 
treatment by the OP. With respect to aspects that helped in the post-RTW phase, 
participants (39% in the intervention group and 33% in the control group) frequently 
mentioned that support from colleagues and friends was helpful for RTW.  
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(n = 67) 
 CAU 
(n = 64) 
 OR or MD  
(95% CI) 
Reach   
 0-1 consultations with OP 11 (16)  24 (38)  reference 
 ≥2 consultations with OP 56 (84)  39 (61)  3.2 (1.2 – 8.8) 
 0 consultations with supervisor 4 (6)  12 (19)  reference 
 ≥1 consultations with supervisor 63 (94)  52 (81)  3.6 (1.1 – 12.0) 
 0 consultations with OP and supervisor 47 (70)  49 (77)  reference 
 ≥1 consultations with OP and supervisor 20 (30)  15 (23)  1.4 (0.6 – 3.0) 
Dose delivered   
 Assignments received from OP 49 (73)  5 (8)  58.6 (14.7 – 228.6) 
 OP stimulated being involved, mean (SD) 3.9 (1.2)  3.5 (1.4)  0.6 (0.1 – 1.2) 
 OP stimulated making own decisions, 
mean (SD) 
3.8 (1.1)  3.6 (1.3)  0.2 (-0.3 – 0.6) 
Dose received   
 Assignments completed 47 (70)  5 (8)  33.8 (10.4 – 109.5) 
 Topics discussed related to RTW     
  Problems at work 56 (84)  40 (63)  2.9 (1.3 – 6.6) 
  Possible opportunities at work 33 (49)  17 (27)  3.1 (1.1 – 9.2) 
  Solutions for problems 39 (58)  22 (34)  2.6 (1.2 – 5.4) 
  How to realise opportunities 30 (45)  23 (36)  1.4 (0.6 – 3.0) 
  Who can help 37 (55)  14 (22)  4.3 (2.0 – 9.5) 
  How to make an action plan 17 (25)  16 (25)  1.0 (0.5 – 2.2) 
  Evaluation of RTW process 31 (46)  35 (55)  0.63 (0.3 – 1.4) 
Fidelity OP   
 ≥2 consultations with OP and first 
assignment  delivered by OP 
42(63)  -  - 
Fidelity participant   
 ≥2 consultations with OP and first 
assignment completed by participant 
43 (64)  - 
 
 - 
Context   
 Good communication with OP in general  
(1-5), mean (SD) 
4.4 (0.7)  3.8 (1.0)  0.2 (-0.2 – 0.6) 
 Good communication with supervisor in  
general (1-5), mean (SD) 
3.6 (1.1)  3.8 (1.1)  -0.6 (-1.1 – -0.1) 
 Supervisor helped with RTW (1-5), mean 
(SD) 
3.3 (1.1)  3.7 (1.0)  -0.7 (-1.3 – -0.1) 
 Supervisor positive about treatment OP  
(1-5), mean (SD) 
3.6 (0.9)  3.9 (0.8)  -0.3 (-0.8 – 0.1) 
 Major life event in the year before 
baseline  
33 (49)  28 (44)  1.1 (0.5 – 2.4) 
 Organisational change during RTW 34 (51)  25 (39)  1.6 (0.7 – 3.5) 
 Impact of organisational change2      
 Positive 12 (35)  14 (56)  - 
 Negative  9 (26)  7 (28)  - 
 Positive nor negative  13 (38)  4 (16)  - 
Satisfaction    
 Treatment helped with RTW (1-5), mean 
(SD) 
4.0 (1.0)  3.4 (1.2)   0.5 (-0.0 – 1.1) 
 Treatment appreciated (1-5) , mean (SD) 4.0 (0.9)  3.6 (1.1)  0.4 (-0.2 – 0.9) 
 Treatment overall positive (1-5), mean 
(SD) 
4.2 (1.0)  3.7 (1.1)  0.03 (-0.4 – 0.5) 
 Enough consultations with OP (1-5), 
mean (SD)  
4.1 (0.8)  3.6 (1.2)  0.5 (-0.1 – 1.1) 
 Treatment had good structure (1-5) , 
mean (SD) 
3.9 (1.0)  3.3 (1.2)  0.5 (-0.1 – 1.0) 
 Good communication with OP during 
consultations (1-5), mean (SD) 
4.3 (0.8)  3.8 (1.0)  0.3 (-0.2 – 0.8) 
 Implemented solutions positive (1-5), 
mean (SD) 
3.6 (1.0)  3.6 (1.0)  -0.02 (-0.6 – 0.6) 
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(n = 67) 
 CAU 
(n = 64) 
 OR or MD  
(95% CI) 
 What helped with RTW      
 Consultations OP  35 (52)  16 (25)  3.3 (1.5 – 7.3) 
 Consultations supervisor  21 (31)  24 (38)  0.7 (0.4 – 1.5) 
 Consultations supervisor + OP  14 (21)  18 (28)  0.7 (0.3 – 1.5) 
 Assignments  11 (16)  2 (3)  6.0 (1.3 – 28.2) 
 Something else  23 (34)  33 (52)  0.5 (0.2 – 0.9) 
SHARP = intervention group; CAU = care as usual; OP = occupational physician; RTW = return to work; OR = 
odds ratio; MD = mean difference; CI = confidence interval. 
1N (%) reported unless indicated otherwise. 
2No significance tests due to small sample that reported organisational changes. 
 
 




(n = 48) 
 CAU 
(n = 52) 
 OR or MD  
(95% CI) 
Reach participant   
 0-1 consultations with participant 2 (4)  17 (33)  reference 
 ≥2 more consultations with participant 46 (96)  35 (67)  15.5 (1.7 – 141.9) 
 0 consultations with participant and 
supervisor 
38 (79)  43 (83)  reference 
 ≥1 consultations with participant and 
supervisor 
9 (19)  9 (17)  0.1 (0.0 – 0.3) 
Dose delivered   
 Assignments given to participant  48 (100)  15 (29)  N.E. 
 Stimulated participant to be involved 4.2 (0.6)  3.9 (1.0)  0.4 (-0.1 – 1.0) 
 Stimulated participant to make own 
decisions 
4.3 (0.6)  4.2 (0.8)  0.0 (-0.3 – 0.4) 
Dose received   
 Assignments completed by participant  43 (90)  11 (21)  28.8 (6.7 – 124.5)2 
Fidelity OP   
 ≥2 consultations with OP and first 
assignment delivered by OP 
46 (96)  - 
 
 - 
Fidelity participant   
 ≥2 consultations with OP and first 
assignment completed by participant 
38 (79)  - 
 
 - 
Context   
 Good communication with participant 
in general (1-5), mean (SD) 
4.2 (0.6)  4.2 (0.7)  -0.2 (-0.5 – 0.1) 
 Good communication with supervisor 
in general (1-5), mean (SD) 
4.0 (0.9)  3.9 (0.8)  0.0 (-0.6 – 0.6) 
 Supervisor helped with RTW (1-5), 
mean (SD) 
3.9 (0.8)  4.0 (0.8)  0.25 (-0.2 – 0.7) 
 Supervisor positive about treatment 
OP (1-5), mean (SD) 
3.9 (0.8)  3.9 (0.7)  0.0 (-0.5 – 0.5) 
 Organisational change during RTW  24 (50)  24 (46)  1.3 (0.4 – 4.3) 
 Impact of organisational change3     
 Positive  11 (46)  11 (46)  - 
 Negative  5 (21)  5 (21)  - 
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(n = 48) 
 CAU 
(n = 52) 
 OR or MD  
(95% CI) 
Satisfaction   
 Treatment helped with RTW (1-5), 
mean (SD) 
3.8 (0.8)  4.1 (0.9)  -0.4 (-0.9 - -0.0) 
 Treatment applicable (1-5), mean (SD) 3.8 (1.0)  n.a.   
 Treatment overall positive (1-5), mean 
(SD) 
3.8 (0.8)  4.3 (0.6)  -0.5 (-1.0 - -0.1) 
 Enough consultations with worker (1-
5), mean (SD) 
4.3 (0.8)  4.1 (0.7)  0.0 (-0.5 – 0.5) 
 Treatment had good structure (1-5), 
mean (SD) 
4.0 (0.7)  4.0 (0.6)  -0.2 (-0.5 – 0.2) 
 Good communication with participant 
during consultations (1-5), mean (SD) 
4.3 (0.5)  4.3 (0.6)  -0.2 (-0.5 – 0.2) 
 Implemented solutions positive (1-5), 
mean (SD) 
3.9 (0.9)  4.0 (0.8)  -0.3 (-0.9 – 0.3) 
 What helped with RTW     
 Consultations OP  24 (50)  18 (35)  1.8 (0.6 – 6.1) 
 Consultations supervisor   18 (38)  10 (19)  2.4 (0.6 – 9.3) 
 Consultations supervisor + OP  12 (25)  19 (37)  0.5 (0.2 – 1.4) 
 Assignments  29 (60)  4 (8)  138.4 (5.3 – 3838.4) 
 Something else  14 (29)  30 (58)  0.2 (0.1 – 0.6) 
SHARP = intervention group; CAU = care as usual; OP = occupational physician; RTW = return to work; OR = 
odds ratio; MD = mean difference; CI = confidence interval; N.E. = not estimable. 
1N (%) reported unless indicated otherwise. 
21st order maximised quasi-likelihood used as estimation method. 
3No significance tests due to small sample that reported organisational changes. 
 
 
Relationship between intervention components and the incidence of recurrent 
sickness absence 
Three intervention components were significantly related to recurrent sickness absence 
at three, six and 12 months follow-up (Table 5). These components were: the inventory 
of problems/opportunities (OR = 15.3, 95% CI = 1.78 to 132.4), the inventory on 
whether help is needed with solving problems or realising opportunities (OR = .10, 95% 
CI = .02 to .69]), and the discussion with the OP on how to realise opportunities at work 
(OR = 0.17, 95% CI = .04 to .73]). Participants that made the inventory on whether help 
is needed and had discussed with the OP how opportunities could be realised at work, 
had a significantly lower risk of recurrent sickness absence. In contrast, participants 
that made the problem inventory had a significantly higher risk of recurrent sickness 
absence. Participants who received more intervention components did not have a 
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Table 5. Multivariable multilevel logistic regression model showing the relationship 
between the key intervention components and the incidence of recurrent sickness 
absence. 
     95% CI  
Components B SE OR LL UL    P-value 
Consultations with OP  2.16 1.14 8.67 0.93 81.00 0.058 
 (reference = <2 consultations)       
Consultations with supervisor  -0.81 1.19 0.44 0.04 4.58 0.498 
 (reference = <1 consultations)       
Inventory of problems/opportunities  2.73 1.10 15.3 1.78 132.4 0.013 
 (reference = not made)       
Inventory of help needed -2.27 0.97 0.10 0.02 0.69 0.019 
  (reference = not made)       
Problems at work discussed with OP  -1.73 1.14 0.18 0.02 1.66 0.129 
 (reference = no)       
Opportunities at work discussed with OP  0.61 0.69 1.84 0.48 7.11 0.377 
 (reference = no)       
Solutions for problems discussed with OP  1.24 0.81 3.46 0.71 16.90 0.126 
 (reference = no)       
How to realise opportunities discussed with OP  -1.78 0.75 0.17 0.04 0.73 0.018 
 (reference = no)       
Total number of components received (0-8) 0.01 0.16 1.00 0.74 1.38 0.956 




We conducted a process evaluation, analysing for both the intervention and control 
group: recruitment, reach, dose delivered, dose received, fidelity, contextual factors 
and satisfaction with the treatment. Furthermore, we analysed the relationship 
between intervention components and the primary outcome, i.e. incidence of recurrent 
sickness absence. The results showed that the majority of the participants in the 
intervention group received the key components of the SHARP-at work intervention. 
The intervention reached the participants through the OP consultations. The majority of 
the intervention group made the first assignment, which was one of the key elements 
of the intervention. When comparing the results on reach, dose delivered and dose 
received for the intervention group with the control group, fewer activities took place in 
the control group. Less often consultations with the OP took place, and assignments 
were rarely provided to participants by OPs. Furthermore, important topics related to 
the intervention were more often discussed between participants and the OPs in the 
intervention group compared to the control group. There were no major differences 
between the intervention and control group for satisfaction with the treatment and for 
contextual factors that might have influenced the treatment or the study outcomes. 
Overall, participants and OPs in the intervention group were satisfied with the 
intervention, considered it helpful for RTW and applicable. We conclude that the 
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intervention accounted for the lower risk of recurrent sickness absence that was found 
in the effect evaluation for the intervention group compared to the control group 
because the intervention was properly conducted for the majority of the participants in 
the intervention group and the control group received only few activities. The results 
provide support for implementing the intervention in practice.  
 The analysis of the relationship between the key components of the intervention 
and the incidence of recurrent sickness absence showed that participants that made 
the inventory of problems or opportunities at work had a significantly higher risk of 
experiencing recurrent sickness absence. Participants had a significantly lower risk of 
recurrent sickness absence when they made the inventory of whether help was needed 
to solve a problem or realise an opportunity at work, and when they talked with the OP 
about how opportunities could be realised. A possible explanation for these results 
could be that making an inventory of problems/opportunities at work by itself is not 
beneficial. It may be necessary that a worker also thinks about whether help is needed 
to solve/realise problems/opportunities and talks about concrete improvements that 
can be implemented at work, as has been suggested in solution focused theories33,34. 
The results need to be interpreted carefully due to the small sample size. The incidence 
of recurrent sickness absence was rather low for the intervention group at three 
months follow-up. Furthermore, for some intervention components, the majority of the 
participants had received the component, and thus, no clear contrast could be made 
between participants receiving and not receiving the components. Nonetheless, 
reporting these results is important. Within occupational health care, multicomponent 
interventions have proven to be more effective than single component 
interventions35,36. However, without evaluating the relationship between separate 
intervention components and study outcomes, we have no clear understanding of why 
multicomponent interventions are more effective and what the strength of these 
interventions is. Thus, future research needs to focus more on how multicomponent 
interventions work. To do this, larger sample sizes are essential in order to detect 
robust associations within the intervention group. 
 To the best of our knowledge, no studies have been published that evaluate the 
effect and process of an intervention for the prevention of recurrent sickness absence 
in workers with CMDs. Our study showed that a process evaluation helps to explain the 
results of the effect evaluation. Furthermore, the investigation of the relationship 
between intervention components and the primary outcome provided insight into which 
components are important to achieve a reduced risk of recurrent sickness absence. 
This analysis also showed that the total amount of received intervention components 
did not affect the risk of recurrent sickness absence.  
 When comparing our study with other process evaluations of interventions within 
the occupational health care field, it is striking that these studies often do not have a 
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theoretical framework for the process evaluation. Researchers have frequently focused 
on investigating whether the intervention was conducted according to the protocol and 
feasible, but they have not connected the process evaluation to the results of the effect 
evaluation. An important goal of a process evaluation is to investigate whether the 
intervention can account for the results on the primary outcome. Thus, linking process 
and effect outcomes is essential32. Also, some researchers concluded in the process 
evaluation that the intervention was conducted according to the protocol and feasible, 
while the effect evaluation showed no relevant differences between intervention and 
control groups. However, these contradicting findings were not further explained37-40. 
This impedes decision making on using the intervention in practice.  
 
Strengths and limitations 
The present study provides rich information. We did not only examine whether the 
intervention was conducted according to the protocol and feasible, we also 
investigated whether the intervention explained the results of the effect evaluation. 
One of the main strengths of this study is the thorough process evaluation based on a 
theoretical framework. Furthermore, we were able to link different intervention 
components to the study outcome to explore the working mechanism of the 
intervention. The use of similar questionnaires for participants and OPs enabled us to 
compare perceptions of both groups and to report on a more complete picture of how 
the intervention was conducted. Including multiple perspectives in a process evaluation 
can overcome one-sided and biased information41-43. Furthermore, information from 
multiple stakeholders may provide an understanding of the level at which problems can 
be expected when implementing the intervention in practice22,42. We found that the 
perspectives of participants and OPs regarding the implementation of the intervention 
(i.e. reach, dose delivered, etc.) were in the same direction. A final strength of the study 
is that we investigated the differences and similarities between the treatment in the 
intervention and control group. Often, process evaluations only evaluate the treatment 
process of the intervention group37,38,44,.  The disadvantage of such an evaluation is 
that it does not provide insight into why an intervention, conducted as planned, has no 
effect when participants in the control group received (unintentionally) similar or more 
intensive care. Based on our process evaluation, we were able to conclude that 
treatment in the control group was different from and less intensive than treatment in 
the intervention group, as expected.  
 Our study has several limitations. One limitation is that not all included participants 
and OPs responded to the process evaluation questionnaires. It is possible that 
participants or OPs not satisfied with the intervention or care as usual refrained from 
completing the process questionnaire which could have biased the results. 
Furthermore, the OPs were not blinded for the study design, which might have 
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influenced their responses. When comparing the responses of the participants (who 
were blinded) and the OPs, it can be concluded that the OPs gave somewhat more 
positive answers regarding the treatment provided, which could be due to social 
desirability. A third limitation is that we had to develop our own process evaluation 
questionnaires. No generic tools are available to analyse process components because 
interventions often vary in content and are context-dependent. However, by developing 
similar questionnaires for the participants and the OPs, we were able to compare the 
answers of both groups. The fact that participants and OPs gave comparable answers 
to the questions strengthens the reliability of the data. Moreover, although the context 
of our process evaluation was specific, the method of evaluation can be transferred to 
other interventions in a different context. Another problem was the small sample size 
that impeded a robust analysis of the relationship between the key intervention 
components and the incidence of recurrent sickness absence. We could not draw firm 
conclusions about which key components were significantly related to recurrent 
sickness absence and why. However, because earlier studies in the occupational 
health care field have not related intervention components to the primary outcome of a 
study and because this information can be very valuable in getting insight into why an 
intervention is effective, we did report these results as to explore the relationships but 
also to provide an example for future research. Finally, considering the generalisability 
of the results, we have to acknowledge that the SHARP-at work intervention was 
developed in a Dutch context. OPs have an important role in the Dutch social security 
system and, therefore, were a suitable group of treatment providers for delivering the 
intervention. For countries where OPs play a less significant role in the RTW process, or 
where sickness absence due to CMDs is not compensated, the SHARP-at work 
intervention might not be applicable in its current form.  
 
Conclusion 
An important contribution of the process evaluation is that it helped explain the results 
of the effect evaluation. The process evaluation showed that the SHARP-at work 
intervention was conducted according to the protocol for the majority of the 
participants. Also, the intervention differed from care as usual by the OP. Based on this, 
we conclude that the intervention accounted for the reduced risk of recurrent sickness 
absence that was found in the effect evaluation for the intervention group compared to 
the control group. Furthermore, the intervention was well-received by OPs and 
participants. Overall, the results provide support for implementing the intervention in 
practice.  
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Statements on context and treatment satisfaction for workers 
Context 
 1 In general, communication with the OP goes well 
 2 The supervisor had a positive attitude regarding the guidance 
 3 In general, communication with the supervisor goes well 
 3 My supervisor helped to accomplish a smooth return to work 
Satisfaction 
 1 The guidance of the OP helped me to start working again 
 2 I appreciated the guidance of the OP during my return to work 
 3 In general, I am positive about the guidance of the OP 
 4 I have had enough consultations with the OP 
 5 The guidance of the OP had a good structure 
 6 During a consultation, I can have a good conversation with the OP 
 7 I experience the solutions that were realised during my return to work as positive 
OP = occupational physician. 
 
 
Statements on context and treatment satisfaction for occupational physicians 
Context 
 1 In general, communication with the worker goes well 
 2 The supervisor had a positive attitude regarding the guidance 
 3 In general, communication with the supervisor goes well 
 4 The supervisor helped to accomplish a smooth return to work 
Satisfaction 
 1 My guidance helped the worker to start working again 
 2 My guidance was applicable to the situation of the worker (only intervention group) 
 3 In general, I am positive about my guidance  
 4 I have had enough consultations with the worker 
 5 My guidance had a good structure 
 6 During a consultation, I can have a good conversation with the worker 
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Purpose: To investigate barriers and facilitators for research participant recruitment by 
occupational physicians. 
Methods: A mixed-methods approach was used. Focus groups and interviews were 
conducted with OPs to explore perceived barriers and facilitators for recruitment. 
Based on data of a cluster-randomised controlled trial (cluster-RCT), univariate and 
multivariate analyses were conducted to investigate associations between OPs’ 
personal and work characteristics and the number of recruited participants for the 
cluster-RCT per OP.  
Results: Perceived barriers and facilitators for recruitment were categorised into: study 
characteristics (e.g. concise inclusion criteria); study population characteristics; OP’s 
attention; OP’s workload; context (e.g. working at different locations); and OP’s 
characteristics (e.g. motivated to help). Important facilitators were encouragement by 
colleagues and reminders by information technology tools. Multivariate analyses 
showed that the number of OPs within the clinical unit who recruited participants was 
positively associated with the number of recruited participants per OP (rate ratio = 
1.43, 95% confidence interval = 1.24-1.64).  
Conclusion: When mobilising OPs for participant recruitment, researchers need to 
engage entire clinical units rather than approach OPs on an individual basis. OPs 
consider regular communication, especially face-to-face contact and information 
technology tools serving as reminders, as helpful. 
 
  




Recruiting a sufficient number of participants into randomised controlled trials (RCTs) 
is a challenge. Recruitment difficulties can reduce the statistical power for detecting 
differences between treatment groups1. Bower et al. (2007) investigated recruitment 
delays in UK primary care trials and found that only 29% of 70 trials recruited 
according to their timetable. Thirty-five per cent of the trials needed 50% more time for 
recruitment than planned, and 35% of the trials required even more than 50% 
additional time2. Similar numbers were found in a survey among researchers in Dutch 
primary care research; in more than 50% of 78 studies, the fieldwork period was 
extended to recruit sufficient participants3. The problem of participant recruitment has 
been described by clinical pharmacologist Louis Lasagna in what is called “Lasagna’s 
Law,” which implies that researchers tend to overestimate the number of eligible 
participants available in the population they want to recruit from4.  
 Recruitment problems are even more pronounced when non-researcher clinicians 
are solicited to recruit participants from their normal patient caseload2,3. Bower et al. 
found that when general practitioners (GPs) recruited participants, only 12.5% of the 
trials recruited in time compared to 61.5% when others were responsible for 
recruitment2. Previous systematic reviews have reported on clinician barriers to 
participant recruitment, effective strategies to improve recruitment and clinicians’ 
attitudes towards recruiting for RCTs5,6. However, these reviews are solely based on 
hospital and primary care studies. Few studies have reported details of participant 
recruitment challenges in the occupational health care (OHC) setting. 
 In OHC research, interventions are often conducted by clinicians, such as 
occupational physicians (OPs) or occupational therapists, who can also be responsible 
for participant recruitment7-9. Recruitment problems for OHC providers might be 
different from hospital and primary care settings. OHC providers have a dual role being 
advocates of workers and employers. They might have difficulties with recruiting 
participants when employers are not keen on participating in research. Furthermore, 
patients might be unsure how participation in research affects their jobs when 
recruited by OHC providers10,11. Although problems with participant recruitment by 
clinicians are experienced in OHC research, only one study is available on clinician 
participation in research and recruitment. This is a Dutch short report solely based on 
researchers’ experiences12. Research is needed on how OHC providers experience 
participant recruitment. Furthermore, (also in hospital and primary care research) 
studies are lacking that analyse which clinician characteristics are associated with 
successful participant recruitment. Currently, only one study has analysed which family 
physician characteristics were related to recruitment13. Knowing which characteristics 
Chapter 6 | Recruitment problems 
146 
 
of OHC providers relate to participant recruitment can be helpful when approaching 
OHC providers for participation in recruitment.  
 The overall aim of this study was to provide insight into the barriers and facilitators 
for participant recruitment by OPs enrolled in a cluster-randomised controlled trial 
(cluster-RCT) to reduce recurrent sickness absence for mental health conditions. In this 
cluster-RCT, 500 participants had to be recruited by OPs according to the power 
calculation. At the end of the trial, 212 participants were recruited (Arends et al., 
submitted for publication). Several OPs were successful in recruiting participants but 
many did not recruit any participant. Therefore, we investigated the following research 
questions: 1) “Which barriers and facilitators were experienced by OPs during 
participant recruitment?” and 2) “Which OP personal and work characteristics are 
associated with participant recruitment?”  
 
METHODS 
The STROBE statement14, developed to improve the reporting of observational studies, 
and the COREQ guideline15, developed to improve the reporting of qualitative studies, 
were used for reporting on the quantitative and qualitative parts of the study, 
respectively. More detailed information on the design of the cluster-RCT has been 
reported elsewhere16. A mixed-methods approach was employed because we wanted 
to examine relationships between OP characteristics and successful recruitment 
(based on survey data of a cluster-RCT) and explore OPs’ perspectives on participant 
recruitment (based on focus groups and interviews).  
 
Cluster-randomised controlled trial 
The cluster-RCT was designed to evaluate the effectiveness of a problem solving 
intervention on the prevention of recurrent sickness absence in workers who returned 
to work after sickness absence due to CMDs, compared to care as usual. OPs were 
randomised to an intervention group (and received training in the intervention and 
treated participants according to the intervention) or a control group (where OPs 
treated participants according to care as usual.  OPs recruited participants. Allocation 
of participants followed the allocation of their OPs. More detailed information on the 
design of the cluster-RCT has been reported elsewhere16. 
 
Recruitment of OPs 
OPs were recruited by collaborating with a large occupational health service (OHS) in 
the Netherlands. Within the OHS, OPs were organised in clinical units, called “group 
practices.” All OPs of the OHS were eligible to participate, unless they were already 
participating in other research projects. The OHS’ research coordinator randomly 
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selected clinical units in different regions of the Netherlands because participation of 
only 100 OPs was needed for the cluster-RCT. In September 2009, a first wave of 134 
OPs (n=67 in both intervention and control group) was invited to participate in the 
cluster-RCT. Because of an insufficient number of recruited participants, a second 
wave of 122 OPs (n=60 in the intervention group and n=62 on the control group) was 
invited to participate in September 2010. A total of 87 OPs of the first wave (response 
rate 65%; n=43 in intervention and n=44 in the control group) and 67 OPs of the 
second wave (response rate 53%; n=30 in intervention and n=37 in control group) 
agreed to participate. Main reasons for non-participation were pregnancy, upcoming 
retirement or a busy work schedule. 
 
Recruitment of participants 
To recruit participants, OPs had to screen their patients for eligibility based on a list of 
10 inclusion and exclusion criteria (see Arends et al.16 for the criteria). If a patient was 
eligible, OPs could introduce the research shortly and hand over an information leaflet. 
After this, contact information of the patient was given to the researchers who took 
over the recruitment procedure. Based on data from the OHS, the OPs would see 32 to 
39 eligible patients per year and we asked each OP to approach 8 eligible patients16. 
 
Data collection 
Data on the number of recruited workers (for the cluster-RCT) per OP were collected at 
the end of the recruitment period (June 30th, 2011). Information on OP’s personal and 
work characteristics was obtained from administrative data provided by the OHS and 
from a process evaluation questionnaire developed for the cluster-RCT. This 
questionnaire was distributed to OPs in the intervention group before they started their 
intervention training and contained questions on readiness for change (two items) and 
attitudes towards the intervention (three items). The items were scored on a 5-point 
Likert scale from totally disagree to totally agree. Participation in feedback sessions, on 
working according to the intervention protocol, (yes/no) was documented for each 
intervention OP. From the OHS, administrative data were obtained on: sex, age, OHS 
tenure, clinical unit, size of clinical unit, percentage of OPs in the same clinical unit that 
participated in the cluster-RCT (including the index person), sector (companies >500 
workers yes/no), geographical working area, number of companies the OP works for, 
number of clients (i.e. the workers), number of OPs within the clinical unit who recruited 
participants and productivity in 2011 (% of hours worked according to the work 
contract; e.g. <100% = less hours worked in 2011 than contracted for). 
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Focus groups and interviews 
Recruitment of OPs 
For the focus groups, all OPs from the intervention group were invited by e-mail to 
participate in a discussion of experiences with participant recruitment and conducting 
the intervention. Based on convenience sampling, to focus groups were organised at 
the end of the inclusion period, in June 2011, including six OPs in each focus group 
following recommendations for optimal group dynamics17. Additionally, telephone 
interviews were organised from November 2011 until March 2012 to complement the 
information from the two focus groups. For the individual telephone interviews, OPs 
were invited by email to talk with the first author about their experiences with 
participant recruitment. Purposive sampling was used reflecting different demographic 
backgrounds and different levels of recruitment success. OPs who had not participated 
in the focus groups were grouped based on sex (male/female), study group 
(intervention group/control group) and having recruited participants (yes/no). From 
each group, one OP was randomly selected by the use of a computer program. If an OP 
declined participation, another OP from the same group was randomly selected. 
Because six OPs did not reply to the emails, two OPs were recruited based on 
convenience sampling to reach data saturation. After six interviews, the researchers 




The focus groups took place in a conference room of the OHS and lasted 1.5 hours. 
Two authors (IA, psychologist, and JK, occupational physician and psychologist) acted 
as focus group moderators. Both moderators knew the participating OPs because of 
previous training and feedback sessions. The telephone interviews were performed by 
IA to ensure continuity in the interview process. The interviews lasted approximately 15 
minutes. The same semi-structured, open-ended interview protocol was used for both 
focus groups and interviews to collect data on experienced barriers and facilitators for 
participant recruitment. The following questions were asked: 
1. How did you manage to recruit participants for the research? 
2. What made it difficult for you to recruit participants? 
• Which environmental factors played a role? 
• Which patient-related factors played a role?  
• Which personal factors played a role? 
3. What would have made it easier for you to recruit participants (e.g. what could 
the researchers have done differently)?  
 




The Medical Ethical Board of the University Medical Center Groningen, the Netherlands, 
approved of the cluster-RCT and judged that no ethical approval was necessary for 
conducting focus groups, individual interviews and for using administrative data on the 
OPs, provided by the collaborating occupational health service (OHS). The 
administrative data were anonymised for the researchers by deleting OPs’ names and 
ascribing random numbers to the OPs. Before the start of the focus groups, OPs had to 
read and sign an informed consent form. The form provided information about the 
purpose of the focus group and the assurance of confidentiality. For the telephone 
interviews, OPs were asked to give oral consent. Audiotapes of the focus groups and 
interviews were destroyed after transcription, and names by which the OPs could be 
identified were omitted from the transcripts. 
 
Data analysis 
Qualitative data analysis 
The focus group discussions and telephone interviews were audio taped and 
transcribed verbatim. During focus groups and interviews, one author (IA) took detailed 
notes. These data were analysed based on the qualitative description method, as 
described by Sandelowski18,19. Qualitative content analysis was used to summarise the 
manifest content of the focus group texts20. Three authors (IA, UB and JK) read the 
focus group and interview transcripts several times and independently grouped words 
related to the same central topic into meaning units. Subsequently, the meaning units 
were condensed and given a code. The three authors discussed the abstracted 
meaning units and codes and differences were solved based on consensus. Then, the 
three authors grouped codes related to each other into categories. The iterative 
process of coding and categorising was manually performed, and the meaning units 
and corresponding codes and categories were documented in tables. These tables 
were used for discussions with all authors to reach agreement on how the data were 
labelled and categorised. The final list of categories was presented to the participating 
OPs. The OPs could comment on the document to improve credibility of the data 
analysis process.  
 
Quantitative data analysis 
Multilevel Poisson regression analysis was used because the number of recruited 
participants per OP (dependent variable) had a skewed distribution and the clustering 
of OPs in different clinical units had to be taken into account. We investigated the 
relationship between OP’s characteristics (independent variables) and the number of 
recruited participants per OP, with control for over-dispersion. Five OPs (3%) were 
excluded from the multilevel analyses, because of missing data on the clinical unit. 
Chapter 6 | Recruitment problems 
150 
 
First, univariable analyses were performed and variables with a p-value of <0.20 were 
included in the multivariable model21. In a backward, stepwise selection procedure, the 
variable with the highest p-value was manually deleted from the model until the model 
only contained variables with p-values of <0.0521.  The variables “readiness for 
change,” “attitudes towards the intervention” and “participation in feedback moments” 
were only available for intervention OPs and, therefore, not included in the multivariate 
analyses. We used SPSS, version 20.0, for the descriptive analyses and MLwiN, version 




Cluster-randomised controlled trial 
Of the 256 OPs invited to participate in the cluster-RCT, 154 agreed to participate. 
When comparing the participating and non-participating OPs on sex, working area 
(North, East, South or West of the Netherlands) and study group (intervention or control 
group), they significantly differed on working area with more non-participating OPs in 
the Eastern part of the Netherlands. Five OPs (3%) were excluded from the multilevel 
analyses, because of missing data on the clinical unit. A total of 149 OPs working in 40 
different clinical units were included in the analyses. OPs were 50.2 ± 7.2 years of age 
and 63.1% (n=94) were male. The mean number of years worked for the OHS was 10.6 
± 7.1 and 52.3% (n=78) worked in Western regions of the Netherlands. The mean 
number of recruited workers per OP was 1.3 ± 2.3. More details of the study population 
are presented in Table 1. 
 
Focus groups and interviews  
A total of 18 OPs participated in the focus groups (two groups of n=6) and interviews 
(n=6). Their mean age was 51.4 ± 6.3 years and 72% (n=13) was male. Five OPs (28%) 
belonged to the control group of the cluster-RCT. Thirteen OPs (72.2%) worked in 
Western regions of the Netherlands.  The mean number of workers recruited by each 
OP was 2.8 ± 3.3, with a minimum of zero workers (by 4 OPs) and a maximum of 11 
workers (by 2 OPs).  
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    Age in years 
    Gender 
        Male  
        Female 




















    Number of clients  
    Number of companies  










Work environment factors 
    Working area 
        North of Netherlands 
        East of Netherlands 
        West of Netherlands 
        South of Netherlands 
    Sector 
        Small/medium sized companies  
        Large companies   
    Number of OPs within clinical unit 
    Percentage of OPs within clinical unit participating 
   in the cluster-RCT 





































    Study group 
        Control group  
        Intervention group 
    Start inclusion period 
        January 2010  
        January 2011 
    Attitude towards intervention1 (range 3-15) 
    Readiness for change1 (range 2-10) 
    Participation in feedback moments1 
        Yes 






































1.3 (2.3) / 0 (0 -2) 
 
1Only measured in the intervention group (n = 70). 
 
 
Barriers and facilitators for participant recruitment according to OPs 
After individually creating codes for each piece of distinctive information and discussing 
these codes, the authors agreed upon 136 unique codes. The codes were grouped into 
six different categories: (1) study and intervention characteristics, (2) characteristics of 
the study population, (3) OP's attention, (4) OP's workload, (5) context and (6) OP's 
characteristics. Each category was divided into two or more subcategories. Of the 18 
participating OPs, three responded that they agreed with the categorisation. The other 
15 OPs did not respond. The final categories and subcategories are presented in Figure 
1 and quotes related to the categories are presented in Table 2.  
 
























OP = occupational physician; OHS = occupational health service. 
 











own acting attitude regarding 
the research 
Study and intervention 
characteristics 
research design side effects research material 











burden of research 
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Table 2. Quotes related to barriers and facilitators for participant recruitment. 
Category Quote 
Study and intervention characteristics “I... I think that... as few as possible of those criteria. 
I think that... it is probably simpler if you just say that 
everyone who experiences distress, eh... they can 
just participate in the research. Just eh... then I 
don’t need to think as much anymore... I would only 
be triggered by distress.” (OP 4, interview, 
intervention group) 
“Because it takes… well… if you want to do it 
correctly, it takes you 45 minutes for the first 
consultation. To motivate people, to explain, et 
cetera.” (OP 12, focus group, intervention group) 
Characteristics of the study population “Some people... cannot always understand what is 
written. You have… how do you say it… a type of 
category of low educated people. If you want… to 
present this to them… it costs a lot of time. That 
could be a barrier.” (OP 8, focus group, intervention 
group) 
OP’s attention “Yes, how I succeeded [in participant recruitment]… 
In any case of course the moments that we had a 
meeting with you. Then you have a more face-to-
face reminder, and you are better able to start with 
it. So, that is very important, I think, that after such a 
meeting or story from you, that you have more of a 
drive, to call it that way. That is something that 
diminishes after a vast amount of time.” (OP 6, 
interview, intervention group) 
OP’s workload “There are so many things that need to be done 
during a consultation that you just forget about it” 
(OP 13, focus group, intervention group). 
“It is difficult that you have to ask permission of the 
people [before sending their contact information to 
the researchers], so you have to be alert during the 
consultation” (OP 5, interview, control group). 
Context “Some internal person [of the OHS]… who once a 
week passes every door to remind everyone about 
the research. … One coordinator per group 
practice.” (OP 11, focus group, control group).  
“They [the employer] decide when someone can 
come [for a consultation]. And if you ask, I would like 
to see that person within two weeks, then it could 
just as well be that they plan a new consultation 
after two months.” (OP 12, focus group, intervention 
group) 
OP’s characteristics “Personally, I was very driven to help because I have 
been in the same position when I was writing my 
master thesis.” (OP 2, interview, control group) 
OP = occupational physician; OHS = occupational health service. 
 
 
Study and intervention characteristics 
Facilitators for participant recruitment were clear inclusion criteria and research 
material, such as workbooks or a checklist with criteria. One OP explained that concise 
or simple inclusion criteria were important for recruitment. As a positive “side effect” of 
the intervention, one OP stated that participating in research was an impulse for the 
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OHS and that the intervention could contribute to the development of new services. 
This stimulated the OP to participate and recruit participants. However, study 
characteristics could also act as barriers for participant recruitment. OPs experienced 
problems with recruitment because they could only include workers at a specific point 
in time (i.e. when workers were ready to return to work) and not directly when they saw 
the worker during the first consultation. Furthermore, the intervention had negative 
“side effects,” i.e. it took extra time for the OPs to conduct the intervention and this 
prevented some OPs from recruiting participants. 
 
Characteristics of the study population 
OPs mentioned that they were more eager to recruit workers who had an optimistic and 
enthusiastic attitude in general, and they rather recruited workers that were able to 
participate in the study without being overstrained. OPs from the intervention group 
pointed out that they thought that workers had to have some level of basic intelligence 
to be able to participate in the intervention, and thus, they felt they could not include 
lower educated workers. Other barriers for recruitment were, for example, being 
restricted by exclusion criteria (e.g. pregnancy, English-speaking), a worker who started 
return to work without waiting for the OP’s advice (workers had to be recruited before 
return to work started) or the inclusion criterion of common mental disorders (CMDs). 
For some OPs, guiding workers with CMDs took much consultation time, and this made 
it difficult to invest additional time to explain and discuss study participation.  
 
OP’s attention 
An important problem pointed out by all OPs was focusing their attention on participant 
recruitment. OPs mentioned that they often forgot to approach eligible patients 
because they were more focused on their regular tasks and did not have enough time 
left at the end of their consultation to discuss recruitment. However, OPs also 
described facilitators that could help focusing attention on recruitment. One frequently 
mentioned facilitator was regular face-to-face contact sessions with the researcher. 
Other facilitators were having the research material at hand to enhance visibility and 
receiving reminders and weekly newsletters by email, although some OPs thought this 
would not help as much as actual face-to-face contact. For the future improvement of 
recruitment, a facilitator mentioned by several OPs was use of ICT tools as a reminder, 








Another aspect affecting participant recruitment was OP’s workload. Workload 
consisted of OPs’ perceived burden of work (i.e. OPs felt they were very busy and did 
not have time to introduce the research project) and burden of the research project (i.e. 
being focused on recruitment during a consultation, keeping track of all eligibility 
criteria, time spent on explaining the study). 
 
Context 
Regarding OP’s own work context, many OPs reported that recruitment could have 
been encouraged to a higher extent in the clinical units. For example, an OP mentioned 
that it would have been helpful if one OP had functioned as an ambassador of the 
research and done a weekly check on colleagues asking about how recruitment was 
going. In line with this, several OPs said that it was helpful when colleagues reminded 
them of the study and the recruitment that had to be done. One reported barrier was 
the reorganisation at the time the cluster-RCT was conducted. OPs referred to this 
period as a hectic time with a lot of commotion and changes. OPs’ colleagues were also 
overloaded, which made the OPs reluctant to invest time in participant recruitment. 
Also, OPs experienced problems with recruitment when they worked at different 
location and did not have the recruitment folders available at all locations. For some 
OPs, another contextual barrier was the employer they had to deal with. In particular, 
when the employer controlled the timing and number of consultations between the OP 
and the worker this could be problematic for recruitment. When the OP was not able to 
see the worker on time, participation was no longer possible. As a solution to this 
problem, some OPs mentioned that involving the worker’s employer in the research 
was helpful (e.g. by giving information about the study).  
 
OP’s characteristics 
Key barriers to recruitment were related to the OP’s own acting; OPs felt they could stay 
passive without major consequences and they prioritised other matters. OPs differed 
substantially with regard to their commitment to research in general. Some considered 
themselves treatment and guidance-oriented and less focused on research. Others had 
research experience, could empathise with the researchers and were driven to help 
with recruitment. 
 
Factors associated with recruitment of workers 
Univariable associations of survey and administrative data to recruitment success are 
presented in Table 3. The univariable analyses showed that OHS tenure, working area, 
number of OPs within the clinical unit who recruited participants, start of inclusion 
period and productivity had significant positive relationships with successful 
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recruitment. OPs from the intervention group who participated in at least one feedback 
moment recruited significantly more workers than OPs who did not participate in 
feedback moments. Multivariable analyses showed that, after deleting the variables 
with the highest p-values, only the number of OPs within the clinical unit who recruited 
participants remained significant in the multivariable analysis (rate ratio = 1.43, 95% 
confidence interval = 1.24-1.64) (Table 4). 
 
 




Workers recruited by OP 




    Age 
    Gender 
        Male (reference) 
        Female 
    OHS tenure in years 
 












    Number of clients  
    Number of companies 









Work environment factors 
    Working area 
        North of Netherlands (reference) 
        East of Netherlands 
        West of Netherlands 
        South of Netherlands 
    Sector 
        Small/medium sized companies (reference) 
        Large companies  
    Number of OPs within clinical unit 
     Percentage of OPs within clinical unit 
     participating in the cluster-RCT 
     Number of OPs within clinical unit who recruited 




























    Study group 
        Control group (reference) 
        Intervention group 
    Start inclusion period 
        January 2010 (reference) 
        January 2011 
    Attitude towards intervention2 
    Readiness for change2 
    Participation in feedback moments2 
        No (reference) 

























OHS = occupational health service; OP = occupational physician; RCT = randomised controlled trial. 
1A rate ratio of >1 indicates more recruited workers by the OP. 





































































































































































































































































































































































































































































































































































































To investigate recruitment problems in the OHC setting, the present study explored 
barriers and facilitators related to participant recruitment by OPs using different data 
sources in a mixed-methods study. The focus group and interview study provided six 
main categories of barriers and facilitators for participant recruitment by OPs. These 
categories can be addressed by researchers when developing future studies in which 
participant recruitment is (mainly) relying on OPs. Three categories were related to the 
OPs themselves, like OP’s workload, and three categories were related to external 
factors, such as the organisational context. Although not all categories can be 
influenced by researchers, the categorisation can be helpful in determining the 
suitability of a recruitment strategy. It may be advisable to explore if some factors in the 
categorisation act as barriers and consider these when developing the recruitment 
strategy. Fortunately, many (sub)categories can be modified by researchers. For 
example, inclusion criteria can be formulated in a concise and not too exclusive way. 
Frequent visits to talk face-to-face to OHC providers responsible for recruitment are 
recommended, as well as providing clear research material and using reminder tools. 
 The main finding, based on the multivariable analysis, is that the number of OPs 
within the clinical unit who recruited participants is significantly associated with the 
number of recruited participants by the OP. Thus, OPs who work in clinical units where 
colleague OPs recruit participants are more likely to recruit participants themselves 
compared to OPs who work in clinical units where colleagues do not recruit. The finding 
that the number of OPs in the clinical unit who participated in the cluster-RCT was not 
related to recruitment shows that is not about how many colleague OPs agree to 
participate in the study but about how many colleague OPs really do something (i.e. 
recruit participants). Thus, researchers should not only motivate individual OPs to 
recruit participants for a study but also OPs’ entire clinical unit. This finding was 
supported by the qualitative data where OPs stressed the importance of support by 
colleagues of the clinical units and the OHS for recruitment. The results of the 
univariable analyses may be valuable for future trials where OHC providers are not 
organised in clinical units. Based on the univariable analyses, OPs working in the South 
of the Netherlands recruited fewer participants than OPs working in the North of the 
Netherlands. An explanation for this finding could be that the OPs in the Southern 
clinical units started recruitment one year later than the OPs in the other regions, but 
the recruitment duration was included in the multivariate analyses and did not remain 
significant. Another factor seems to have influenced recruitment in the Southern 
clinical units. Possibly, patients in the South were less willing to participate. During the 
cluster-RCT, information was collected from OPs on if they had been unable to include 
eligible patients and why. OPs from the North as well as the South often mentioned 
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that they forgot about recruitment or that the patient declined participation. However, 
the frequency of patients declining did not differ between OPs from the North and 
South. The fact that the researchers were located in the North of the Netherlands, and 
were thus at greater distance from the Southern regions, might have played a role. It is 
advisable for researchers to think about possible regional differences that could affect 
participant recruitment by OHC providers. Other important aspects to consider when 
involving OHC providers in participant recruitment are the time OHC providers are given 
to recruit and the organisation of feedback moments during the intervention trial.  
 When comparing the present study with other research, only one Dutch publication 
is available on OP participation in RCTs. Steenstra et al. discussed OP participation 
from the viewpoint of researchers and the main problems mentioned were research 
that does not fit the OPs' practice, high work pressure and unfamiliarity with RCTs12. 
Our study adds to this knowledge by (1) presenting the problems that are experienced 
from the viewpoint of OPs which supports some findings (e.g. work pressure) but also 
differs on some points (e.g. unfamiliarity with RCTs was not mentioned in our study) 
and (2) presenting new findings (e.g. use of ICT-tools, research is experienced as an 
impulse for the services of the OHS).  There are several studies that have investigated 
barriers to participation in research for other types of clinicians and found comparable 
results. Based on a survey among 78 studies in Dutch primary care research, van der 
Wouden et al. (2007) concluded that a software module linked to the electronic 
medical record may be helpful in reminding GPs about eligible patients, which is in 
agreement with our current findings3. Ross et al. reviewed barriers to clinician 
participation in RCTs and identified 78 papers describing problems related to clinician 
and participant recruitment in hospital and primary care settings5. The main barriers to 
clinician participation (i.e. as a treatment provider and recruiter of participants) were 
lack of time, not being prepared for a research role, alteration of the doctor-patient 
relationship, loss of clinical autonomy and burden of the research for the clinician and 
the participant. Some of these barriers were also pointed out by the OPs in this study, 
such as work pressure (i.e. lack of time), burden of the research and being more 
focused on patient care than on research (i.e. not prepared for a research role). Taking 
the similarities between our findings and those from other research areas into account, 
our results may have a broader applicability than the OHC setting of this study.   
 Our study contributes to the current knowledge on recruitment problems, as this is 
first study that quantitatively and qualitatively investigated recruitment problems in the 
OHC context. Furthermore, this is the first study that has found that participant 
recruitment by an OP is positively related to the number of OPs within the clinical unit 
who recruit participants. This finding might be specific to the Dutch OHC context where 
OPs are actively cooperating in clinical units but can be very relevant for other research 
contexts as well. Often, practitioners are approached individually to participate in 
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research, while most are part of some kind of practitioner group, such as peer coaching 
and feedback groups. Our research shows that it might be worthwhile to investigate in 
what kind of group practitioners are organised and to approach these groups instead of 
various individual practitioners. Also, the univariate analyses revealed potential 
relevant factors in participant recruitment that have not been found in recruitment 
studies within clinical and primary care contexts. Finally, compared to a recent 
qualitative meta-analysis on improving recruitment for RCTs, which included studies 
from hospital and primary care settings6, we found several major themes that were not 
found in the meta-analysis, such as “OP’s attention,” “OP’s characteristics” and 
“context.” Thus, research on recruitment problems in the OHC setting is necessary as 
several factors seem to specifically influence participant recruitment in the OHC 
context. 
 
Strengths and limitations 
A strength of this study was the use of different data sources and a mixed-methods 
approach to investigate barriers and facilitators for participant recruitment by OPs. The 
results from the quantitative and qualitative analyses did not only complement each 
other but also confirmed each other on some parts. For the quantitative analyses, data 
of most OPs, involved in participant recruitment for the cluster-RCT, could be used. 
Another strength is the combination of focus groups and, additionally, telephone 
interviews as input for the qualitative analyses. In the focus group setting, OPs were 
able to react to each other’s ideas and came up with new insights based on what they 
heard from others, while in the interview setting, OPs were not influenced by possible 
group dynamics. Finally, we collected data from OPs that were very successful in 
recruiting participants which enabled us to not only report on barriers but also on 
facilitators for participant recruitment.  
 A limitation of the focus group and interview study is that the coordinating 
researcher (IA) of the cluster-RCT acted as interviewer and moderator, implicating that 
OPs might not have spoken speak freely about problems with participant recruitment. 
However, the results showed that OPs were open in mentioning problems related to the 
study design and protocol. Further, the list of categories and subcategories extracted 
from the focus groups and interviews was only confirmed by three of the 18 OPs that 
participated; the other OPs did not respond. We do believe that the categorisation 
reflects the perspective of the OPs based on conversations with different OPs during 
feedback moments and visits to the clinical units where often similar barriers and 
facilitators were mentioned as presented in the categorisation. Another limitation is the 
cross-sectional analysis of the quantitative data, which makes it impossible to draw 
causal inferences between OP characteristics and participant recruitment. The 
independent variable “number of OPs within the clinical unit who recruited 
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participants” included the participation of the OP of interest, and this might have 
influenced the results because of its relationship with the outcome variable “number of 
workers recruited per OP.” Furthermore, the qualitative data showed that work 
pressure was an important barrier to recruitment, but we were not able to include in 
the quantitative analysis as there were no quantitative data available on work pressure. 
Finally, as three variables (“readiness for change,” “attitudes towards the intervention” 
and “participation in feedback moments”) were only measured for the intervention 
group it would have been interesting to make a separate multivariate regression model 
for the intervention group, but this was not feasible due to the small sample size. 
 
Conclusion 
Barriers to research participant recruitment in the OHC setting are comparable to 
hospital and primary care settings. However, an important difference seems to be the 
influence of the OP’s organisational context on recruitment, such as support from the 
OHS and patients’ employers. Recruitment in the OHC setting can be facilitated when 
researchers not only motivate individual OPs but entire clinical units. OPs consider 
continuous attention on recruitment strategies, especially face-to-face contact and ICT 
tools as reminders, as helpful for improving participant recruitment. 
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Objectives: Workers with common mental disorders (CMDs) frequently experience 
recurrent sickness absence but scientifically evaluated interventions to prevent 
recurrences are lacking. The objectives of this study are to evaluate the cost-
effectiveness and cost-benefit of a problem solving intervention aimed at preventing 
recurrent sickness absence in workers with CMDs compared to care as usual care as 
usual.  
Methods: An economic evaluation was conducted alongside a cluster-randomised 
controlled trial with 12 months follow-up. Treatment providers were randomised to 
either a 2-day training in the SHARP-at work intervention, i.e. a problem solving 
intervention, or care as usual. Effect outcomes were the incidence of recurrent 
sickness absence and time to recurrent sickness absence. Self-reported health care 
utilisation was measured by questionnaires. A cost-effectiveness analysis (CEA) from 
the societal perspective and a cost-benefit analysis (CBA) from the employer’s 
perspective were conducted.  
Results: The CEA showed that the intervention was more effective but also more 
expensive than care as usual. The CBA revealed that employer’s occupational health 
care costs were significantly higher in the intervention group compared to care as 
usual. Overall, the SHARP-at work intervention showed no economic benefit compared 
to care as usual. 
Conclusions: As implementation of the SHARP-at work intervention might require 
additional investments, health care policy makers need to decide if these investments 
are worthwhile considering the results that can be accomplished in reducing recurrent 
sickness absence.  
Trial registration number: NTR1963. 




The costs of mental disorders to society are substantial in terms of medical care 
consumption, but even more because of productivity loss due to sickness absence, 
work disability and at-the-job productivity loss1-7. Common mental disorders (CMDs, i.e. 
depressive, anxiety and adjustment disorders), as opposed to severe mental disorders, 
account for the majority of costs related to mental ill-health7. However, evidence for 
work-related interventions is much more established for severe mental disorders, such 
as supported employment programs8. In the last decade, several studies have focused 
on workers suffering from CMDs and have evaluated interventions to enhance return to 
work (RTW)9-12. In these studies, RTW has been defined as endpoint while recent 
research has shown that 20% to 30% of the workers who returned to work after 
sickness absence due to CMDs experience recurrent sickness absence13,14. Moreover, 
recurrent sickness absence is often more serious and long-lasting than the initial 
sickness episode due to CMDs13. Thus, more attention is needed for enhancing 
sustainable RTW of workers with CMDs by preventing recurrent sickness absence.  
 The SHARP-at work intervention is developed to prevent recurrent sickness absence 
in workers who returned to work after sickness absence due to CMDs15. The 
intervention consists of problem-solving treatment provided by occupational physicians 
(OPs). OPs guide workers through a problem-solving process focused on establishing 
solutions for problems and opportunities encountered when back at work. 
Furthermore, consultations between the worker and the supervisor are stimulated by 
the OP to achieve solutions that can be readily implemented. The intervention was 
compared to care as usual (CAU) in a cluster-randomised controlled trial (cluster-RCT) 
and has shown to be effective in reducing recurrent sickness absence (Arends et al., 
submitted).  
 Before implementing the SHARP-at work intervention in the occupational health 
care practice, insight is needed in the relationship between intervention costs and 
benefits compared to CAU16.  Therefore, the objective of this study was to perform an 
economic evaluation of the SHARP-at work intervention compared to CAU. Cost-
effectiveness was evaluated from the societal perspective and cost-benefit from the 




An economic evaluation was conducted alongside a cluster-RCT. OPs, who conducted 
the intervention, were recruited through 365/ArboNed, one of the largest Occupational 
Health Services in the Netherlands. The Medical Ethical Board of the University Medical 
Center Groningen provided approval for the study design, the research protocol, 
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questionnaires, information letters and the informed consent. More detailed 




In the Netherlands, the employer pays sickness absence benefits to the sick-listed 
worker for two years. During these two years, both the employer and sick-listed worker 
are responsible for RTW. The employer is obliged to contract an OP to help guiding the 
RTW process. If RTW has not been accomplished after two years, the Social Security 
Agency (SSA) evaluates if sufficient RTW efforts have been made by the employer and 
worker and decides on the percentage of work disability for which the worker will be 
compensated by the SSA. Costs for treatment and work accommodations are the 
responsibility of the employer, but compensation can be requested from the SSA for 
work accommodations.  
 
Study population 
Participants were recruited by OPs between January 2010 and June 2011. Eligible 
participants were workers between 18 and 63 years, had to be diagnosed with a CMD 
by their OP at the start of sickness absence and had to be ready to (partially) RTW. A 
detailed overview of all inclusion and exclusion criteria has been presented 
elsewhere15. 
 
Randomisation and blinding 
OPs were randomised to the intervention or control group based on a computer-
generated random allocation sequence because workers could not be randomly 
allocated to OPs as OPs are bound to companies. Since a worker’s allocation was 
predefined based on the OP’s allocation, we only provided information on the 
treatment the worker would receive and blinded the worker for study design and 
comparison group. OPs were not blinded for study design and allocation. 
 
Interventions 
SHARP-at work intervention 
A detailed description of the intervention has been provided elsewhere (Arends et al., 
submitted for publication). In brief, the SHARP-at work intervention was developed to 
prevent recurrent sickness absence by structured OP guidance after RTW. The 
intervention was started by OPs when participants on sickness absence due to CMDs 
were ready to RTW. Five steps had to be followed by the participant when RTW was 
started. The OP monitored that all steps were taken and activated the participant when 
needed. For each step, facilitating assignments for the worker were at the OP’s 
Economic evaluation of the SHARP-at work intervention | Chapter 7 
169 
 
disposal. The five steps comprised: (1) making an inventory of problems and/or 
opportunities encountered at work after RTW, (2) brainstorming about 
solutions/realisations, (3) writing down solutions/realisations and the support needed 
and assessing the applicability of these solutions, (4) discussing solutions/realisations 
and making an action plan with the supervisor, and (5) evaluating the action 
plan/implementation of solutions. Two to five consultations, of 30 minutes each, were 
recommended to OPs. The first of five assignments (i.e. making an inventory of 
problems and opportunities and assessing the help needed to solve them) instigated 
the problem solving process and was therefore a key element. OPs received a two-day 
training in the SHARP-at work intervention and had three feedback moments to discuss 
their experiences with conducting the intervention. 
 
Care as usual 
All participating OPs were already trained in the evidence-based guideline of the 
Netherlands Society of Occupational Medicine “The treatment of workers with mental 
health problems by the OP”17,18. The guideline is primarily directed at structuring OP’s 
treatment to help sick-listed workers with mental health problems to RTW.  Though one 
consultation has to take place after RTW to address relapse prevention, limited 




An economic evaluation was performed from the societal and employer perspective. 
The evaluation from the societal perspective consisted of a cost-effectiveness analysis 
(CEA) with the difference in incidence of recurrent sickness absence and time to 
recurrent sickness absence between the two study groups as the outcomes. Costs 
associated with health care utilisation and the intervention or CAU costs were included 
in the CEA. From the employer perspective, a cost-benefit analysis (CBA) was 
performed comparing the two study groups regarding costs associated with health care 




The effect measures were the incidence of recurrent sickness absence over 12 months 
follow-up and time to recurrent sickness absence. Recurrent sickness absence was 
defined as ≥ 30% decrease in working days per week due to sickness absence. 
Recurrent sickness absence days were corrected for partial RTW by dividing the 
sickness absence days by 1/RTW percentage. 
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Health care costs 
Data were collected using the Trimbos/iMTA questionnaire for Costs associated with 
Psychiatric Illness (TiC-P) with a 4-week recall period at baseline and at 3, 6 and 12 
months follow-up. The data were linearly interpolated over 12 months. The unit prices 
used for valuing resource utilisation are presented in Table 1. The study's index year 
was 2009. The Dutch Manual for Costing was used for calculating standard prices 19. 
Costs for alternative care were based on real costs reported by the participants. 
Medication costs were valued with cost prices of the Royal Dutch Society for 
Pharmacy20. Two questions on number of consultations with the OP and company 
social worker were added to the Tic-P to collect data on use of occupational health 
services. For the calculation of costs from the societal perspective, the OP 
consultations were valued using the cost level for general practitioners, and 
consultations with the company social worker were valued using the cost level for 
social workers. For the calculation of costs from the employer perspective real 
employer prices for OPs and company social workers were used which were provided 
by the Occupational Health Service.  
 
Productivity loss 
Costs associated with productivity loss were estimated from an employer perspective. 
Productivity loss was operationalized as costs resulting from sickness absence and at-
work productivity loss (i.e. presenteeism). To measure sickness absence costs, 
administrative data were collected on cumulative number of days of sickness absence 
over a period of 12 months. Calendar days of sickness absence were corrected for 
part-time sickness absence and converted to number of working hours based on 
participants’' work contract. For the calculation of productivity loss costs, we assumed 
that participants were 100% productive during the hours of work resumption. At-work 
productivity loss was assessed with one question of the TiC-P stating: "How many extra 
hours would you have to work to catch up on tasks you were unable to complete in 
normal working hours due to health problems over the past two weeks?" Sickness 
absence costs and costs for at-work productivity loss were calculated by multiplying the 
number of sickness absence hours by the estimated cost of production loss for a 
worker per hour of absence, differentiating between costs for men and women. We 
used the Human Capital Approach (HCA) and the Friction Cost Approach (FCA) to 
calculate the total costs of production loss. A friction period of 154 days and an 
elasticity of 0.8 were applied in the FCA19,21. 
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Table 1. Unit prices used and mean (SD) total costs per study group. 
   Mean costs (SD)  
Type of costs Unit prices  SHARP CAU 
Health care costs for society    
 General practitioner  291 59 (63) 61 (70) 
 Regional Institute for Community Mental Health Care 701 69 (140) 96 (194) 
 Psychiatrist 1071 22 (74) 67 (212) 
 Psychologist 83 1 212 (228) 209 (205) 
 Occupational physician 29 81 (48) 60 (46) 
 Company social worker 68 34 (80) 16 (48) 
 Medical specialist 751 103 (239) 91 (208) 
 Physiotherapist 371 61 (138) 68 (118) 
 Social worker 681 15 (52) 15 (80) 
 Alternative health care 31 - 642 66 (137) 91 (189) 
 Psychiatric part-time or day program 2001 48 (347) 27 (186) 
 Hospitalisation  452-5971 164 (1000) 42 (163) 
 Prescribed medication Variable3 43 (83) 38 (65) 
 Self-purchased medication Variable2 33 (105) 80 (158) 
 Out-of-pocket costs Variable2 29 (109) 38 (159) 
 SHARP-at work intervention 661 661 0 
 Total health care costs  4167 (9407) 2403 (2360) 
Costs of occupational health services for employer    
 Occupational physician 154 420 (250) 314 (240) 
 Company social worker 121 248 (239) 178 (125) 
 SHARP-at work intervention 661 661 0 
 Total costs of occupational health services  1143 (342) 343 (254) 
Costs of productivity loss    
 Productivity loss net HCA    
  Only sickness absence  37265 (26227) 32019 (22442) 
  Combined4  36072 (20015) 31342 (24039) 
 Productivity loss net FCA    
  Only sickness absence  27789 (17185) 24594 (15993) 
  Combined4  28194 (14529) 24264 (18069) 
All costs are given in euros. SHARP = intervention group; CAU = care as usual; HCA = human capital 
approach; FCA = friction cost approach. 
1Price according to Dutch guidelines for costing studies.  
2Price according to self-report of participants. 
3Price according to the Royal Dutch Society for Pharmacy. 





The economic evaluation was performed according to the intention-to-treat principle. 
Discounting of costs was not applied because the follow-up was limited to one year. 
Sickness absence data were collected for 145 (92%) participants and a complete 
follow-up on self-reported data was available for 99 (63%) participants. 
 For the CEA, the incremental cost-effectiveness ratio (ICER) was calculated by 
dividing the incremental costs by the incremental effects. The incremental costs 
consisted of the difference in all health care utilisation costs (including the intervention 
costs) between the intervention and control group. Two incremental effect measures 
were calculated: (1) the difference in incidence of recurrent sickness absence and (2) 
the difference in time (measured in days) to recurrent sickness absence between the 
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intervention and control group. The ICER represents the additional investments needed 
to prevent one case of recurrent sickness absence or to prevent one day of recurrent 
sickness absence. For the CBA from the employer's perspective, the net monetary 
benefit (NMB) was calculated by subtracting the difference in costs for occupational 
health services (including the intervention costs) between the intervention and control 
group from the difference in costs of productivity loss between the two groups. Total 
costs of productivity loss was calculated with and without costs due lost productivity at 
work, next to costs of sickness absence, as data on lost productivity at work were only 
available for 51% of the study sample. The CBA was performed using both the HCA and 
FCA. The mean difference in costs and benefits between the intervention and control 
group and the 95% confidence intervals (CI) were calculated with multilevel regression 
analysis to account for the study’s multilevel design.  
 The 95% CI’s for the incremental costs were estimated using a bias corrected and 
accelerated bootstrapping procedure with 5000 replications22. Bootstrapped cost-
effect pairs were plotted on a cost-effectiveness plane. Cost-effectiveness acceptability 
curves were generated if the ICER was located in the north-east quadrant 23. Sensitivity 
analysis for the CEA was conducted to assess the effect of one extreme outlier. 
Sensitivity analyses for the CEA and CBA were conducted to assess the effect of 
reducing the intervention costs to €30 per participant. This reduction in costs was 
calculated under the assumption that, in practice, OPs will treat more workers 
according to the intervention than the 80 workers that were included in the 
intervention group of the present study. In this way, the training costs of the 
intervention could be divided over more workers causing a reduction in intervention 
costs per worker. Based on the OHS’s data, every OP treats 2500 to 3000 workers of 
which 32 to 39 experience sickness absence due to CMDs within one year15. Taking 
the conservative assumption that OPs can treat 24 of the 32 to 39 workers according 
to the intervention per year, the intervention training costs for the 73 OPs that 
participated in the study can be divided over 1752 (73 x 24) workers, leading to a total 
amount of €30 per worker instead of €661 (see also Table 2). Data processing was 
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Table 2. Costs of the SHARP-at work intervention. 
Resources Description Aggregated costs in 
euros 
Costs for training OPs in the intervention   
 Trainer costs1 Preparation of training: 2 trainers, 2-
10 hours, €100 per hour 
Training sessions: 2 trainers, 12-108 
hours, €100 per hour 
Follow-up meetings: 1 trainer, 6 hours, 







 OP attendance costs2 Training of OPs: 73 OPs, 12 hours, 
€40 per hour 
Follow-up meetings: 40 OPs, 1,5 





 Additional training costs Rent for training location, 
refreshments and study materials 
 1660 
 Total training costs Sum of trainer costs, OP attendance 
costs and additional training costs 
52900 
 Training costs per worker Total training costs divided by 80 
workers 
661 
 Training costs per worker sensitivity 
analysis 
Total training costs divided by 1740 
workers 
30 
OP = occupational physician. 
1Based on price requested by trainer. 






OPs recruited 212 workers of whom 158 agreed to participate. Eighty participants were 
treated by OPs in the intervention group and received the SHARP-at work intervention, 
and 78 participants were treated by OPs in the control group and received CAU. 
Baseline characteristics of the study population are presented in Table 3.  
 
Effects on recurrent sickness absence 
The incidence of recurrent sickness absence during 12 months follow-up was 39% for 
the SHARP group and 62% for the CAU group. The mean effect difference between the 
SHARP and CAU group was 24% (95% CI 3% to 45%) in favour of the SHARP group, i.e. 
there was 24% less recurrent sickness absence in the SHARP group (Table 4). The 
median number of days to recurrent sickness absence was 365 (inter quartile range 
(IQR) 174 to 365) in the SHARP group and 253 (IQR 117 to 365) in the CAU group. The 
mean effect difference between the SHARP and CAU group was 55 (95% CI 2.85 to 
106.09) days in favour of the SHARP group, i.e. the SHARP group experienced 
recurrent sickness absence 55 days later than the CAU group (Table 4). 
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(n = 80) 
 CAU 
(n = 78) 
Characteristics M / n SD / %  M / n SD / % 
Socio-demographic characteristics    
 Age (years) 41.3 9.4  43.3 9.8 
 Gender (male) 27 33.8  38 48.7 
 Marital status (married or living together) 67 83.8  60 76.9 
 Breadwinner (yes) 40 50.0  49 62.8 







16.7  Low 
 Intermediate 36 45.0  40 51.3 
 High 38 47.5  23 29.5 
Clinical characteristics    







15.4  F32.9 Depressive episode, unspecified 
 F41.9 Anxiety disorder, unspecified 0 0.0  2 2.6 
 F43.2 Adjustment disorders 58 72.5  39 50.0 
 F43.9 Reaction to severe stress, 
unspecified 
1 1.25  0 0.0 
R45 Symptoms and signs involving 
emotional state  
7 8.75  14 17.9 
Z73.0 Burn-out 2 2.5  7 9.0 
Other 8 10.0  4 5.1 
Work-related characteristics    
 Type of occupation    
 Commercial service providers 23 28.8  11 14.1 
 Management 11 13.8  15 19.2 
 Administrative staff 19 23.8  12 15.4 
 ICT staff 4 5.0  4 5.1 
 Sales staff 2 2.5  5 6.4 
 Health care providers 12 15.0  12 15.4 
 Hotel and catering staff 3 3.8  0 0.0 
 Stock and/or transport staff 1 1.3  11 14.1 
 Designers/planners 3 3.8  2 2.6 
 Mechanics/repairmen 2 2.5  5 6.4 
 Employment (hours per week) 32.6 7.0  32.9 7.3 
 Irregular work (e.g. shift work) 6 7.5  10 12.8 
 Executive/manager responsibilities 23 28.8  21 26.9 
 Duration of sickness absence 130.9 94.2  99.3 66.1 
 WRFQ-Total score 66.9 15.5  61.0 20.0 
Health-related characteristics    
 4DSQ Distress 13.8 7.5  15.5  7.5 
 Depression 1.5 2.1  2.0  2.4 
 Anxiety 3.1 3.3  3.6   3.5 
 Somatisation 7.9 5.3  7.9   5.5 
 HADS Depression 7.0 4.5  7.3   4.4 
 Anxiety 7.2 3.9  7.8   3.4 
SHARP = intervention group; CAU = care as usual group; OP = occupational physician; WRFQ = Work Role 
Functioning Questionnaire; 4DSQ = Four-Dimensional Symptom Questionnaire; HADS = Hospital Anxiety and 
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Health care and productivity loss costs 
The mean costs of health care utilisation are presented in Table 1. An important cost 
driver was care by the psychologist. There were small differences between the SHARP 
and CAU group regarding non-occupational health care use. The SHARP group more 
frequently visited the OP and company social worker. Following this, total occupational 
health care costs for the employer were significantly higher in the SHARP group (Table 
4). The costs of the SHARP-at work intervention were €661 per worker. We also 
calculated the intervention costs based on the assumption that, in practice, every OP 
could treat at least 24 workers according to the intervention lowering intervention costs 
per worker to €30 (Table 2). The difference in mean total health care costs between 
the two study groups was mainly due to one outlier in the SHARP group whose total 
health care costs were more than nine times higher than the upper limit of the 95% CI 
of the total health care costs of the SHARP group. The high costs for this outlier were 
mainly due to hospitalisation in a psychiatric ward.  
 No significant differences were found between the SHARP and CAU group regarding 
cost of productivity loss (Table 4). For both groups, cost of productivity loss represented 
87% to 93% of the total costs, depending on how it was measured (HCA or FCA).  
 
 
Table 4. Mean cost and effect differences between the SHARP and CAU group. 
 
Analysis1 
ΔC (95% CI) ΔE (95% CI)   
euros  percentage/days/euros4 ICER NMB5 
Total group      
 CEA-incidence of RSA 1932 (-318 to 5350)  0.24 (0.03 to 0.45) 10605  
 CEA-time to RSA 1358 (-945 to 4886)  55 (2.85 to 106.09) 2183  
 CBA HCA only sickness 
absence 
800 (678 to 922)  5246 (-2701 to 13192)  6046 
 CBA FCA only sickness 
absence 
800 (678 to 922)  3195 (-2214 to 8604)  3995 
 CBA HCA combined2 800 (678 to 922)  4730 (-5699 to 15158)  5530 
 CBA FCA combined2 800 (678 to 922)  3929 (-3764 to 11623)  4729 
Excluding outlier3      
 CEA-incidence of RSA -133 (-1155 to 914)  0.25 (0.03 to 0.46)  -533  
 CEA-time to RSA -129 (-1266 to 964)  59 (5.95 to 111.15) -2  
CEA = cost-effectiveness analysis; RSA = recurrent sickness absence; CBA = cost-benefit analysis; ΔC = mean 
cost difference; ΔE = mean effect difference; HCA = human capital approach; FCA = friction cost approach; 
ICER = incremental cost effect ration; NMB = net monetary benefit. 
1In the CEA, ΔC is the mean difference in total health care costs and ΔE is the mean difference in percentage 
of workers that experienced recurrent sickness absence; in the CBA, ΔC is the mean difference in total 
occupational health care costs, including the intervention, for the employer and ΔE is the mean difference in 
sickness absence costs estimated by the HCA or FCA. 
2Productivity loss costs are a combination of sickness absence costs and costs due to lost productivity at 
work. 
3Sensitivity analysis excluding one extreme outlier. 
4Differences in CEA effects are presented in (1) percentage of workers that experienced recurrent sickness 
absence, (2) number of days to recurrent sickness absence; differences in CBA benefits are presented as 
costs in euros. 
5Negative values of the NMB imply lower costs for the intervention group compared to the control group.   
 




The CEA with incidence of recurrent sickness absence as effect measure showed an 
ICER of €10.605 per percent of prevented recurrent sickness absence episode, i.e. an 
additional €10.605 were needed in the SHARP group to have 1% less recurrent 
sickness absence compared to the CAU group (Table 4). The cost-effectiveness plane 
showed that 92% of the bootstrap cost-effectiveness pairs were in the north-east 
quadrant (Figure 1A). The cost-effectiveness acceptability curve showed that if one is 
willing to invest €20.000 for 1% less recurrent sickness absence, there is a 0.84 
probability that the intervention is cost-effective compared to CAU (Figure 1A). The CEA 
with time to recurrent sickness absence as effect measure showed an ICER of €2813 
per one day of prevented recurrent sickness absence, meaning that an additional 
€2813 was needed in the SHARP group to prevent one day of recurrent sickness 
absence. The cost-effectiveness plane showed that 77% of the bootstrap cost-
effectiveness pairs were in the north-east quadrant (Figure 1B). The cost-effectiveness 
acceptability curve showed that if one is willing to invest €70 to prevent one day of 
recurrent sickness absence, there is a 0.85 probability that the intervention is cost-
effective compared to CAU (Figure 1B). Thus, the SHARP-at work intervention was more 
effective but also more costly compared to CAU.  
 The sensitivity analysis excluding the outlier showed an ICER of €-533 for the 
incidence of recurrent sickness absence, indicating that the intervention was cost-
effective: 1% less recurrent sickness absence saved €533. In the cost-effectiveness 
plane 60% of the bootstrap cost-effectiveness pairs were in the south-east quadrant 
(Figure 2). The cost-effectiveness acceptability curve showed a 0.98 probability that the 
intervention is cost-effective compared to CAU if one is willing to invest €15.000 for 1% 
less recurrent sickness absence (Figure 2). Similarly, the sensitivity analysis excluding 
the outlier changed the direction of the primary results regarding time to recurrent 
sickness absence. An ICER of €-2 was found, indicating that the intervention was cost-
effective compared to care as usual: the prevention of one day of recurrent sickness 
absence saved €2. The cost-effectiveness plane showed that 58% of the bootstrap 
cost-effectiveness pairs are in the south-east quadrant (Figure 2). The cost-
effectiveness acceptability curve showed a 0.98 probability that the intervention is 
cost-effective compared to CAU if one is willing to invest €70 to prevent one day of 
recurrent sickness absence (Figure 2). 
 Sensitivity analyses with reduced intervention costs did not change the direction of 























































































































































































































































































































   






























































































































































































































































































































The CBA from the employer's perspective showed that the mean cost difference for 
occupational health services was in favour of the CAU group. The mean costs were 
€800 (95% CI 678 to 922) higher in the SHARP group compared to the CAU group. The 
mean cost difference for productivity loss was also in favour of the CAU group. 
According to the HCA, only including sickness absence costs, the mean costs for 
productivity loss were €5246 (95% CI -2701 to 13192) higher in the SHARP group. 
Following the FCA, only including sickness absence costs, the mean costs for 
productivity loss were €3195 (95% CI -2214 to 8604) higher in the SHARP group. Thus, 
no net monetary benefit was achieved with the SHARP-at work intervention compared 




The SHARP- at work intervention had a superior effect on the incidence of and time to 
recurrent sickness absence but had no economic benefit compared to care as usual. 
From a societal perspective, there were no significant differences in health care costs 
between the SHARP group and CAU group. Employer costs for occupational health care 
were significantly higher in the SHARP group compared to CAU. Costs due to lost 
productivity did not significantly differ between the two study groups. Thus, to realise 
the effect on recurrent sickness absence, additional monetary investments in the 
SHARP-at work intervention were needed. Even though an economic benefit of the 
intervention was not found, a societal benefit may be realised when the reduction in 
recurrent sickness absence results in more stable work participation. Sensitivity 
analyses for the CEA excluding one major outlier changed the direction of the primary 
CEA results. Excluding the outlier, the SHARP-at work intervention was cost-effective in 
preventing the incidence of recurrent sickness absence and increasing time to 
recurrent sickness absence. 
 Although the SHARP-at work intervention was effective in reducing the incidence of 
recurrent sickness absence and increased the time to recurrent sickness absence, the 
CBA showed no effect on reduced costs of productivity loss. This result might be 
counterintuitive as a reduced incidence of recurrent sickness absence would be 
expected to result in reduced sickness absence days and, thus, reduced costs due to 
productivity loss. However, costs due to productivity loss were found to be somewhat 
higher for the SHARP group, meaning that the SHARP group had more sickness 
absence days. This result may be partly explained by the fact that the CAU group had a 
shorter duration of sickness absence and a higher RTW percentage at baseline, 
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resulting in less sickness absence days. Possibly, the study's one-year follow-up 
timeframe was too short to pick up long-term effects on sickness absence. 
 No previous studies have been published on an economic evaluation of an 
intervention to prevent recurrent sickness absence in workers who returned to work 
after sickness absence due to CMDs. Recently, several economic evaluations of RTW 
interventions for workers with mental health problems were published25-28. Comparing 
our study results with these RTW studies is complicated as the study populations and 
the effect measures differ. The participants in the RTW studies were still off work and 
the interventions aimed to facilitate RTW. Effect measures in the economic evaluations 
of these RTW studies are focused on days to first or full RTW. Most of the RTW studies 
showed no economic benefit of the RTW intervention under investigation25,27,28. 
 
Strengths and limitations 
The strengths of this study are the pragmatic design, data collection on productivity 
loss and the use of a societal and employer perspective for the economic evaluation. 
Firstly, the pragmatic study design enabled an economic evaluation of the SHARP-at 
work intervention in a real life situation and in a heterogeneous study population. 
Participants lived in different parts of the Netherlands, worked for small and large 
companies in different branches and occupied various job positions. This increased the 
external validity of the study results. Secondly, data on productivity loss included costs 
due to self-reported lost productivity at work, i.e. presenteeism, next to costs due to 
sickness absence. Even though information on productivity loss at work was only 
collected for 51% of the study sample, the CBA including this information gives a clear 
indication of the underestimation of productivity loss costs when only using sickness 
absence data and assuming that participants are 100% productive when at work. As 
presenteeism seems to be an important contributor to productivity loss among workers 
with mental health problems, this is an important variable to include in economic 
evaluations6,29,30. However, previous studies on the economic benefit of occupational 
health care interventions for workers with mental health problems often missed 
information on presenteeism26-28. Lastly, the cost-effectiveness evaluation from the 
broad societal perspective increased the generalisability of the results, while the cost-
benefit analysis from the employer perspective provided a realistic perspective on the 
distribution of costs and benefits of the SHARP-at work intervention within the Dutch 
social security context.  
 Some methodological limitations need to be considered. Data on health care 
utilisation were collected based on retrospective, self-reported questionnaires which 
may have biased the results. Although participants received diaries to keep track of 
health care utilisation to improve the reliability of the self-reported questionnaires, 
these diaries were sent for participants' own convenience and not recollected. Thus, we 
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were not able to check whether the diaries were used. Furthermore, data on health 
care utilisation during the past month were only collected at four measurement points 
and were linearly interpolated to 12 months, assuming a linear time trend in health 
care utilisation. Health care costs may have been overestimated or underestimated if 
health care utilisation between two time measurements was not linear over time. 
However, this probably will not have affected the direction of our results, as the health 
care costs only presented a small proportion of the total costs and data were linearly 
interpolated for both study groups. Another limitation is the missing data due to loss to 
follow-up: 62% of the participants had complete cost data. By using a bootstrap 
procedure with 5000 replications for the CEA, the problem of missing data was partly 
averted. Furthermore, we chose to conduct complete case analysis because we 
assumed that the data were missing completely at random: no significant differences 
were found between participants who were lost to follow-up and those who completed 
the study (Arends et al. submitted for publication). One exception might have been the 
data collected on productivity loss at work. Many participants responded to this 
question with a question mark, indicating that participants had trouble understanding 
this item. Therefore, we decided to also conduct the CBA excluding the information on 
lost productivity at work. As 62% of the data could be used for the CEA and CBA and no 
power calculation was conducted for the economic evaluation, it could be possible that 
the study was underpowered. For example, sensitivity analyses excluding one major 
outlier in the intervention group showed that the CEA results were strongly influenced 
by this outlier as the direction of the results changed after excluding the outlier. Finally, 
no information was collected on the costs of workplace adaptations that possibly 
resulted from the SHARP-at work intervention. This might have caused an 
underestimation of the intervention costs. However, costs due to possible workplace 
adaptations would be difficult to measure in a population of workers with CMDs. These 
workers do not so much require adaptations in workplace equipment or design but are 
more in need of, for example, frequent/longer breaks, lower work pace or other job 
content31 of which the costs are hard to estimate. Comparable workplace adaptations 
could also have been introduced in the CAU group, as participants in this group also 
had consultations with their OPs. Thus, differences in total health care costs between 
the two study groups would probably not drastically increase by including costs related 
to workplace adaptations.  
 
Conclusion 
The SHARP-at work intervention is effective in reducing recurrent sickness absence and 
in increasing time to recurrent sickness absence but is associated with higher costs 
compared to CAU. Bearing in mind the study’s limitations, future research needs to 
confirm that the SHARP-at work intervention is not cost-effective and cost-beneficial. As 
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implementation of the SHARP-at work intervention might require additional 
investments, health care policy makers need to decide if these investments are 
worthwhile considering the results that can be accomplished in reducing recurrent 
sickness absence.  
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Objective: To investigate whether socio-demographic, disease-related, personal, and 
work-related factors, measured at baseline, are predictors of recurrent sickness 
absence at 6 and 12 months follow-up in workers who returned to work after sickness 
absence due to common mental disorders (CMDs).  
Methods: A prospective study based on a cluster-randomized controlled trial with 6 and 
12 months follow-up conducted in an occupational health care setting. Occupational 
physicians included 158 participants, aged 18-63 years and diagnosed with a CMD, 
who had returned to work. The outcome was the incidence of recurrent sickness 
absence at 6 and 12 months follow-up.  
Results: At 6 and 12 months follow-up, 32% and 37% of the participants experienced 
recurrent sickness absence, respectively. Longitudinal logistic regression analysis with 
backward elimination showed that company size >100 (odds ratio [OR] = 2.59, 95% 
confidence interval [CI] 1.40 to 4.80) and conflicts with the supervisor (OR = 2.21, 95% 
CI 1.21 to 4.04) were predictive of recurrent sickness absence. Having one or more 
chronic diseases decreased the risk of recurrent sickness absence (OR = 0.54, 95% CI 
0.30 to 0.96).  
Conclusions: Work-related factors rather than disease-related factors predicted the 
incidence of recurrent sickness absence in workers with CMDs. Health care providers 
can use the findings to detect and help workers who returned to work and are at higher 
risk for recurrent sickness absence. Furthermore, future interventions to prevent 














Common mental disorders (CMDs, i.e. depressive, anxiety, and adjustment disorders) 
are a frequent cause of sickness absence, work disability, and reduced on-the-job 
productivity1-6. Several studies investigated predictors of first sickness absence and 
return to work (RTW) in workers with CMDs7-11, but limited evidence is available about 
factors predicting recurrent sickness absence in workers who have returned to work 
after sickness absence due to CMDs. Recent studies have shown that recurrent 
sickness absence is a frequent problem in this worker population; 20% to 30% of the 
workers who returned to work after sickness absence due to a CMD experiences a 
recurrence of sickness absence12,13. Furthermore, studies have demonstrated that 
workers on sickness absence due to mental disorders have an increased risk of 
another sickness absence episode14,15. Recurrent sickness absence has a significant 
health impact. Recurrent sickness absence due to CMDs is often more serious and 
long-lasting than the first sickness absence episode12. Additionally, frequent sickness 
absence episodes are related to an increased risk of work disability in later years15,16, 
and. 
 Few studies have investigated predictors for recurrent sickness absence in workers 
who returned to work after sickness absence due to CMDs. Based on a Dutch register 
study and a large Swedish cohort study, age <45 years and being married for women, 
age 44 to 55 years for men, and low socio-economic position for men and women were 
related to recurrent sickness absence12,13. However, these two studies did not 
investigate other potential predictors. Several studies have identified predictors of first 
sickness absence and RTW in workers with CMDs, such as disease-related factors (e.g. 
severity of mental health problems, problem duration, sickness absence) and work-
related factors (e.g. decision authority, skill discretion, work motivation)7,8,10,11,17-19. 
Predictors of recurrent sickness absence could be different because workers might 
have had treatment or guidance during the previous sickness absence period and work 
accommodations might have been installed to enable RTW. Therefore, the goal of this 
prospective study was to investigate whether socio-demographic, disease-related, 
personal, and work-related factors predict recurrent sickness absence in workers who 




Data of a cluster-randomized controlled trial (cluster-RCT) were used in which problem 
solving treatment by occupational physicians (OPs) was compared to care as usual 
(CAU) by OPs on effectiveness in preventing recurrent sickness absence in workers who 
returned to work after sickness absence due to CMDs. Participants were recruited from 
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January 2010 to June 2011 by OPs working for a large Dutch Occupational Health 
Service (OHS). OPs worked in different regions of the Netherlands, for companies of 
different sizes, and in different sectors. Inclusion criteria were: aged 18 to 63 years; 
employed in a paid job; diagnosed with a CMD by the OP (based on ICD-10 codes) at 
the start of the sickness absence episode; sickness absence for at least two weeks; 
RTW within two weeks. Exclusion criteria were: sickness absence episode > 12 months; 
prior sickness absence episode due to CMDs in past three months; severe mental 
disorders, such as psychotic disorder or bipolar disorder; somatic complaints/disorders 
that affect RTW; pregnancy, upcoming retirement/resignation/lay-off; not able to read, 
write, and understand Dutch. Participants received the baseline questionnaire when 
they had resumed work (mostly partial RTW) for two to four weeks. More detailed 
information on study design and setting can be found elsewhere (reference withheld to 
ensure anonymity). The Medical Ethical Board of the University Medical Center 
Groningen provided approval for the study.  
   
Predictors 




Sex, age, educational level (low/medium/high) and cohabiting (yes/no).  
 
Disease-related factors 
The 14-item self-report Hospital Anxiety and Depression Scale (HADS) was used to 
assess depression (7 items) and anxiety (7 items). Item scores range from 0 to 3 with 
higher scores indicating more symptoms21,22. Distress symptoms were assessed with 
the 16-item distress scale of the Four-Dimensional Symptom Questionnaire (4DSQ) 
with scores ranging from 0 = no to 2 = frequently, often or very often23,24. All mental 
health measures were dichotomized at the cut-off score for clinical relevance (8 for the 
HADS en 20 for the distress scale25,26). Data on psychopharmacologic medication use 
(yes/no) was collected with the Trimbos/iMTA questionnaire for Costs associated with 
Psychiatric Illness (Tic-P)27. Sickness absence duration (in days) at baseline was 
obtained from the OHS registry and divided into tertiles because of the skewed data. 
General health was assessed with one question of the 36-item Short-Form Heath 
Survey (SF-36): “In general, how would you rate your health?’’ The response categories 
were dichotomized to very good, good, or fair versus poor or very poor. Participants 
were also asked if they had one or more physical and/or mental chronic diseases 
(yes/no).  
 




Coping behavior was assessed with the 14-item Utrecht Coping List28. The 
questionnaire consists of three scales: (1) active problem focused coping, (2) 
emotional coping, and (3) avoidance coping. Item scores range from 1 = seldom or 




Work status was assessed by questionnaire data on tenure (0-5 years, >5 years), 
contract type (temporary/permanent), company size (<100, ≥100), supervisor (yes/no), 
monthly income in euro’s, work accommodations for RTW (yes, no), and consultations 
with OP in the past month (0, 1, >1). Based on administrative data from the OHS’ 
registry, we collected data on RTW percentage at the start of RTW and at baseline (two 
to four weeks after RTW started).  
 Work functioning was assessed with the 27-item Work Role Functioning 
Questionnaire 29,30. Response categories ranged from 100% (all of the time) to 0% 
(none of the time), with an option to score “not applicable.” Scores were converted to a 
total score between 0 and 100, with higher scores indicating better work functioning. 
Work engagement was assessed with the 9-item Utrecht Work Engagement Scale 
(UWES). Item scores range from 0 = never to 6 = always with higher scores indicating 
more work engagement31,32. 
 Readiness to stay at work (RSAW) was assessed with the Stay At Work subscale (6 
items) of the Readiness to Return to Work Scale33. Item scores range from 0 = totally 
disagree to 4 = totally agree with higher scores indicating more readiness to stay at 
work. 
 Work-related psychosocial factors, i.e. decision latitude, psychological job demands, 
supervisor social support, and co-worker social support, were measured with the Job 
Content Questionnaire 34-36. Scores were divided into tertiles. Conflicts with colleagues 
and supervisors were both measured with one question from the Dutch Questionnaire 
on Perception and Judgment of Work37 and dichotomized to never versus sometimes, 
often or always. Job insecurity was assesses with one question: “Are you afraid to lose 
your job within the near future?” (yes/no). 
 
Outcome 
Recurrent sickness absence (yes/no) was examined at 6 and 12 months follow-up. 
Recurrent sickness absence was defined as a 30% decrease in working days per week 
due to all-cause sickness absence, regardless of partial or full RTW. For example, a 
participant who had partially returned to work for 50% of the contract hours and went 
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To identify predictors of recurrent sickness absence at 6 and 12 months follow-up, 
univariable and multivariable logistic Generalized Estimating Equations (GEE) analyses 
with exchangeable correlation matrices were conducted. Random effects at the OP 
level were examined in a mixed model but these did not improve model fit and were not 
included in the analyses. Intervention and control group were combined in the 
analyses. To investigate whether the intervention modified the relation between the 
predictor and the outcome variable, treatment type x predictor interactions were 
analyzed38. We first identified predictors with a p-value ≤ 0.20 in univariable analyses 
for inclusion in a multivariable model39. Subsequently, we tested interactions between 
each of these predictors and treatment type (problem solving treatment or CAU) in 
univariable models. Interaction terms with a p-value ≤ 0.20 were also included in the 
multivariable model. In the multivariable model, a backward selection procedure was 
used until the model only contained variables with p-values of <0.0539. Dummy 
variables were included when at least one of the dummies had a p-value <0.05 and 
when the model fit did not decrease due to the dummy variable. Treatment type was 
included as a covariate. For the final multivariable model, interactions with time were 
tested to examine whether the strength of associations between predictors and 
recurrent sickness absence differed at 6 and 12 months follow-up. In a sensitivity 
analysis, a multivariable model with a p-value <0.10 was analyzed. All analyses were 




Between January 2010 and June 2011, 212 participants were recruited by OPs of 
which 54 (25%) declined participation. Workers who declined participation did not 
significantly differ from those who agreed to participate regarding gender and age.The 
total study sample consisted of 158 participants (80 participants in the intervention 
group and 78 in the control group). For 146 participants administrative data were 
collected on recurrent sickness absence at 6 months follow-up and for 145 
participants at 12 months follow-up (92%). One participant was excluded because of 
missing data on all variables. Baseline values for potential predictors are presented in 
Table 1. Recurrent sickness absence was experienced by 51 participants between 
baseline and 6 months follow-up (cumulative 6-month incidence 32%) and by 59 
participants between 6 and 12 months follow-up (cumulative 6-month incidence 37%).  
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Predictors of recurrent sickness absence 
In the univariable GEE analyses, 11 potential predictors showed a p-value of ≤0.20 
(Table 2). Significant interactions with treatment group were shown for 
psychopharmacologic medication use and supervisor social support. Thus, 11 potential 
predictors and two interactions were entered into the multivariable GEE model. After 
backward elimination, the final multivariable model contained one disease-related 
predictor and two work-related predictors (Table 2). Company size >100 workers (OR = 
2.59, 95% CI 1.40 to 5.80) and conflicts with supervisor (OR = 2.21, 95% CI 1.21 to 
4.04) increased the risk of recurrent sickness absence. Reporting one or more chronic 
diseases (OR = 0.54, 95% CI 0.30 to 0.96) decreased the risk of recurrent sickness 
absence. None of these predictors had significant interactions with treatment group or 
time. 
 Sensitivity analysis with a p-value of ≤0.10 for the multivariable model resulted in 
two extra work-related predictors, i.e. job tenure and supervisor social support (Table 
2). Longer job tenure increased the risk of recurrent sickness absence (OR = 1.89, 95% 
CI 0.99 to 3.61). Supervisor social support showed a significant interaction with 
treatment type. For workers in the control group, those in the highest tertile of 
supervisor social support scores were at lower risk of recurrent sickness absence 
compared to workers in the lowest tertile (OR = 0.28, 95% CI 0.07 to 1.14), while for 
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Table 1. Baseline characteristics of study population. 
Factors Total (n = 158) 
 Socio-demographic factors  
  Gender, male (N, %) 65 (41) 
  Age (mean, SD) 42.3 (9.6) 
  Educational level (N, %)  
   Low 19 (12) 
   Medium 76 (48) 
   High  61 (39) 
  Cohabiting, yes 126 (80) 
 Disease-related factors  
  General health, poor or very poor (N, %) 45 (29) 
  One or more chronic diseases, yes (N, %) 82 (52) 
  HADS anxiety score (mean, SD) (0-21) 7.5 (3.7) 
  HADS depression score (mean, SD) (0-21) 7.1 (4.4) 
  4DSQ distress score (mean, SD) (0-32) 14.7 (7.5) 
  Psychopharmacologic medication use (N, %) 39 (25) 
  Sickness absence duration (median, interquartile range [IQR]) 101.8 (59.3-145.1) 
 Personal factor  
  UCL subscale scores (mean, SD)  
   Active problem focused coping (5-20) 13.2 (3.1) 
   Emotional coping (5-20) 10.4 (2.7) 
   Avoidance coping (4-16) 8.7 (1.9) 
 Work-related factors     
  Tenure, 0-5 years (N, %) 69 (44) 
  Contract type, permanent (N, %)  
  Company size, <100 (N, %) 62 (39) 
  Supervisor (N, %) 44 (28) 
  Monthly income in euros (median, IQR) 1750 (1300-2100) 
  Work accommodation for RTW 109 (69) 
  Consultation with OP  
   0 consultations 20 (13) 
   1 consultation 91 (58) 
   >1 consultation 43 (27) 
  RTW percentage at start of RTW (median, IQR) 40.0 (22.0-63.0) 
  RTW percentage at baseline (median, IQR) 25.0 (0.0-50.0) 
  WRFQ total score (mean, SD) (0-100) 63.6 (18.4) 
  Work engagement, mean total score (mean, SD) (0-6) 3.3 (1.3) 
  RSAW total score (mean, SD) (0-24) 20.4 (3.7) 
  JCQ subscale scores (mean, SD)  
   Decision latitude 67.58 (10.4) 
   Psychological job demands 33.9 (6.6) 
   Supervisor social support 10.6 (2.5) 
   Colleague social support 12.0 (1.6) 
  Conflicts with colleagues, never (N, %) 76 (48) 
  Conflicts with supervisor, never (N, %) 75 (48) 
  Job insecurity, yes (N, %) 20 (13) 
HADS = Hospital Anxiety and Depression SCALE; 4DSQ = Four-Dimensional Symptom Questionnaire; RTW = 






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































The goal of this study was to identify predictors of recurrent sickness absence in 
workers who returned to work after sickness absence due to CMDs. The multivariable 
analyses revealed three main predictors for recurrent sickness absence at 6 and 12 
months follow-up: company size >100 workers and conflicts with supervisor increased 
the odds of recurrent sickness absence, while one or more chronic diseases decreased 
the odds. The finding that more than 30% of the study population experienced 
recurrent sickness absence is comparable to previous research, and supports the 
recommendation of Koopmans et al. (2011) to monitor workers who returned to work 
after sickness absence due to CMDs 12,13. Although a predictor such as company size 
cannot be modified, health care providers can use our results to identify and follow 
workers at greater risk of recurrent sickness absence. Conflicts with supervisor are 
more amendable to change as health care providers can help the worker to adequately 
deal with supervisor conflicts. In the future design of interventions to prevent recurrent 
sickness absence, a treatment component might be incorporated focusing on how to 
deal with supervisor conflicts. We also found that having one or more chronic diseases 
was predictive of reduced incident recurrent sickness absence. A possible explanation 
might be that workers that have succeeded in returning to work despite chronic 
diseases have acquired more experience in dealing with health-related problems that 
hinder work functioning and are better equipped to prevent recurrent sickness absence 
(e.g. more knowledgeable and competent in asking help to overcome work-related 
problems). Finally, we found that working in a small company was protective for the 
incidence of recurrent sickness absence. This might be counterintuitive as larger 
companies have more resources to accommodate workers that have health-related 
work functioning problems. However, work accommodations were also included in the 
analyses but not found to be predictive of recurrent sickness absence. A possible 
explanation for the protective effect of small companies might be that workers in small 
companies experience more commitment and responsibility towards colleagues and 
the employer, more supervisor support is provided, and the impact of the worker's 
behavior on others (e.g. sickness absence) is more visible. In the present study, no 
information on organizational commitment was included. Future studies should include 
this variable when analyzing recurrent sickness absence.  
 Two previous studies have investigated predictors of recurrent sickness absence in 
workers with CMDs12,13. Comparisons with these studies, however, are constrained 
because the studies were based on register data and did not include a great variety of 
predictors. Koopmans et al. (2010) examined the effect of sex and age on recurrent 
sickness absence and did not find differences between men and women which is 
comparable to our results40. The authors did find an age effect for women and showed 
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that women aged <35 years and between 35-44 years were at greater risk of recurrent 
sickness absence. Due to the small sample size of our study, we were not able to 
conduct gender-specified analyses. Virtanen et al. (2011) primarily investigated the 
effect of socio-economic position on recurrent sickness absence and found that 
manual occupations had a significantly higher risk of recurrent sickness absence 
compared to higher, non-manual occupations13. In the present study, no data on type 
of occupations were available. Educational level and income were included as proxy 
measures, but both measures were not significantly associated with recurrent sickness 
absence. When comparing our results with studies that have investigated predictors of 
sickness absence duration in workers on sickness absence due to CMDs, some 
differences can be observed. From several studies it is known that older age and also 
severity of the mental health problems (e.g. depression severity, comorbidity, duration 
of the problems) predict longer sickness absence9,11,19,20,41. Our results showed that 
both age and symptom severity did not predict recurrent sickness absence. The 
present study showed for the first time that conflicts with supervisor is a predictor of 
recurrent sickness absence. This factor has not been frequently investigated in 
prognostic studies on duration of sickness absence although the role of the supervisor 
in the RTW process has been stressed by OPs, psychologists, and workers42,43.  
 
Strengths and limitations 
Strengths of this study are its prospective design and the inclusion of participants 
based on OP diagnoses instead of self-report. An additional strength is the use of 
registry data to measure the incidence of recurrent sickness absence at different time 
points which allowed us to examine phase-specificity of predictors. Furthermore, the 
study is the first examining a wide variety of factors in different domains for the 
prediction of recurrent sickness absence in workers who returned to work after 
sickness absence due to CMDs.  
 A limitation is the relatively small sample size which has limited the power to detect 
relevant predictors. The sensitivity analysis showed that when increasing the power of 
the study by applying a p-value <0.10, two extra predictors were included in the final 
multivariable model. As this sensitivity analysis increased the chances of a Type-I error, 
future studies should include more participants. The small sample size also forced us 
to dichotomize several categorical variables, thereby loosing important information. 
This might have led to underestimations of the associations under study. The 
generalizability of the findings to other populations may be limited as participants were 
selected for a cluster-RCT based on specific eligibility criteria. Finally, even though a 
broad range of factors was included in this study, there might be some unmeasured 
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constructs, such as previous sickness absence episodes44, which impact recurrent 
sickness absence.  
 
Conclusion 
This study found that company size >100 workers and conflicts with supervisor 
increased the odds of recurrent sickness absence at 6 and 12 months follow-up, while 
one or more chronic diseases decreased the odds  in workers returned to work after 
sickness absence due to CMDs. Factors related to symptom severity did not predict 
recurrent sickness absence. As this is the first study that has investigated a broad 
range of predictors for recurrent sickness absence in workers with CMDs, future 
research, consisting of larger study populations, needs to further investigate predictors 
of recurrent sickness absence in this worker population to corroborate our findings. 
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The objective of this thesis is to generate knowledge on the prevention of recurrent 
sickness absence in workers who returned to work after sickness absence due to 
common mental disorders (CMDs). Therefore, a systematic review has been conducted 
to evaluate the effectiveness of interventions to facilitate return to work (RTW) in 
workers with adjustment disorders; the effectiveness, process and economic benefit 
have been evaluated of the SHARP-at work intervention which was developed to 
prevent recurrent sickness absence in workers with CMDs; and finally, predictors of 
incident recurrent sickness absence in workers with CMDs were investigated. In this 
chapter, the main findings of the thesis are summarised, methodological 
considerations are discussed, a reflection on the main findings is provided and 
implications for research and practice are presented. 
 
MAIN FINDINGS 
Effectiveness of interventions to facilitate return to work in workers with 
adjustment disorders 
In a Cochrane systematic literature review, interventions to facilitate RTW in workers 
with adjustment disorders were evaluated. Nine randomised controlled trials were 
included, reporting on eleven interventions consisting of cognitive behavioural therapy 
(CBT) or problem solving therapy (PST). The interventions were compared to either no 
treatment or usual care which was mostly treatment by a general practitioner (GP) or 
occupational physician (OP). Meta-analysis showed that CBT did not reduce time to 
partial RTW and time to full RTW compared to no treatment. PST did reduce time to 
partial RTW but not full RTW compared to non-guideline based treatment by the GP or 
OP. To conclude, there is insufficient evidence that CBT or PST is effective in restoring 
workers with adjustment disorders back to their full duties. 
 
The effectiveness of the SHARP-at work intervention in preventing recurrent 
sickness absence in workers with common mental disorders 
The SHARP-at work intervention consists of problem solving guidance by OPs in a five-
step process. OPs activate workers to: (1) make an inventory of problems and/or 
opportunities at work, (2) brainstorm on solutions/realisations, (3) write down 
solutions/realisations and prepare themselves for a consultation with the supervisor, 
(4) discuss the problems/opportunities and solutions/realisations with the supervisor 
and develop an action plan and (5) evaluate the implementation of solutions. For each 
step of the intervention, OPs can provide workers with a facilitating assignment. A key 
component of the intervention is the first assignment in which workers are asked to 
write down concrete problems/opportunities experienced when they are back at work. 
Additionally, workers are asked to rate for each problem or opportunity whether it (A) 
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could be solved/realised by themselves, (B) could be solved/realised with the help of 
others or (C) is unsolvable/unrealisable for the moment.  
 In a cluster-randomised controlled trial with 12 months follow-up, the effectiveness 
of the SHARP-at work intervention in preventing recurrent sickness absence in workers 
who returned to work after sickness absence due to CMDs was evaluated. OPs were 
randomised to either the intervention or control group. OPs in the intervention group 
received a two-day training in the SHARP-at work intervention, and OPs in the control 
group provided care as usual. Eligible participants were recruited by the OPs when 
ready to start RTW.  
 Multilevel longitudinal analyses showed that workers in the intervention group had a 
statistically significant 60% reduced likelihood of experiencing recurrent sickness 
absence compared to the control group. Additionally, time to recurrent sickness 
absence was significantly longer for the intervention group compared to the control 
group. This resulted in a median number of days to recurrent sickness absence of 253 
days for the control group and 365 days for the intervention group (participants with no 
recurrent sickness absence were censored after 12 months follow-up). Both the 
intervention and control group reported reduced mental health complaints and 
improved work functioning during the 12 months follow-up but did not report changes 
in coping behaviour. No significant differences were found between the intervention 
and control group regarding changes in mental health complaints, work functioning and 
coping behaviour.  
 
Process evaluation of the SHARP-at work intervention: compliance, accountability 
for study outcome, feasibility and relationship between intervention components 
and study outcome 
A process evaluation was conducted to:  (1) evaluate whether the SHARP-at work 
intervention was conducted according to the protocol and accounted for the study 
outcome (i.e. lower incidence of recurrent sickness absence for participants in the 
intervention group compared to the control group), (2) evaluate whether the 
intervention was feasible, and (3) investigate the relationship between the key 
elements of the intervention and the effect outcome. Results based on 67 participants 
of the intervention group showed that 82% had 2 or more consultations with the OP 
and 70% made one or more intervention assignments as recommended in the 
intervention protocol. Thus, compliance to the intervention protocol by OPs was high. In 
the control group, consultations with the OP took also place but less frequently (60% of 
64 workers reported that they had 2 or more OP consultations). Furthermore, 
assignments were rarely provided to participants (7% made assignments). Following 
that (1) the intervention was conducted according to the protocol for the majority of the 
participants, (2) few activities took place in the control group and (3) no important 
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contextual differences were found between the intervention and control group, it was 
concluded that the SHARP- at work intervention accounted for the lower incidence of 
recurrent sickness absence in the intervention group.  
 Both participants and OPs reported that they were satisfied with the SHARP-at work 
intervention. Overall, OPs judged the intervention as well-structured, applicable and 
helpful during the worker's RTW-process. These results indicate that the SHARP-at work 
intervention may be feasible for application in daily practice. 
 Analysis of the relationship between key intervention components and the study 
outcome (recurrent sickness absence) was difficult due to the small sample size, and 
the results need to be interpreted with caution. Participants who made the inventory of 
problems/opportunities at work had a significantly higher risk of experiencing recurrent 
sickness absence. However, participants who made the assignment in which they 
evaluated if help was needed to solve a problem/opportunity had a significantly lower 
risk of recurrent sickness absence. Also, when participants talked with the OP about 
how opportunities could be realised the risk of recurrent sickness absence was 
significantly reduced.  
 
Barriers and facilitators for participant recruitment by occupational physicians 
Recruitment of research participants for the intervention study was difficult. 
Recruitment was conducted by OPs of which some were successful but many did not 
recruit any participant. To understand the reason of the recruitment problems and to 
prevent future recruitment problems, barriers and facilitators experienced by OPs 
during recruitment were investigated. Additionally, the relationship between OP 
personal and work characteristics and the number of recruited participants was 
investigated. Results showed that barriers and facilitators for participant recruitment 
as experienced by OPs could be divided into six categories: study characteristics (e.g. 
concise inclusion criteria); study population characteristics (e.g. educational level); OP’s 
attention (e.g. having face-to-face contact with the researcher); OP’s workload (e.g. 
busy consultations); context (e.g. working at different locations); and OP’s 
characteristics (e.g. motivated to help). Analysis of the relationship between OP 
personal and work characteristics and the number of recruited participants showed 
that OPs recruited significantly more participants when colleagues in the same clinical 
unit recruited more participants. Based on the results, it is recommended to engage 
entire clinical units instead of approaching individual OPs when recruiting participants. 
Furthermore, frequent communication between the researchers and OPs, especially by 
face-to-face contact, and the use of ICT reminder tools are experienced as helpful by 
OPs. 
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Cost-effectiveness and cost-benefit of the SHARP-at work intervention 
An economic evaluation of the SHARP-at work intervention was conducted alongside 
the cluster-randomised controlled trial to investigate the cost-effectiveness and cost-
benefit of the intervention compared to care as usual. For the cost-effectiveness 
analysis (CEA) from the societal perspective, differences between the intervention and 
control group in health care utilisation costs were compared to differences between the 
two study groups in incidence of recurrent sickness absence and time to recurrent 
sickness absence. For the cost-benefit analysis (CBA) from the employer perspective, 
differences between the two study groups in health care utilisations costs for the 
employer were compared to differences between the two groups in costs of productivity 
loss. The results of the economic evaluation showed no economic benefit of the 
SHARP-at work intervention compared to care as usual. 
 
Predictors of recurrent sickness absence in workers who returned to work after 
sickness absence due to common mental disorders 
Data of the cluster-randomised controlled trial were used to investigate predictors of 
recurrent sickness absence in workers who returned to work after sickness absence 
due to CMDs. Baseline data on socio-demographic, disease-related, personal and work-
related factors were related to recurrent sickness absence at six and 12 months follow-
up. The results showed that a company size of over 100 employees and conflicts with 
the supervisor were predictive of incident recurrent sickness absence. Having one or 
more chronic diseases reduced the risk of recurrent sickness absence.  
 
METHODOLOGICAL CONSIDERATIONS 
Evaluation of the SHARP-at work intervention 
An important strength of this thesis is the comprehensive evaluation of the SHARP-at 
work intervention consisting of an effect, process and economic evaluation. Often, 
interventions are only evaluated for their effectiveness and no process evaluation 
takes place to investigate whether the intervention has truly been conducted according 
to protocol and whether the intervention is feasible1,2. A process evaluation can help 
interpret the findings of an effect evaluation. When no effect is found, a process 
evaluation can help evaluate if program failure or theory failure has occurred. Program 
failure refers to the possibility that an intervention has not been conducted as planned, 
while theory failure encompasses that the hypothesized working mechanisms of an 
intervention are incorrect3. A process evaluation is also valuable when the intervention 
has shown to be effective. In case of the SHARP-at work intervention, the process 
evaluation confirmed that the intervention was conducted according to the protocol 
and that treatment in the control group differed. Furthermore, no contextual factors 
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were found to have influenced the results. The process evaluation also provided 
information on the feasibility of the SHARP-at work intervention and on specific 
intervention components that were linked to the study outcome. Economic evaluations 
add to the knowledge on the effectiveness of an intervention by analysing the cost-
effectiveness and/or cost-benefit of the intervention. This information provides 
valuable input for the decision to implement an intervention or not4. Thus, the data that 
have become available with the effect, process and economic evaluation of the SHARP-
at work intervention allow health care providers and policy makers to come to a more 
balanced decision about whether or not the intervention should be implemented, 
compared to having only information available about the effectiveness of the 
intervention. 
 
Efficacy versus effectiveness 
The SHARP-at work intervention was evaluated in an effectiveness trial, also referred to 
as a pragmatic trial. The goal of an effectiveness trial is to investigate the effectiveness 
of an intervention in a “real life” context. Effectiveness trials are often contrasted with 
efficacy trials (or explanatory trials). Efficacy trials aim to determine whether an 
intervention works in a highly selected participant population and in tightly controlled 
study conditions5-8. The choice for evaluating an intervention in an efficacy or 
effectiveness trial depends on several aspects (e.g. is there already evidence 
supporting the intervention, can study conditions be controlled), but there is always a 
trade-off between advantages and disadvantages for either option. 
 Evaluating the SHARP-at work intervention in an effectiveness trial provided the 
opportunity to analyse the intervention in the complex environment of the actual 
occupational health care practice. A fairly broad range of participants (e.g. with 
different mental health problems and sickness absence periods varying in time, and 
from various geographical locations, companies and occupations) was included in the 
study, and OPs conducted the intervention during their daily routine. The study 
conditions closely reflected the real-life context in which the intervention would be 
implemented in practice, supporting the intervention’s external validity.  
 A drawback of an effectiveness trial is the large number of participants that needs 
to be recruited to detect an effect in a heterogeneous study population. In the SHARP-
at work study, recruitment was entirely embedded in the practice of OPs and could not 
be supported by researchers as they were not allowed to scan medical files for eligible 
participants with a CMD diagnosis. Recruiting research participants proved to be 
difficult for OPs and this caused recruitment to seriously lag behind the sample size 
calculation. Additionally, evaluating the SHARP-at work intervention in a real-life context 
resulted in having limited control over what the OPs did. For example, OPs were 
sometimes selective in participant recruitment. During feedback moments with OPs in 
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the intervention group, a frequent comment was that it was difficult to conduct the 
intervention with participants with a low educational level. This may have influenced 
baseline differences between the intervention and control group in educational level: 
the intervention group contained almost 20% more participants with a high educational 
level and 10% less participants with a low educational level. Having no control over the 
actions of the OPs also resulted in suboptimal treatment adherence, even though over 
80% of the participants in the intervention group had two or more consultations with 
the OP and one consultation with the supervisor, and over 70% received assignments 
from the OP as recommended in the intervention protocol. Finally, by evaluating the 
SHARP-at work intervention in a real-life context, the effect of contextual factors on 
recurrent sickness absence cannot be ruled out. Although important contextual factors 
were explored in the process evaluation (e.g. major life events, organisational changes) 
some unmeasured factors could have had an impact on the results of the effectiveness 
trial. 
 Taking these considerations into account, the question arises whether the SHARP-at 
work intervention should have been evaluated in an efficacy study. Despite the 
drawbacks, the choice to evaluate the SHARP-at work intervention in an effectiveness 
trial was supported by the conceptual framework of the intervention and the Dutch 
occupational health care context. Based on the conceptual framework, the intervention 
is developed to be conducted after workers have returned to work. The intervention is 
not focused on treatment of the CMD but on how to manage to stay at work, as all 
workers will have recovered to some extent when ready to RTW. This supported the 
inclusion of a broad range of participants who suffered from different CMDs. 
Furthermore, the Dutch occupational health care context provided the opportunity to 
conduct the intervention on a broad scale as OPs already have a guideline for treating 
workers with mental health problems. The intervention is based on and developed as 
an extension of this guideline and consists of treatment procedures that are familiar to 
the OPs. Thus, evaluating the SHARP-at work intervention in an effectiveness trial was 
a right decision, but the execution of the effectiveness trial could have been improved. 
For example, in future studies, the recruitment procedure could be organised 
differently with more responsibility for researchers. A possible recruitment strategy 
could be to send all workers on sickness absence a letter about the study and to ask 
them to contact the researchers if interested in participation.  
 
REFLECTION ON MAIN FINDINGS 
The effectiveness of the SHARP-at work intervention 
Compared to care as usual, the SHARP-at work intervention was effective in preventing 
recurrent sickness absence among workers who returned to work after sickness 
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absence due to CMDs. The risk of recurrent sickness absence was significantly lower 
and time to recurrent sickness absence was significantly longer in the intervention 
group during 12 months follow-up compared to care as usual. Results of the process 
evaluation showed that it is likely that these effects were truly a consequence of the 
SHARP-at work intervention. Although these results are positive, an important question 
remains unanswered: “What is the duration of the recurrent sickness absence 
episodes and what happens after the recurrence?” An exploration of descriptive data 
on recurrence duration indicated that workers in the intervention group had somewhat 
longer recurrence episodes. However, due to the small sample size of the intervention 
study, it was not possible to statistically analyse the differences in duration of the 
recurrences between the intervention and control group. Furthermore, a limitation is 
that the diagnoses related to the recurrences were not consistently available in the 
occupational health service registry system. It would be valuable to know which 
diagnoses were related to recurrent sickness absence. For example, it is possible that 
the diagnoses related to recurrent sickness absence differed between the two study 
groups. Also, it would be interesting to know whether type of diagnosis influenced the 
duration of recurrent sickness absence. The RTW trajectory after a recurrence is also of 
great interest. Research has shown that the risk of sickness absence and permanent 
disability increases when workers have experienced previous sickness absence 
episodes9,10. It has not been investigated whether the SHARP-at work intervention 
prevented a RTW trajectory consisting of more than one recurrent sickness absence 
episode. The time window of one year follow-up should be extended in future studies to 
two or three years follow-up to properly investigate RTW trajectories after the SHARP-at 
work intervention. To conclude, the results of the SHARP-at work intervention on 
preventing recurrent sickness absence are encouraging but show only one part of a 
bigger picture. 
 The economic evaluation provided additional information on the effectiveness of 
the intervention and the RTW process of study participants. Somewhat surprisingly, the 
SHARP-at work intervention was not cost-beneficial. Although occupational health care 
costs were expected to be higher in the intervention group due to extra consultations 
with the OP, the effect on the incidence of recurrent sickness absence was expected to 
result in lower sickness absence costs. However, sickness absence costs were higher 
in the intervention group. This result may, at least partially, be explained by the fact 
that participants in the control group already started with higher RTW percentages at 
baseline. Whereas the intervention group had a mean RTW percentage of 24% at 
baseline, the control group had a mean RTW percentage of 42%. Although time to full 
RTW was not investigated, a closer look at the sickness absence data indicated that 
participants in the intervention group more frequently had a gradual RTW process 
taking them longer to full RTW compared to participants in the control group. An 
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explanation for the higher sickness absence costs in the intervention group could also 
(partly) be due to the longer duration of the recurrent sickness absence episodes in 
this group. 
 
Predictors of recurrent sickness absence 
Having conflicts with the supervisor was strongly predictive of incident recurrent 
sickness absence and confirmed the importance of incorporating consultations 
between the worker and supervisor in the SHARP-at work intervention. No previous 
research has investigated the effect of conflicts with the supervisor on recurrent 
sickness absence in workers with CMDs, but conflicts with the supervisor have been 
stressed as an important factor in qualitative RTW studies with OPs, psychologists and 
sick-listed workers11,12. Surprisingly, sensitivity analyses (in which the power of the 
study was slightly increased) showed that low supervisor social support was only 
predictive of recurrent sickness absence for the control group. A possible explanation 
for this result could be that the SHARP-at work intervention led to improved 
communication with the supervisor for participants in the intervention group with low 
supervisor support at baseline. However, the intervention did not specifically consist of 
a component that focused on dealing with conflicts with the supervisor. 
 
IMPLICATIONS FOR RESEARCH 
Defining and operationalizing common mental disorders 
There is no universal agreement on the group of mental disorders that constitute 
CMDs. Various studies have investigated different types of disorders under the 
umbrella term of CMDs. Some researchers define CMDs as consisting of anxiety and 
depressive disorders13, others also include somatoform disorders14,15 or adjustment 
disorders16,17 or go even broader by also including substance abuse disorders, post-
traumatic stress disorders and manic episodes18. The systematic review on 
interventions to facilitate RTW in workers with adjustment disorders showed that there 
is also no consensus on how to define this subcategory of CMDs. Terms such as “minor 
mental disorders,” “stress-related disorders” and “distress” have been used to 
describe study populations with symptoms that resemble the symptoms associated 
with adjustment disorders.  
 The operationalization of CMDs might be even more divergent. Most studies use 
questionnaires, but often different questionnaires, to screen for workers with 
symptoms related to CMDs such as the Hospital Anxiety and Depression Scale (HADS), 
the Depression, Anxiety and Distress Scale (DASS), the Four-Dimension Symptom 
Questionnaire (4DSQ), the Symptom Checklist-90. In other studies CMDs have been 
diagnosed by a trained health care provider, but rarely do researchers use a diagnostic 
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interview with participants (e.g. the Composite International Diagnostic Interview) while 
this is a good method to derive at a specific diagnosis and to cover the whole range of 
mental disorders of the ICD-10 and DSM-IV 19. This diversity in defining and 
operationalizing CMDs is problematic because it complicates direct comparison of 
studies. A different operationalization of CMDs can lead to studies consisting of 
different study populations of which it may be questionable that an intervention works 
in a comparable way. Furthermore, combining the results of participants with varying 
CMDs is not desirable when it cannot be presumed that an intervention works similar 
for every participant regardless of the type of CMD. In the SHARP-at work study, 
workers with adjustment disorders, depressive disorders and anxiety disorders were 
included based on OPs’ diagnoses. As explained above, it was hypothesized that the 
intervention would equally work for workers with varying CMDs. However, future 
research would benefit from distinguishing intervention effects for the different types of 
CMDs. Such analyses require bigger sample sizes to be able to conduct subgroup 
analyses on types of CMD. Still, a shared understanding is needed of how to 
operationalize CMDs and which diagnostic/measurement tools are valid and reliable. 
 
Improving the SHARP-at work intervention 
The analysis of predictors of recurrent sickness absence in workers with CMDs showed 
that conflicts with the supervisor increase the risk of incident recurrent sickness 
absence for the control group as well as the intervention group. Furthermore, research 
has shown that positive supervisor behaviour facilitates RTW20,21. Based on these 
results, it would be advisable to further investigate whether a stronger focus on worker-
supervisor communication should be integrated in the SHARP-at work intervention. An 
additional intervention component could be developed focusing on how to deal with 
supervisor conflicts. Moreover, focus groups with OPs and psychologists and interviews 
with supervisors have shown that supervisors experience difficulties in communicating 
with workers who suffer(ed) from mental health problems12,22. Thus, the responsibility 
of the supervisor in the worker’s RTW process could be even more acknowledged in the 
SHARP-at work intervention by adding a training program for supervisors on how to 
communicate about work processes with workers who have returned to work.  
 
Selection of outcome measures 
Primarily, the effect of the SHARP-at work intervention on preventing recurrent sickness 
absence was investigated in this thesis. A study by Hees et al. (2012) has shown that 
different stakeholders (OPs, supervisors and workers) perceive this outcome as an 
important aspect of successful RTW. However, other outcomes were also regarded as a 
prerequisite of successful RTW, such as work functioning23. Until now, work functioning 
has rarely been investigated in workers with CMDs and validated measurement tools to 
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assess work functioning in CMD populations are lacking24. In the SHARP-at work study, 
work functioning was assessed with the Work-Role Functioning Questionnaire 
(WRFQ)25,26 as a secondary outcome measure. Although there was no difference 
between the WRFQ-scores between the two study groups, the results of the WRFQ did 
show that the workers improved in work functioning during 12 months follow-up after 
RTW. Some aspects of work functioning that were deemed important by the 
stakeholders in the study of Hees et al. (2012) are not evaluated in existing work 
functioning tools, e.g. whether the worker fulfils the tasks agreed upon with the 
employer. Future research should include additional information that is important for 
stakeholders in work functioning tools and these tools need to be validated for workers 
with CMDs.  
 In the SHARP-at work study, symptoms of mental health problems were measured 
as a secondary outcome. The question rises whether this outcome should be included 
in future research on the effectiveness of interventions to prevent recurrent sickness 
absence in workers with CMDs. The results of the intervention study showed that no 
difference was found between the intervention and control group for improved mental 
health. This result has also repeatedly been found in intervention studies aimed at 
facilitating RTW of workers with CMDs15,27-29. When focussing on preventing recurrent 
sickness absence among workers who returned to work and have (partly) recovered 
from their mental health problems, it might be less important to focus on further 
improvement in mental health. Although it might be important to assess whether an 
intervention aimed at improving sustainable RTW at least does not deteriorate mental 
health. The study of Hees et al. (2012) showed that stakeholders did not ascribe great 
importance to a worker having limited psychological symptoms when returned to work. 
It was found more important that a worker has the insight and skills to deal with his 
psychological vulnerability23. Future studies on workers with CMDs should look beyond 
traditional outcome measures, such as sickness absence days and time to RTW, to 
outcome measures that are relevant to stakeholders such as the worker, OP and 
supervisor. 
 
The SHARP-at work intervention in other contexts 
The development and evaluation of the SHARP-at work intervention is connected to the 
Dutch occupational health care context. Therefore, generalising the results to other 
contexts is difficult. Although it might be interesting to investigate whether the 
intervention’s five-step problem solving process would also help to prevent recurrent 
sickness absence in other countries, it will be difficult to translate the intervention and 
study protocol one-on-one. The responsibility of employers to invest in RTW and the 
central role of the OP in the RTW process which follow from the Dutch social security 
legislation created a context in which stakeholders are willing to invest in interventions 
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such as the SHARP-at work intervention. In countries where (a) sickness absence is 
only compensated when caused by an occupational injury, (b) compensation benefits 
are paid by the government and (c) OPs do not have a role in guiding workers in the 
RTW process, conducting the SHARP-at work intervention in its current form would not 
be possible30. However, future research might investigate how the SHARP-at work 
intervention could be adapted to align with the socio-political context of other countries 
so that it can be evaluated in different contexts.  
 
IMPLICATIONS FOR PRACTICE 
Use of the SHARP-at work intervention in practice 
Although it is not the role of the researcher to decide whether an intervention should be 
implemented in practice, a judgement on whether the SHARP-at work intervention 
could be implemented in practice can be formed based on the study results. Especially 
the results of the process evaluation are helpful as these results showed that workers 
and OPs were satisfied with the content of the intervention, that the intervention 
helped in the process beyond RTW and that it was applicable. As the intervention was 
also effective in preventing recurrent sickness absence, implementation of the SHARP-
at work intervention seems possible. However, feedback moments organised with the 
OPs at the end of the study provided additional information that showed that a broad 
implementation would require additional actions. Most importantly, OPs indicated that 
employer contracts with the occupational health service should be extended to 
incorporate the additional consultations that are needed to conduct the intervention. 
Thus, an important prerequisite for implementing the intervention in practice is getting 
the employers aboard.  
 The growing research area on implementation science emphasizes that barriers to 
implementing interventions may arise at different health care system levels such as the 
patient level, the provider level, the organisational level and the policy level 31. Even 
effective interventions rarely get implemented in practice. The Consolidated Framework 
for Implementation Research (CIFR) offers a comprehensive theoretical framework to 
analyse whether an intervention could be implemented in a specific context and what 
actions/adaptations are needed to foster successful implementation. The CIFR 
consists of five main dimensions: the intervention, the inner and outer setting, the 
individuals involved and the process by which implementation is accomplished31. To 
implement the SHARP-at work intervention, different stakeholders, such as workers, 
supervisors, employers, OPs, occupational health services and policy makers, need to 
collaborate to investigate the possible barriers and facilitators to implementation within 
the five dimensions of the CIFR. For example, are OPs who were not involved in the 
SHARP-at work study open to the intervention (individuals involved)? Would 
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governmental policy makers be willing/able to provide financial incentives to 
organisations to implement the intervention (outer setting)? Does the organisation 
have the facilities to implement the intervention; does the intervention align with the 
norms and values of the organisational culture (inner setting)? How can people be 
involved or motivated to implement the intervention (process by which implementation 
is accomplished)? An evaluation of whether the intervention costs are outweighed by 
the monetary, societal, personal or organisational benefits would also be part of the 
implementation assessment. To conclude, a thorough analysis of the context in which 
the intervention would be implemented and an implementation plan to overcome 
possible barriers is of paramount importance when any stakeholder considers 
implementing the SHARP-at work intervention. 
 
Are occupational physicians the appropriate treatment provider? 
The SHARP-at work intervention was conducted by OPs to align with the current Dutch 
occupational health care practice, in which OPs monitor the RTW process of workers 
with CMDs, and because OPs are closest to the work context compared to other health 
care providers. It can be questioned, however, whether OPs are the most appropriate 
treatment providers for conducting the intervention. During the intervention training 
and feedback moments, several OPs mentioned that they would rather approach the 
company social worker (CSW) to conduct the intervention and be only responsible for 
monitoring the RTW process. In the Netherlands, the CSW works for an occupational 
health service like most OPs. OPs can refer workers to the CSW to help address 
psychosocial problems. For example, CSWs help workers to deal with problems due to 
reorganisations, (sexual) intimidation, sickness absence, conflicts with colleagues or 
the supervisor. The CSW has also contact with the supervisor or a human resource 
manager when needed. Thus, on the one hand, the CSW does indeed have the 
competencies and the connections with the work context that are important for 
conducting the SHARP-at work intervention. On the other hand, the CSW is not involved 
in a worker's RTW process from beginning to end which could hamper the 
implementation of the intervention. Furthermore, CSWs are not present in every 
occupational health service and, therefore, not available for every company.  
 Continuity in the treatment provider who guides a worker with a CMD through the 
RTW process and after RTW would be desirable. This way the treatment provider knows 
what has happened at every stage of the RTW process and how this could influence the 
future course. One treatment provider can establish a strong relationship with the 
worker which provides clarity to the worker about who can be contacted when having 
problems during and after the RTW process. Currently, most OPs might not be 
sufficiently educated to guide and treat workers with CMDs as the treatment of CMDs 
gets limited attention in their standard education. Moreover, OPs who participated in 
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the intervention study frequently mentioned that it was difficult to conduct the 
intervention within their 30-minute consultations and that they struggled with a high 
work load. This work load will probably continue to rise in the future as there is a 
growing need for new OPs because few medical students choose this specialisation. 
Considering these difficulties and the fact that CMDs take up a large proportion of OP’s 
consultations, there is a need to look for alternative solutions such as other treatment 
providers that could take over the OP’s role in guiding workers with CMDs within the 
occupational health care context. This treatment provider should have close contact 
with the work environment to know how situations are at work. Furthermore, keeping 
close contact with other health care professionals that are treating the worker with a 
CMD (e.g. the general practitioner, psychologist) would be essential as, currently, 
coordination between different health care professionals is minimal 32. A possible 
option for a treatment provider that could be responsible for guiding workers with 
CMDs within the work context is the occupational psychologist. The organisational 
psychologist is educated in workplace factors that contribute to a healthy working life 
and could take over the coordinating role of the OP and the treatment role of the CSW 
for workers that suffer from CMDs. A possible difficulty could be that an occupational 
psychologist works stigmatising for a worker. Additionally, contrary to OPs, occupational 
psychologists are not institutionalised within the Dutch occupational health care 
context. Another possible solution might be found in better attuning the actions of the 
various treatment providers that are involved in the treatment of workers with CMDs. A 
first initiative is the recently developed multidisciplinary guideline for the treatment of 
adjustment disorders by primary care providers32. The guideline describes the 
role/tasks of the general practitioner, the psychologist and the OP and how these 
treatment providers can coordinate their roles in the benefit of the worker. For either 
option, i.e. the institutionalisation of the occupational psychologist or attuning the 
actions of the treatment providers involved in the RTW process and the post-RTW 
phase, research and practice need to work together to evaluate whether it is truly 
beneficial for the worker, the organisation and society.  
 
GENERAL CONCLUSION 
This thesis is the first to focus on the post-RTW phase of workers who have been on 
sickness absence due to CMDs and adds to the knowledge on the prevention of 
recurrent sickness absence in this worker population. The thoroughly conducted effect 
and process evaluation of the SHARP-at work intervention showed that the intervention 
was effective in preventing recurrent sickness absence compared to care as usual, 
conducted according to the protocol, well-received by OPs and workers and feasible. 
The economic evaluation showed that although the SHARP-at work intervention is 
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effective, it is also more costly. The evaluation of predictors of recurrent sickness 
absence in workers with CMDs showed that the risk of recurrent sickness absence was 
increased when workers had conflicts with their supervisor. Occupational health care 
providers can use the information generated by this thesis to provide guidance to 
workers with CMDs, and future researchers can build upon the results of the SHARP-at 









1. Lamontagne AD, Keegel T, Louie AM, Ostry A, Landsbergis PA. A systematic review of the job-
stress intervention evaluation literature, 1990-2005. Int J Occup Environ Health. 
2007;13(3):268-280.  
2. Egan M, Bambra C, Petticrew M, Whitehead M. Reviewing evidence on complex social 
interventions: Appraising implementation in systematic reviews of the health effects of 
organisational-level workplace interventions. J Epidemiol Community Health. 2009;63(1):4-11.  
3. Kristensen TS. Intervention studies in occupational epidemiology. Occup Environ Med. 
2005;62(3):205-210.  
4. Tompa E, Dolinschi R, de Oliveira C, Irvin E. A systematic review of occupational health and 
safety interventions with economic analyses. J Occup Environ Med. 2009;51(9):1004-1023.  
5. Price D, Hillyer EV, van der Molen T. Efficacy versus effectiveness trials: Informing guidelines 
for asthma management. Curr Opin Allergy Clin Immunol. 2013;13(1):50-57.  
6. Chalkidou K, Tunis S, Whicher D, Fowler R, Zwarenstein M. The role for pragmatic randomized 
controlled trials (pRCTs) in comparative effectiveness research. Clin Trials. 2012;9(4):436-446.  
7. Ware JH, Hamel MB. Pragmatic trials--guides to better patient care? N Engl J Med. 
2011;364(18):1685-1687.  
8. Tunis SR, Stryer DB, Clancy CM. Practical clinical trials: Increasing the value of clinical 
research for decision making in clinical and health policy. JAMA. 2003;290(12):1624-1632.  
9. Koopmans PC, Roelen CA, Groothoff JW. Risk of future sickness absence in frequent and long-
term absentees. Occup Med (Lond). 2008;58(4):268-274.  
10. Koopmans PC, Roelen CA, Groothoff JW. Frequent and long-term absence as a risk factor for 
work disability and job termination among employees in the private sector. Occup Environ Med. 
2008;65(7):494-499.  
11. Noordik E, Nieuwenhuijsen K, Varekamp I, van der Klink JJ, van Dijk FJ. Exploring the return-
to-work process for workers partially returned to work and partially on long-term sick leave due to 
common mental disorders: A qualitative study. Disabil Rehabil. 2011;33(17-18):1625-1635.  
12. Oomens PCJ, Huijs JJJM, Blonk RWB. Obstakels in werk: Wat belemmert werkhervatting bij 
werknemers met psychische klachten? (obstacles in work: What impedes return-to-work in 
employees with mental health problems?). Tijdschr Bedrijfs Verzekeringsgeneeskd. 
2009;17(6):231-236.  
13. Butterworth P, Leach LS, McManus S, Stansfeld SA. Common mental disorders, 
unemployment and psychosocial job quality: Is a poor job better than no job at all? Psychol Med. 
2012:1-10.  
14. Soegaard HJ. Undetected common mental disorders in long-term sickness absence. Int J 
Family Med. 2012;2012:474989.  
15. van der Feltz-Cornelis CM, Hoedeman R, de Jong FJ, et al. Faster return to work after 
psychiatric consultation for sicklisted employees with common mental disorders compared to 
care as usual. A randomized clinical trial. Neuropsychiatr Dis Treat. 2010;6:375-385.  
16. Rebergen DS, Bruinvels DJ, Bezemer PD, Van Der Beek AJ, Van Mechelen W. Guideline-based 
care of common mental disorders by occupational physicians (CO-OP study): A randomized 
controlled trial. J Occup Environ Med. 2009;51(3):305-312.  
17. Nieuwenhuijsen K, Noordik E, van Dijk FJ, van der Klink JJ. Return to work perceptions and 
actual return to work in workers with common mental disorders. J Occup Rehabil. 2012.  
18. Sunderland M, Slade T, Andrews G. Developing a short-form structured diagnostic interview 
for common mental disorders using signal detection theory. Int J Methods Psychiatr Res. 
2012;21(4):247-257.  
19. Aalto AM, Elovainio M, Kivimaki M, Uutela A, Pirkola S. The beck depression inventory and 
general health questionnaire as measures of depression in the general population: A validation 
General discussion | Chapter 9 
221 
 
study using the composite international diagnostic interview as the gold standard. Psychiatry 
Res. 2012;197(1-2):163-171.  
20. Holmgren K, Dahlin Ivanoff S. Supervisors' views on employer responsibility in the return to 
work process. A focus group study. J Occup Rehabil. 2007;17(1):93-106.  
21. Nieuwenhuijsen K, Verbeek JH, de Boer AG, Blonk RW, van Dijk FJ. Supervisory behaviour as 
a predictor of return to work in employees absent from work due to mental health problems. 
Occup Environ Med. 2004;61(10):817-823.  
22. Lemieux P, Durand MJ, Hong QN. Supervisors' perception of the factors influencing the return 
to work of workers with common mental disorders. J Occup Rehabil. 2011;21(3):293-303.  
23. Hees HL, Nieuwenhuijsen K, Koeter MW, Bultmann U, Schene AH. Towards a new definition 
of return-to-work outcomes in common mental disorders from a multi-stakeholder perspective. 
PLoS One. 2012;7(6):e39947.  
24. Abma FI, van der Klink JJ, Terwee CB, Amick BC,3rd, Bultmann U. Evaluation of the 
measurement properties of self-reported health-related work-functioning instruments among 
workers with common mental disorders. Scand J Work Environ Health. 2012;38(1):5-18.  
25. Abma FI, Amick Iii BC, Brouwer S, van der Klink JJ, Bultmann U. The cross-cultural adaptation 
of the work role functioning questionnaire to dutch. Work. 2012.  
26. Abma FI, van der Klink JJ, Bultmann U. The work role functioning questionnaire 2.0 (dutch 
version): Examination of its reliability, validity and responsiveness in the general working 
population. J Occup Rehabil. 2012.  
27. van der Klink JJ, Blonk RW, Schene AH, van Dijk FJ. Reducing long term sickness absence by 
an activating intervention in adjustment disorders: A cluster randomised controlled design. 
Occup Environ Med. 2003;60(6):429-437.  
28. van Oostrom SH, van Mechelen W, Terluin B, de Vet HC, Knol DL, Anema JR. A workplace 
intervention for sick-listed employees with distress: Results of a randomised controlled trial. 
Occup Environ Med. 2010;67(9):596-602.  
29. Blonk RW, Brenninkmeijer V, Lagerveld SE, Houtman IL. Return to work: A comparison of two 
cognitive behavioural interventions in cases of work-related psychological complaints among the 
self-employed. Work Stress. 2006;20(2):129-144.  
30. Anema JR, Schellart AJ, Cassidy JD, Loisel P, Veerman TJ, van der Beek AJ. Can cross country 
differences in return-to-work after chronic occupational back pain be explained? an exploratory 
analysis on disability policies in a six country cohort study. J Occup Rehabil. 2009;19(4):419-
426.  
31. Damschroder LJ, Aron DC, Keith RE, Kirsh SR, Alexander JA, Lowery JC. Fostering 
implementation of health services research findings into practice: A consolidated framework for 
advancing implementation science. Implement Sci. 2009;4:50-5908-4-50.  
32. Verschuren CM. Multidisciplinaire richtlijn overspanning en burnout voor eerstelijns 
professionals. [multidisciplinary guideline distress and burnout for primary care professionals]. 
Utrecht: NVAB [Netherlands Society of Occupational Medicine]; 2011.  
   


















The objective of this thesis is to generate knowledge on the prevention of recurrent 
sickness absence in workers who returned to work after sickness absence due to 
common mental disorders (CMDs). 
 
In Chapter 1, an overall introduction is provided to address the importance of the topic 
of the thesis, to explain the context and to describe relevant constructs. CMDs, such as 
depression, anxiety and adjustment disorder, are highly prevalent in the working 
population and a major cause of sickness absence. Considering the impact of CMDs on 
sickness absence and the associated negative consequences for the individual (not 
being able to work) and society (high sickness absence costs), interventions have been 
developed to facilitate return to work (RTW) in this worker population. However, in 
occupational health care research and practice, the focus is shifting from facilitating 
RTW to improving functioning at work of workers with CMDs. This is due to research 
that has shown that workers with CMDs frequently experience: 1) at-work productivity 
loss, and 2) recurrent sickness absence. Thus, there is a need to look beyond RTW and 
develop interventions to realise a sustainable RTW. Therefore, this thesis describes the 
evaluation of the SHARP (Stimulating Healthy participation And Relapse Prevention)-at 
work intervention which is developed to prevent recurrent sickness absence in workers 
who returned to work after sickness absence due to CMDs. 
 
Chapter 2 presents a systematic literature review in which the effectiveness of 
interventions to facilitate RTW in workers with adjustment disorders is investigated. 
Studies with a randomised controlled trial design were included in the review, leading 
to nine included studies all evaluating psychological interventions. Studies that were 
considered clinically homogeneous (e.g. comparable intervention and control groups, 
comparable outcome measures) were grouped into comparison groups to conduct 
meta-analyses. The results of the meta-analyses showed moderate quality evidence of 
no significant difference in time to partial RTW between workers receiving cognitive-
behavioural therapy (CBT) or no treatment at one-year follow-up. For time to full RTW, it 
was also found that CBT did not significantly reduce days to full RTW compared to no 
treatment at one-year follow-up, based on low quality evidence. Problem solving 
therapy (PST) significantly reduced time to partial RTW compared to non-guideline 
based care with (-)17 days (95% CI -26.48 to -7.52) at one year follow-up. No 
significant differences between PST and non-guideline based care were found for time 
to full RTW. Because most studies included relatively few participants, it was concluded 
that studies are needed with >300 participants to increase the power of the meta-
analyses and thus the reliability of the results found in the review. Furthermore, to be 
able to make good comparisons between studies, international consensus should be 




Chapter 3 describes the content of the SHARP-at work intervention and the study 
design for evaluating the effectiveness of the intervention. The SHARP-at work 
intervention is a problem solving intervention developed to prevent recurrent sickness 
absence in workers with CMDs. The intervention is delivered by the occupational 
physician (OP) when a worker has started RTW and consists of five problem solving 
steps: 1) make an inventory of problems and/or opportunities encountered at work 
after RTW, 2) brainstorm about solutions, 3) write down solutions and the support 
needed to realise them and assess the applicability of the solutions, 4) discuss 
solutions and make an action plan with the supervisor, and 5) evaluate the 
implementation of solutions. OPs monitor that all steps are taken and activate the 
worker when needed. OPs can use assignments to stimulate the worker to write down 
and structure the process. Two to five consultations are recommended to the OPs to 
conduct the intervention.  
 A cluster-randomised controlled trial (cluster-RCT) was developed to evaluate the 
effectiveness of the SHARP-at work intervention. OPs were randomised to the 
intervention or control group. OPs in the intervention group received a two-day training 
in the intervention and delivered care according to the intervention. OPs in the control 
group received no training and provided care as usual which is based on the guideline 
of the Netherlands Society of Occupational Medicine on "Management of mental health 
problems of workers by the OP." The primary outcome was recurrent sickness absence, 
defined as a 30% decrease in working days per week due to all-cause sickness 
absence, regardless of partial or full RTW. Secondary outcomes were mental health 
complaints, work functioning and coping. All outcomes were measured at baseline and 
at 3, 6, and 12 months follow-up. 
 
The results of the cluster-RCT are presented in Chapter 4. In total, 158 participants 
were included in the study; 80 participants were treated by OPs from the intervention 
group and 78 participants were treated by OPs from the control group. The majority of 
the participants in both treatment groups were diagnosed with an adjustment disorder 
by the OP. Effectiveness analyses showed that the risk of recurrent sickness absence 
was significantly lower in the intervention group compared to the control group 
(adjusted odds ratio [OR] = 0.40, 95% confidence interval [CI] 0.20 to 0.81). 
Furthermore, time to first recurrent sickness absence episode was significantly longer 
for the intervention group compared to the control group (adjusted hazard ratio = 0.53, 
95% CI 0.33 to 0.86). Regarding the secondary outcome measures, mental health 
complaints, work functioning and coping behaviour, no significant group differences 
were found. It was concluded that for workers who returned to work after sickness 
absence due to CMDs, the SHARP-at work intervention in effective in reducing the risk 





Chapter 5 focuses on the process evaluation of the SHARP-at work intervention. The 
aims of this study were: 1) to evaluate whether the SHARP-at work intervention was 
conducted according to the protocol and differed from care as usual, and 2) to 
investigate the relationship between the key elements of the intervention and the 
primary outcome of the effect evaluation (i.e. recurrent sickness absence). The process 
evaluation revealed that, compared to the control group, the participants in the 
intervention group more frequently had ≥2 consultations with the OP (OR = 3.2, 95% CI 
1.2 to 8.8) and ≥1 consultation with the supervisor (OR = 3.6, 95% CI 1.1 to 12.0), as 
recommended in the SHARP-at work intervention protocol. Furthermore, participants in 
the intervention group more often received (73%) and completed (70%) assignments 
from the OP compared to participants in the control group (only 8% received and 
completed assignments). Thus, the SHARP-at work intervention was conducted 
according to the protocol for the majority of the participants and significantly differed 
from care as usual. Therefore, it was concluded that the intervention accounted for the 
lower risk of recurrent sickness absence that was found in the effect evaluation for the 
intervention group compared to the control group.  
 The analysis of the relationship between the key components of the intervention 
and the risk of recurrent sickness absence showed the following results. Receiving 
more intervention components was not associated with a lower risk of recurrent 
sickness absence. Participants who made an inventory of whether help is needed to 
solve problems/realise opportunities at work and who had discussed with the OP how 
opportunities could be realised at work, had a significantly lower risk of recurrent 
sickness absence. In contrast, participants that made an inventory of problems at work 
had a significantly higher risk of recurrent sickness absence. A possible explanation for 
this result could be that making an inventory of problems by itself is not beneficial. It 
may be necessary that a worker also thinks about whether help is needed to solve 
problems and talks about concrete improvements that can be implemented at work. 
These results need to be interpreted carefully due to the small sample size that was 
available for the analyses. 
 
Chapter 6 provides an in-depth exploration of the barriers and facilitators for recruiting 
research participants by OPs. This study was conducted because fewer participants 
were recruited for the cluster-RCT by OPs than anticipated. Recruiting a sufficient 
number of research participants is important to improve the statistical power for 
detecting differences between treatment groups. The following research questions 
were investigated: 1) Which barriers and facilitators were experienced by OPs during 
participant recruitment; and 2) Which OP personal and work characteristics are 
associated with participant recruitment? Based on focus groups and interviews with 




extracted: 1) study and intervention characteristics, 2) characteristics of the study 
population, 3) context, 4) OP's attention, 5) OP's workload, and 6) OP's characteristics. 
These categories (and the underlying elements) can be addressed by researchers when 
developing future studies in which participant recruitment relies on OPs.  
 The analysis of the relationship between OP personal and work characteristics and 
the number of recruited participants, showed that the number of OPs within the OP's 
clinical unit (i.e. group practice) who actively recruited participants was significantly 
associated with the number of recruited participants by the OP (rate ratio = 1.93, 95% 
CI 1.61 to 2.32). Thus, when mobilising OPs for participant recruitment, researchers 
need to engage entire clinical units rather than approach OPs on an individual basis. 
 
In Chapter 7, an economic evaluation of the SHARP-at work is presented. From a 
societal perspective, a cost-effectiveness analysis (CEA) was conducted. Differences 
between the intervention and control group in costs associated with health care 
utilisation and the intervention/care as usual costs were calculated. Also, differences 
between the two groups for the following two effect measures were calculated: 1) the 
incidence of recurrent sickness absence, and 2) time to first recurrent sickness 
absence episode. The CEA results with incidence of recurrent sickness absence as 
effect measure showed an Incremental Cost-Effectiveness Ratio (ICER) of €10.605 per 
percent of prevented recurrent sickness absence episode. This means that an 
additional €10.605 was needed in the intervention group to have 1% less recurrent 
sickness absence. The CEA with time to first recurrent sickness absence episode as 
effect measure showed an ICER of €2813 per one day of prevented recurrent sickness 
absence. Sensitivity analyses excluding one major outlier in the intervention group (due 
to psychiatric hospitalisation) showed an ICER of €-533 for the incidence of recurrent 
sickness absence. This indicated that the SHARP-at work intervention was cost-
effective compared to care as usual; the prevention of 1% recurrent sickness absence 
saved €533. Comparably, sensitivity analyses for time to first recurrent sickness 
absence episode showed an ICER of €-2 also indicating that the intervention was cost-
effective compared to care as usual. 
 From an employer's perspective, a cost-benefit analysis (CBA) was conducted. 
Differences between the intervention and control group in costs associated with 
occupational health care costs (in the Netherlands paid by the employer) and the 
intervention/care as usual costs were calculated. Furthermore, differences between 
the two study groups in costs association with productivity loss were calculated. 
Productivity loss was operationalised as costs resulting from sickness absence (also 
paid by the employer in the Netherlands). The CBA results showed that there was no 






Chapter 8 examines factors that predict recurrent sickness absence in workers who 
returned to work after sickness absence due to CMDs. Based on previous research, 
potential predictors were assessed for all participants at baseline and categorised into 
the following domains: 1) socio-demographic factors (e.g. age and sex), 2) disease-
related factors (e.g. distress symptoms, chronic diseases), 3) personal factors (e.g. 
coping behaviour), and 4) work-related factors (e.g. tenure, company size). The 
incidence of recurrent sickness absence at 6 and 12 months follow-up was the 
outcome measure. Multivariabe logistic Generalised Estimating Equations (GEE) with 
backward elimination (p<0.05) revealed three main predictors: company size >100 
workers (OR = 2.59, 95% CI 1.40 to 5.80) and conflicts with supervisor (OR = 2.21, 
95% CI 1.21 to 4.04) increased the risk of recurrent sickness absence, while one or 
more chronic diseases decreased this risk (OR = 0.54, 95% CI 0.30 to 0.96). Factors 
related to symptom severity did not predict the incidence of recurrent sickness 
absence. 
 
Chapter 9 presents a general discussion of the thesis, focusing on the main findings of 
the thesis, methodological consideration, reflection on the main findings and 
implications for research and practice. It is concluded that the SHARP-at work 
intervention is effective in reducing the risk of recurrent sickness absence compared to 
care as usual. Furthermore, the intervention was conducted according to the protocol 
for the majority of the participants, and the intervention was well-received by OPs and 
participants. The thesis' results demonstrate that continuous attention is needed for 
workers who have been on sickness absence due to CMDs.  
 Future research needs to evaluate whether the effects of the SHARP-at work 
intervention also hold in different contexts. Furthermore, the effect of the SHARP-at 
work intervention should be evaluated for other outcome measures, next to recurrent 
sickness absence, relevant for important stakeholders (i.e. workers, supervisors, 
employers) such as fulfilling tasks agreed upon and worker's job satisfaction.  
 An important implication when implementing the SHARP-at work intervention in the 
OPs' practice is that employer contracts need to be extended to incorporate the 
additional consultations necessary to conduct the intervention. Moreover, to ensure 
smooth implementation of the SHARP-at work intervention, different stakeholders (e.g. 
workers, supervisors, employers, OPs, occupational health services, policy makers and 


















Het doel van dit proefschrift is het genereren van kennis over hoe terugval naar 
verzuim voorkomen kan worden bij werknemers die teruggekeerd zijn naar het werk na 
verzuim wegens psychische problemen.  
 
Hoofdstuk 1 biedt een algemene introductie in het onderwerp van het proefschrift met 
als doel het belang van het onderwerp te schetsen, de context toe te lichten en 
relevante constructen te introduceren. Psychische problemen, zoals depressie, angst 
en aanpassingsstoornissen, komen veel voor in de beroepsbevolking en vormen een 
belangrijke oorzaak van ziekteverzuim. Gezien de impact van psychische problemen op 
ziekteverzuim en de hiermee gepaard gaande negatieve consequenties voor het 
individu (niet meer kunnen werken) en de maatschappij (hoge verzuimkosten), zijn de 
afgelopen jaren interventies ontwikkeld om een terugkeer naar werk te faciliteren. In 
de wetenschap en praktijk van de bedrijfsgezondheidszorg verschuift de focus echter 
van het faciliteren van terugkeer naar werk naar het verbeteren van het functioneren in 
werk bij werknemers met psychische klachten. Aanleiding hiervoor is onderzoek dat 
heeft aangetoond dat werknemers met psychische problemen ten eerste regelmatig 
minder productief kunnen zijn op het werk en ten tweede vaak een terugval naar 
verzuim ervaren. Het is dus van groot belang om verder te kijken dan alleen het 
bewerkstelligen van een terugkeer naar werk en interventies te ontwikkelen die het 
mogelijk maken dat werknemers duurzaam terugkeren. Om deze reden wordt in dit 
proefschrift de evaluatie beschreven van de SHARP (Stimulating Healthy participation 
And Relapse Prevention)-at work interventie die ontwikkeld is om terugval naar verzuim 
te voorkomen bij werknemers die teruggekeerd zijn naar het werk na verzuim wegens 
psychische problemen. 
  
Hoofdstuk 2 presenteert een systematische literatuurstudie waarin de effectiviteit van 
interventies werd onderzocht die gericht zijn op het faciliteren van terugkeer naar werk 
bij werknemers met aanpassingsstoornissen. Studies met een gerandomiseerde en 
gecontroleerde studieopzet werden geïncludeerd in de literatuurstudie, wat resulteerde 
in de inclusie van negen studies die psychologische interventies evalueerden. Klinisch 
homogene studies (bv. gelijksoortige interventies, gelijksoortige uitkomstmaten) 
werden gecombineerd in een vergelijkingsgroep om zo meta-analyses uit te kunnen 
voeren. De resultaten van de meta-analyses lieten zien dat het aantal dagen tot 
gedeeltelijke terugkeer naar werk gelijk was voor werknemers die cognitieve 
gedragstherapie (CGT) of geen behandeling ontvingen over een periode van één jaar. 
Wat betreft het aantal dagen tot volledige terugkeer naar werk was er eveneens geen 
significant verschil tussen CGT en geen behandeling over een periode van één jaar. 
Probleemoplossingsgerichte therapie (PT) reduceerde het aantal dagen tot 




de bedrijfsarts of huisarts met (-)17 dagen (95% BI -26.48 tot -7.52) over een periode 
van één jaar. Geen significante verschillen werden gevonden tussen PT en 
gebruikelijke zorg met betrekking tot aantal dagen tot volledige terugkeer naar werk. In 
de conclusie werd onderstreept dat studies met meer dan 300 deelnemers nodig zijn 
om de power van de meta-analyses, en dus de betrouwbaarheid van de resultaten van 
de literatuurstudie, te vergroten. Daarnaast is het, om een goede vergelijkingen tussen 
studies te realiseren, belangrijk om internationale consensus te bereiken met 
betrekking tot de terminologie en de meetinstrumenten om aanpassingsstoornissen te 
diagnosticeren.  
 
Hoofdstuk 3 beschrijft de inhoud van de SHARP-at work interventie en de studieopzet 
om de effectiviteit van de interventie te evalueren. De SHARP-at work interventie is een 
probleemoplossingsgerichte interventie ontwikkeld om terugval naar verzuim te 
voorkomen bij werknemers met psychische problemen. De interventie wordt door 
bedrijfsartsen ingezet wanneer een werknemer begonnen is met de terugkeer naar 
werk en bestaat uit vijf probleemoplossingsgerichte stappen: 1) inventariseren van 
problemen en/of kansen op het werk na terugkeer, 2) brainstormen over oplossingen, 
3) opschrijven van oplossingen en in kaart brengen van ondersteuning die daarvoor 
nodig is en inschatten van de toepasbaarheid van de oplossingen, 4) bespreken van 
oplossingen en maken van een actieplan met de leidinggevende, en 5) evalueren van 
de implementatie van oplossingen. De bedrijfsarts houdt in de gaten dat alle stappen 
genomen worden en activeert de werknemer wanneer nodig. De bedrijfsarts kan 
opdrachten inzetten om de werknemer te stimuleren om het proces op te schrijven en 
te structureren. Twee tot vijf consultaties worden aanbevolen aan de bedrijfsarts om de 
interventie uit te voeren. 
 Er werd een cluster gerandomiseerde onderzoeksopzet ontwikkeld om de 
effectiviteit van de SHARP-at work interventie te evalueren. Bedrijfsartsen werden op 
basis van toeval aan de interventie of controle groep toegewezen. Bedrijfsartsen in de 
interventiegroep ontvingen een tweedaagse training in de interventie en leverden zorg 
volgens de interventie. Bedrijfsartsen in de controle groep ontvingen geen training en 
leverden de gebruikelijke zorg welke gebaseerd is op de richtlijn "Behandeling van 
werknemers met psychische problemen door de bedrijfsarts" van de Nederlandse 
Vereniging voor Arbeids- en Bedrijfsgeneeskunde. De primaire uitkomstmaat was 
terugval naar verzuim gedefinieerd als een 30% vermindering in het aantal werkdagen 
per week door verzuim ongeacht gedeeltelijke of volledige terugkeer naar werk. 
Secundaire uitkomstmaten waren psychische klachten, functioneren in werk en coping. 






De resultaten van de effectstudie worden gepresenteerd in Hoofdstuk 4. In totaal 
werden 158 deelnemers geïncludeerd in de studie; 80 deelnemers werden behandeld 
door bedrijfsartsen uit de interventie groep en 78 deelnemers werden behandeld door 
bedrijfsartsen uit de controlegroep. De meerderheid van de deelnemers in beide 
groepen had een aanpassingsstoornis volgens de diagnose van de bedrijfsarts. In de 
interventiegroep was de gemiddelde verzuimduur op baseline 30 dagen langer ten 
opzichte van de controlegroep. De effectevaluatie toonde aan dat op 3, 6 en 12 
maanden follow-up het risico op terugval naar verzuim voor de interventiegroep 60% 
lager was dan voor de controlegroep, wat een significant resultaat was. Daarnaast was 
de duur tot een eerste terugval significant langer voor de interventiegroep in 
vergelijking met de controlegroep (ten opzichte van de controlegroep was de mediane 
duur tot terugval 112 dagen later voor de interventiegroep). Wat betreft de secundaire 
uitkomstmaten psychische klachten, functioneren in werk en coping, werden er geen 
significante groepsverschillen gevonden. Concluderend werd gesteld dat de SHARP-at 
work interventie effectief is in het verlagen van het risico op terugval naar verzuim voor 
werknemers die teruggekeerd zijn naar het werk na verzuim wegens psychische 
problemen. 
 
Hoofdstuk 5 richt zich op de procesevaluatie van de SHARP-at work interventie. De 
doelen van deze studie waren: 1) evalueren of de SHARP-at work interventie uitgevoerd 
was volgens het interventieprotocol en verschilde van de gebruikelijke zorg, en 2) de 
relatie onderzoeken tussen de belangrijkste interventiecomponenten en de primaire 
uitkomst van de effectevaluatie (d.i. terugval naar verzuim). De procesevaluatie liet 
zien dat, vergeleken met de controlegroep, deelnemers in de interventiegroep vaker ≥2 
consultaties met de bedrijfsarts en ≥1 gesprek met de leidinggevende hadden, zoals 
aanbevolen in het SHARP-at work interventieprotocol. Daarnaast ontvingen deelnemers 
in de interventiegroep vaker een opdracht van de bedrijfsarts (73%) en maakten ze 
deze opdracht ook (70%) ten opzichte van deelnemers in de controle groep (slechts 8% 
ontving en maakte opdrachten). De SHARP-at work interventie is dus uitgevoerd 
volgens het interventieprotocol voor de meerderheid van de deelnemers en verschilde 
significant van de gebruikelijke zorg. Om deze redenen werd geconcludeerd dat het in 
de effectevaluatie gevonden lagere risico op terugval naar verzuim voor de 
interventiegroep ten opzichte van de controlegroep daadwerkelijk aan de interventie 
toegeschreven kon worden.  
 De analyse van de relatie tussen de belangrijkste interventiecomponenten en het 
risico op terugval naar verzuim, leidde tot de volgende resultaten. Het ontvangen van 
meerdere interventiecomponenten was niet gerelateerd aan een hoger of lager risico 
op terugval naar verzuim. Deelnemers die inventariseerden of ondersteuning nodig was 




bedrijfsarts besproken hadden hoe kansen gerealiseerd zouden kunnen worden op het 
werk, hadden een significant lager risico op terugval naar verzuim. Echter, deelnemers 
die problemen op het werk geïnventariseerd hadden, hadden een significant hogere 
kans op terugval naar verzuim. Een mogelijke verklaring voor dit resultaat zou kunnen 
zijn dat het maken van een probleeminventarisatie op zichzelf niet helpend is. Wellicht 
is het juist essentieel dat een werknemer nadenkt over of hulp nodig is voor het 
oplossen van een probleem en over concrete oplossingen praat die op het werk 
geïmplementeerd kunnen worden. Deze resultaten moeten voorzichtig geïnterpreteerd 
worden omdat maar een klein aantal deelnemers beschikbaar was voor de analyses 
wat de onzekerheid van de resultaten vergroot. 
 
Hoofdstuk 6 biedt een overzicht van belemmerende en faciliterende factoren voor het 
rekruteren van onderzoeksdeelnemers via bedrijfsartsen. Deze studie is uitgevoerd 
omdat minder deelnemers door de bedrijfsartsen werden gerekruteerd voor de 
effectstudie dan geanticipeerd. Het rekruteren van genoeg onderzoeks-deelnemers is 
belangrijk om voldoende statistische power te hebben om verschillen tussen 
studiegroepen te detecteren. De volgende onderzoeksvragen werden onderzocht: 1) 
Welke belemmerende en faciliterende factoren werden door bedrijfsartsen ervaren 
tijdens het rekruteren van deelnemers, en 2) Welke persoonlijke en werkgerelateerde 
karakteristieken van de bedrijfsarts zijn geassocieerd met de rekrutering van 
onderzoeksdeelnemers? Op basis van focusgroepen en interviews met bedrijfsartsen 
werden zes categorieën van belemmerende en faciliterende factoren voor de 
rekrutering van onderzoeksdeelnemers geëxtraheerd: 1) karakteristieken van de studie 
en interventie, 2) karakteristieken van de onderzoekspopulatie, 3) context, 4) aandacht 
van de bedrijfsarts, 5) werkdruk van de bedrijfsarts, en 6) karakteristieken van de 
bedrijfsarts. Deze categorieën (en de onderliggende elementen) kunnen in overweging 
genomen worden door onderzoekers bij het ontwikkelen van toekomstig onderzoek 
waarbij rekrutering van deelnemers afhankelijk is van bedrijfsartsen.  
 De analyse van de relatie tussen persoonlijke en werkgerelateerde karakteristieken 
van de bedrijfsarts en het aantal gerekruteerd deelnemers, liet zien dat het aantal 
bedrijfsartsen in de groepspraktijk van de bedrijfsarts die actief deelnemers 
rekruteerden significant geassocieerd was met het aantal gerekruteerde deelnemers 
door de bedrijfsarts zelf. Oftewel, bij het mobiliseren van bedrijfsartsen voor het 
rekruteren van onderzoeksdeelnemers kunnen onderzoekers zich beter richten op het 
betrekken van hele groepspraktijken in plaats van bedrijfsartsen individueel te 
benaderen.  
 
In Hoofdstuk 7 wordt een economische evaluatie van de SHARP-at work interventie 





kosteneffectiviteitsanalyse (KEA) uitgevoerd. Verschillen tussen de interventie- en 
controlegroep in kosten gerelateerd aan gezondheidszorg en de inzet van de 
interventie/gebruikelijke zorg werden berekend. Daarnaast werden verschillen tussen 
de twee groepen berekend voor de volgende twee effectmaten: 1) incidentie van 
terugval naar verzuim, en 2) duur (in dagen) tot aan (de eerste) terugval naar verzuim. 
De KEA met incidentie van terugval naar verzuim als effectmaat liet zien dat €10.605 
in de interventiegroep nodig was om 1% minder terugval naar verzuim te realiseren ten 
opzichte van de controlegroep. De KEA met duur tot terugval naar verzuim als 
effectmaat liet zien dat €2813 in de interventiegroep nodig was om één dag terugval 
naar verzuim te voorkomen. Een sensitiviteitsanalyse waarbij één extreme outlier in de 
interventiegroep (vanwege psychiatrische ziekenhuisopnames) geëxcludeerd werd, liet 
zien dat de SHARP-at work interventie kosteneffectief was ten opzichte van de 
gebruikelijke zorg; het voorkómen van 1% terugval naar verzuim leidde tot een 
besparing van €533. Een vergelijkbaar resultaat werd gevonden op basis van de 
sensitiviteitsanalyse voor duur tot aan terugval naar verzuim; het voorkómen van één 
dag terugval naar verzuim leidde tot een besparing van €2. Ook in dit geval was de 
interventie dus kosteneffectief ten opzichte van gebruikelijke zorg. 
 Vanuit een werkgeversperspectief werd een kosten-batenanalyse (KBA) uitgevoerd. 
Verschillen tussen de interventie- en controlegroep in kosten gerelateerd aan 
bedrijfsgezondheidszorg (in Nederland betaald door de werkgever) en de 
interventie/gebruikelijke zorg werden berekend. Daarnaast werden verschillen tussen 
de twee groepen berekend in kosten gerelateerd aan productiviteitsverlies. 
Productiviteitsverlies was geoperationaliseerd als kosten voor ziekteverzuim (in 
Nederland ook betaald door de werkgever). De KBA liet zien dat er geen netto monetair 
voordeel behaald werd met de interventie in vergelijking tot gebruikelijke zorg.  
 
In Hoofdstuk 8 worden factoren onderzocht die een terugval naar verzuim kunnen 
voorspellen bij werknemers die teruggekeerd zijn naar het werk na verzuim wegens 
psychische problemen. Gebaseerd op eerder onderzoek werden potentiële voorspellers 
bij alle deelnemers gemeten op baseline en gecategoriseerd in de volgende groepen: 
1) socio-demografische factoren (bv. leeftijd, geslacht), 2) ziektegerelateerde factoren 
(bv. psychische klachten, chronische ziekten), 3) persoonlijke factoren (bv. coping 
gedrag), en 4) werkgerelateerde factoren (bv. aanstellingsduur, bedrijfsgrootte, 
functioneren in werk). Het risico op terugval naar verzuim op 6 en 12 maanden follow-
up was de uitkomstmaat. Op basis van de analyses werden drie voorspellers gevonden: 
een bedrijfsgrootte van meer dan 100 werknemers en conflicten met de 
leidinggevende verhoogden het risico op terugval naar verzuim, terwijl het hebben van 




ernst van (psychische) symptomen waren niet voorspellend voor het risico op terugval 
naar verzuim.  
 
In Hoofdstuk 9 wordt het proefschrift bediscussieerd waarbij de focus ligt op de 
belangrijkste bevindingen, methodologische overwegingen, een reflectie op de 
bevindingen en implicaties voor onderzoek en de praktijk. De conclusie wordt 
getrokken dat de SHARP-at work interventie effectief is in het verminderen van het 
risico op terugval naar verzuim ten opzichte van de gebruikelijke zorg. Bovendien is de 
interventie volgens het protocol uitgevoerd voor de meerderheid van de deelnemers en 
is de interventie goed ontvangen door de bedrijfsartsen en de deelnemers. De 
resultaten van het proefschrift demonstreren dat continue aandacht nodig is voor 
werknemers die teruggekeerd zijn naar het werk na verzuim wegens psychische 
problemen om een duurzame terugkeer te realiseren.  
 Toekomstig onderzoek moet evalueren of de effecten van de SHARP-at work 
interventie ook gevonden worden in andere contexten. Daarnaast moet het effect van 
de interventie geëvalueerd worden voor andere uitkomstmaten dan terugval naar 
verzuim, die relevant zijn voor betrokken partijen (werknemers, leidinggevende, 
werkgevers) zoals het uitvoeren van de taken waarover men afspraken heeft gemaakt 
en de werktevredenheid van de werknemer. 
 Een belangrijke implicatie voor de praktijk van de bedrijfsartsen is dat als de 
SHARP-at work interventie geïmplementeerd wordt, contracten met werkgevers 
uitgebreid moeten worden met de extra consultaties die nodig zijn om de interventie uit 
te voeren. Voor een goede implementatie van de interventie in de praktijk is het 
eveneens belangrijk dat verschillende partijen (bv. werknemers, leidinggevenden, 
werkgevers, bedrijfsartsen, arbodiensten, beleidsmakers en onderzoekers) 
samenwerken om de mogelijke barrières en faciliterende factoren voor implementatie 
















Mijn promotietraject is een tijd van continue ontwikkeling geweest waaraan veel 
mensen een belangrijke bijdrage hebben geleverd. Een aantal mensen wil ik graag in 
het bijzonder bedanken. 
 
Om te beginnen, mijn promotores, prof. dr. Jac van der Klink en prof. dr. Ute Bültmann. 
Regelmatig heb ik mij afgevraagd of er wel een betere samenstelling van promotieteam 
mogelijk zou zijn; ik kan het mij niet voorstellen. Jac, jouw ervaring en deskundigheid 
op het gebied van de bedrijfsgezondheidszorg brachten de praktijk dichtbij wat voor mij 
tot vele nieuwe ideeën heeft geleid. Daarnaast heb ik veel geleerd van de 
interventietrainingen en feedbackmomenten die we samen gegeven hebben. Ik 
bewonder je manier van trainen en kennisoverdracht: rustig, gedegen en met humor. 
 Ute, in mijn ogen ben je een vooraanstaand epidemioloog met een tomeloze passie 
voor wetenschap. Dat maakt dat jij voor mij een bron van kennis bent en tevens een 
rolmodel. Al ruim vijf jaar lang hebben wij ons wekelijkse overleg op dinsdag 9.00 en 
altijd kijk ik er naar uit. Zo’n overleg betekent vooruitgang; wanneer ik jouw deur 
uitloop ben ik altijd weer een stukje wijzer. 
 Jac en Ute, ik voel mij gezegend met de begeleiding die jullie mij de afgelopen vijf 
jaar gegeven hebben. Ik heb veel vrijheid gekregen in het opzetten van het 
promotieonderzoek waarbij de ruwe kantjes aan mijn ideeën met jullie kennis en 
ervaring werden bijgeschaafd en gepolijst. Altijd was er ruimte om zaken te bespreken 
en voor alles is altijd een oplossing gevonden. Bedankt. 
 
De leden van de beoordelingscommissie, prof. dr. A.H. Schene, prof. dr. W.B.  Schaufeli 
en prof. dr. C.M. van der Feltz-Cornelis wil ik hartelijk bedanken voor het kritisch lezen 
en beoordelen van mijn proefschrift. De leden van de begeleidingscommissie, prof. dr. 
A.H. Schene, prof. dr. R.W.B. Blonk, dr. D.J. Bruinvels, dr. R.W.M. Gründemann en dr. B. 
Terluin wil ik bedanken voor de adviserende rol die ze de afgelopen 5 jaar op zich 
hebben genomen.  
 
Er is ook een aantal collega’s en coauteurs waar ik even bij stil wil staan. Jos Verbeek, 
voor mij ben je de absolute “Cochrane-goeroe”. Ik heb veel van je geleerd over het 
uitvoeren van gedegen literatuuronderzoek. Het werkbezoek in Kuopio was een 
geweldige ervaring, waarbij je me zo gastvrij hebt ontvangen en we in één week 
praktisch de hele review afgerond hebben. Ook alle andere Cochrane coauteurs wil ik 
bedanken voor hun hulp bij het schrijven van de review. 
 Michiel de Boer, jouw bijdrage als statisticus kan ook niet onbenoemd blijven. Met 
jou langs de zijlijn om mijn analyses te controleren en adviezen te geven bij problemen 
heb ik veel ervaring opgedaan met multilevel/longitudinale analyses. Roy Stewart, wij 




medisch ethische commissies; het bood me een uitlaatklep en interessante gedachte-
experimenten. Tevens wil ik Henk Groen bedanken voor zijn ondersteuning bij het 
uitvoeren van de economische analyses. Door jouw hulp en heldere uitleg ben ik veel 
wijzer geworden op dit vlak en ligt er nu een mooi artikel. Een ander belangrijk persoon 
is Hanneke Vervoort geweest. Hanneke, ik had me geen betere student-assistent 
kunnen wensen. Jouw daadkracht en organisatietalent hebben mij veel taken uit 
handen genomen en ervoor gezorgd dat we veel vragenlijsten van deelnemers 
ontvangen hebben. Je werkt nu ook terecht als fulltime onderzoeksmedewerker op 
onze afdeling. Je bent gewoon een topper. 
 Now I have to switch to English, as I would like to pay some words of gratitude to my 
two international co-authors. Karina Nielsen, I feel that the knowledge I have gained by 
working with you on the process evaluation has contributed greatly to my development 
as a researcher. It has changed my view on intervention research and made me a 
better researcher. Bill Shaw, you were the instigator for trying to make something 
positive out of the somewhat depressing recruitment problems I was experiencing 
during the intervention study. I have very much enjoyed working with you. You have 
been more than a co-author; you have been a supportive and encouraging mentor. 
 
Mijn promotieonderzoek was nooit geslaagd zonder de hulp van 365/ArboNed en in 
het bijzonder Willem van Rhenen. Willem, jij hebt altijd meegedacht met hoe 365 het 
onderzoek zou kunnen faciliteren. Daarnaast heb je waardevolle input geleverd als 
coauteur van verschillende artikelen. Bedankt voor al je steun. Mijn dank gaat ook uit 
naar alle 154 bedrijfsartsen die meegewerkt hebben aan het onderzoek. Graag wil ik 
Petra Koopmans, Corné Roelen, Giny Norder en Johan de Bruin specifiek noemen voor 
hun hulp bij de dataverzameling, al doe ik daarbij vele anderen tekort die eveneens 
veel tijd en moeite geïnvesteerd hebben in mijn onderzoek.   
 Minstens zo belangrijk als alle bedrijfsartsen die meegewerkt hebben, zijn natuurlijk 
de deelnemers. Zij hebben het mogelijk gemaakt dat er nu, met dit proefschrift, nieuwe 
inzichten verworven zijn op het gebied van duurzame terugkeer naar werk na verzuim 
wegens psychische klachten. Bedankt! 
 
De afgelopen vijf jaar heb ik met veel plezier aan mijn promotieonderzoek gewerkt, wat 
ook zonder meer te danken is geweest aan alle ondersteunende, geïnteresseerde en 
gezellige collega’s van de afdeling Gezondheidswetenschappen. In het bijzonder wil ik 
mijn kamergenoten, Femke en Hardy, bedanken. Femke, er is geen officieel “buddy 
systeem” voor nieuwe promovendi die bij ons op de afdeling komen, maar jij bent al 
5,5 jaar lang mijn buddy; in meerdere opzichten. Hardy, nadat Femke en ik een half 
jaar zonder 3e collega hebben gezeten, kwam jij onze kamer weer aanvullen. Ik weet 




geen “poeha”. Femke en Hardy, ik heb het goed met jullie; respect, vertrouwen, 
erkenning. Het lijkt allemaal zo vanzelfsprekend, maar bedankt voor de fijne werksfeer 
die jullie creëren. 
 
Zonder alle sportieve en sociale ontspanning had ik het hoofd niet boven water 
gehouden. Ik wil al mijn lieve teamgenoten (inclusief staf!) van de selectie van 
Nic./Alfa-College van de afgelopen 4 jaar bedanken voor de mooie jaren die we hebben 
meegemaakt. Het groepsproces, de hoogtepunten en de dieptepunten; het is een 
band, een gevoel, dat ik nergens anders zo ervaren heb. Ik ben blij dat ik het allemaal 
met jullie heb mogen meemaken.  
 Gelukkig wordt er in het korfbal ook nog wel eens een drankje gedronken en een 
feestje gehouden. Voor al die gezelligheid wil ik mijn vele lieve vrienden bij Nic. 
bedanken. Ook met name de gezellige etentjes met Anke, Dirk, Michiel en Linda 
hebben me de laatste maanden veel goed gedaan in de stressvolle eindsprint naar de 
promotie toe. Ik hoop dat we de etentjes erin blijven houden. 
 
Dan naar de kern: mijn lieve familie. De “Arendsen”, de “Holmen”; we staan voor elkaar 
klaar, we gaan samen op vakantie, we hebben zelfs nichten-en-neven-dagen. Het is 
een unieke band die van mij een compleet persoon maakt. En sinds 5 jaar is er ook 
nog een hele lieve schoonfamilie bijgekomen waar altijd de deur open staat en een 
luisterend oor is.  
 Mijn lieve broer Jasper en zijn prachtige gezin, Nancy, Xavier, Diego en Phileine, 
nemen een speciaal plekje in mijn hart in. Jasper, ik bewonder hoe je altijd iedereen 
zich goed laat voelen doordat je zo oprecht geïnteresseerd bent. Je ondernemingsdrift, 
je handigheid; jij kunt je alles eigen maken en dan doen alsof het niets bijzonders is. 
Voor mij ben je in elk geval heel bijzonder. 
 Lieve pap en mam, met jullie is het begonnen en is het zover gekomen . Ik kan 
pagina’s volschrijven over hoeveel jullie voor mij betekenen, maar voor nu houd ik het 
bij het volgende. Ik behoor niet tot het gelukkige percentage mensen dat ervan 
overtuigd is dat zijn/haar ouders de geweldigste ouders van de wereld zijn; ik heb 
gewoon de geweldigste ouders van de wereld. En hoe ouder jullie worden, hoe 
geweldiger ook nog eens. Dus ja, het is niet vreemd dat ik zo ontzettend gelukkig ben.  
 Wil ik nog even afsluiten met mijn lieve Jornt. Ik ben je niet vergeten hoor. Ik heb je 
gevonden en laat je nooit meer gaan: jij, naast wie ik altijd gelukkig wakker word, die 
mij perfect aanvoelt, die mijn zwakke punten accepteert en die precies weet wat ik 
nodig heb. Ook voor jou kan ik pagina’s volschrijven, maar weinig woorden zeggen 
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